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The lysosome is the degradation, recycling, and nutrient sensing center of animal cells. 
The importance of lysosomes has been shown from lysosomal storage diseases, which are 
marked with early onset neuron degeneration at the organism level and impaired lysosome 
functions at cellular level. Additionally, insufficient lysosomal clearance of toxic substances is 
thought to be one major contributing factor to aging-related diseases such as Alzheimer’s disease. 
Therefore, understanding the pathways regulating lysosomal metabolism is of great importance. 
Functions of lysosomes rely heavily on the membrane trafficking. Lysosomes travel 
directionally in cells to their destinations, where they undergo membrane fusion or membrane 
fission. The major aim of my doctoral work is to identify major pathways regulating lysosome 
membrane trafficking. I aimed to investigate regulators of the directional movement and the 
membrane fission of lysosomes, and identified TRPML1, a lysosomal cation channel, as a major 
regulator of both processes. I found that TRPML1 is responsible for the perinuclear 
accumulation of lysosomes under acute conditions such as autophagy induction and cytosolic 
alkalization. In this process, activation of TRPML1, which requires the lysosomal 
phosphoinositide PI(3,5)P2, leads to the release of Ca2+ into the cytosol. This in turn recruits a 
Ca2+ effector protein, ALG-2, to the lysosomal membrane through its Ca2+-dependent interaction 
with TRPML1. ALG-2 is associated with the dynactin complex, the adaptor for cytoplasmic 
dynein, and thus promotes microtubule minus-end directed motility of lysosomes. 
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My data also showed that hyper-activity and hypo-activity of TRPML1 both lead to the 
abolishment of lysosome tubulation, a process necessary for the lysosome membrane fission, and 
suggested that this is due to the disruption of the balance between the plus-end and the minus-
end motility of lysosomes. I have also found that one major contributor to the dysfunctional 
lysosome membrane trafficking in lysosome storage disease cells is the accumulation of 
lysosomal cholesterol, which constitutively promotes the perinuclear accumulation of lysosomes 
that disrupts lysosomal membrane trafficking. These findings can greatly advance our 
understanding about the membrane trafficking mechanisms of lysosomes, and may proof 
valuable towards the development of treatment for lysosome storage disease patients.  
Additionally, I generated and characterized a genetically encode fluorescent probe for 
PI(3,5)P2, and showed that it could detect the subcellular localization and dynamics of the lipid 
in living cells. This gives the probe a huge advantage over conventional methods of detecting 






1.1 Overview of Endo-lysosomal membrane trafficking 
1.1.1 Introduction to the endocytic membrane trafficking system 
Imagine that all modern methods of logistics and transportations are gone: no 
supermarkets to gather goods from all over the world for you to purchase; no flights and trains 
to take you to places hundreds or thousands of miles away; no garbage truck to pick up your 
garbage and you have to deal with trash you generate each day. Feel like being thrown back to 
Stone Age? That’s how important logistics and transportations are to our life. 
In eukaryotic cells, the endocytic membrane trafficking system is responsible for the 
logistics and transportation of things inside the cell. Endocytic vesicles take up nutrients and other 
substances from outside of the cell, break them down to basic molecules like amino acids and 
monosaccharides, and release them into the cytosol for energy production or synthesis of cellular 
components. Endocytic vesicles also transport cellular substances between places inside the cell. 
Moreover, many unwanted or damaged cellular components are broken down and recycled in 
endocytic vesicles. All these processes are essential for the cell to maintain its highly
                                                          
1 Parts of this Chapter, including Fig. 1.1 and 1.2, were originally published in Journal of 




organized status. Therefore, the endocytic trafficking system is crucial to the survival of 
eukaryotic cells.  
The endocytic pathway generally begins with a process called endocytosis, in which a 
piece of membrane from the plasma membrane of the cell gets internalized and forms a 
membrane-bound vesicle that contains the initial cargo (Marsh and McMahon 1999). Depending 
on the nature of their generation, newly formed endocytic vesicles can be sorted into three major 
categories: macropinosomes (which are generated non-specifically and simply take up 
extracellular fluids) (Lim and Gleeson 2011), endosomes (which are generated through 
activation of receptors on the plasma membrane by small particles, including clathrin-mediated 
endocytosis (McMahon and Boucrot 2011) and caveolae (Parton and del Pozo 2013)), and 
phagosomes (which are generated through activation of receptors on the plasma membrane by 
large particles such as bacteria or cell debris) (Flannagan, Jaumouille et al. 2012). Among the 
three types of vesicles, phagosomes are generally only present in immune cells. 
After budding off from the plasma membrane, nascent endocytic vesicles quickly mature 
into early endosomes through the acquisition of early endosome markers and the clearance of 
plasma membrane markers (the identities of which are to be discussed below). Early endosomes 
are the first stop in the endocytic pathway. At this stage, endosomes undergo a major sorting 
process, through which membrane-bound plasma membrane proteins such as receptors are 
recognized and sorted on tubular structures that protrude out from early endosomes, and recycled 
back to the plasma membrane through small vesicles called recycling endosomes that bud off 
from the tubular structures (Grant and Donaldson 2009, Hsu and Prekeris 2010) (Fig. 1.1).  
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The early endosomes, after sorting out the reusable components, now contain cargos 
destined for delivery to the lysosomes. Endosomes then undergo acidification of the lumen, 
which is carried by the vesicular ATPase (V-ATPase) that pumps proton from the cytosol to the 
lumen (Nelson and Harvey 1999). During this period, membrane-bound cargos are sorted into 
the lumen through the sequential action of a series of protein complexes named ESCRT–0, –I. –
II, and –III, respectively (Schmidt and Teis 2012). ESCRT stands for the Endosomal Sorting 
Complexes Required for Transport, and the protein complexes work together to sort membrane-
bound cargos into small inward protrusions of the endosomal membrane, and finally bud the 
piece of membrane off into the lumen (Schmidt and Teis 2012). This results in small vesicles 
(known as intraluminal vesicles, or ILV) generated inside the lumen of endosomes. Endosomes 
carrying multiple ILVs are known as multi-vesicular bodies (MVB) (Babst 2011), also more 
commonly referred to as late endosomes (Fig. 1.1). 
Maturation of late endosomes to lysosomes involves further acidification of the lumen 
(from an average pH of 5.5-6 in late endosomes to pH of 4.5 in lysosomes), as well as the 
acquisition of the hydrolytic enzymes. Hydrolytic enzymes are acquired from transport vesicles 
originated from the Golgi complex, or from direct fusion with an existing lysosome (Braulke and 
Bonifacino 2009) (Fig. 1.1). The acidic luminal pH activates the enzymes and breaks down 
cargo macromolecules to single building blocks (amino acids, monosaccharides, unesterified 
lipids, etc.) for reutilization. 
Finally, lysosomes can undergo a process called exocytosis, during which lysosomes fuse 
with the plasma membrane, and release their luminal content into the extracellular space. 
Additionally, lysosomes can undergo a recycling process called lysosome reformation, during 
which lysosomes, similar to early endosomes, form tubular structures, and small vesicles 
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containing lysosomal membrane proteins and lipids bud off as “proto-lysosomes” and thus 
recycle the material from consumed lysosomes (Yu, McPhee et al. 2010) (Fig. 1.1). 
Aside from the main stem, there are multiple branches on the endocytic pathway 
involving communication with other intracellular organelles.  
Late endosomes and lysosomes (collectively LELs) acquire their luminal enzymes, as 
well as new supplies of membrane proteins from the Golgi complex. Newly synthesized 
membrane proteins and luminal enzymes are sorted in Golgi into transport vesicles, and then 
transported to LELs (Braulke and Bonifacino 2009). Upon arrival, the luminal enzymes are 
released into the LELs due to the acidic luminal pH. 
Lysosomes also retrogradely transport materials back to the Golgi complex through 
lysosome-derived transport vesicles (Braulke and Bonifacino 2009). These materials include 
receptors for transporting luminal enzymes, and lipids that are to be processes in the Golgi or ER.  
Autophagosomes are a special type of double membrane-bound organelles. During 
cellular starvation or upon organelle damage, autophagosomes are generated to wrap up the 
materials (proteins or organelles) destined for degradation, and deliver them to the lysosomes 
(Mizushima and Komatsu 2011). Besides autophagosomes, cytosolic materials can also be 
delivered to lysosomes directly through chaperone-mediated autophagy (Kaushik and Cuervo 
2012). 
 




Endocytic membrane trafficking, as depicted above, involves multiple steps, and multiple 
conversions of a vesicle’s identity. As there are processes specific to each state, the vesicles must 
be able to correctly identify themselves to avoid trafficking processes happening on the wrong 
vesicles. Additionally, endocytic trafficking is a sequential process, in which trafficking events 
must be coordinated in a temporally sequential way, thus requiring a mechanism through which 
different steps can be turned on in a sequential manner. 
Through the years of evolution, animal cells have developed an efficient system to “shoot 
two birds with one stone”. Two complementary yet cooperating methods are adopted by cells to 
correctly label the vesicle identities and regulate sequential trafficking steps at the same time. 
Firstly, intracellular vesicles, as well as the whole cell, are bound by membrane bilayers. 
One species of membrane lipid called phosphoinositides localize to the cytosolic side of the 
membranes and serve as identity marker for the vesicles (Di Paolo and De Camilli 2006). 
Phosphoinositides are generated by the phosphorylation of phosphatidylinositol at the 3’, 4’, and 
5’ positions of the inositol ring. Depending on the position of the phosphorylation, there are 
seven kinds of phosphoinositides: PI(3)P, PI(4)P, PI(5)P, PI(3,4)P2, PI(3,5)P2, PI(4,5)P2, and 
PI(3,4,5)P3.  
Different endocytic compartments contain different phosphoinositides to aid their 
identification. Phosphatidylinositol is phosphorylated in the Golgi complex to PI(4)P, which 
determines the identity of the secretary vesicles destined for the plasma membrane (Santiago-
Tirado and Bretscher 2011). Plasma membrane mainly contains PI(4)P and its derivative, 
PI(4,5)P2. Many plasma membrane integral proteins are modulated by PI(4)P and/or PI(4,5)P2, 
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and many plasma membrane associated proteins are localized to the plasma membrane through 
the recognition of PI(4)P or PI(4,5)P2 (Falkenburger, Jensen et al. 2010). 
Upon endocytosis, the membrane PI(4)P and PI(4,5)P2 are quickly turned over by 
phosphatases, and PI(3)P is quickly generated through class III phosphatidylinositol-3-kinase 
(PI3K-III) (Poccia and Larijani 2009). PI(3)P is the major phosphoinositide present on early 
endosomes, and is required for the rapid recruitment of many early endosome proteins such as 
EEA1 and hrs (Poccia and Larijani 2009). The appearance of PI(3)P on endosomes initiates the 
maturation of early endosomes. EEA1 is a tethering protein facilitating the fusion between early 
endosomes (Simonsen, Lippe et al. 1998), and hrs is responsible for the initiation of the ESCRT 
pathway that leads to the generation of ILVs and the progression to late endosomes (Sun, Yan et 
al. 2003, Hurley 2010). Another protein, PIKfyve, which is the kinase responsible for the 
conversion from PI(3)P to PI(3,5)P2, is also recruited to early endosomes by PI(3)P (Sbrissa, 
Ikonomov et al. 2002). 
PIKfyve is a phosphatidylinositol-5-kinase that converts PI(3)P to PI(3,5)P2, and PI to 
PI(5)P, two phosphoinositides that mark late endosomes and lysosomes. PI(5)P is less well-
studied with very few known effectors (Vicinanza, Korolchuk et al. 2015). PI(3,5)P2, on the 
other hand, has been shown to regulate the activity of several proteins important for LEL 
functions. For example, Vps24p (CHMP3 in mammals) has been shown to be an effector of 
PI(3,5)P2 to mediate the last steps of ILV formation (Whitley, Reaves et al. 2003). Also, two 
LEL cation channels, TRPML1 (Transient Receptor Potential MucoLipin 1) (Dong, Shen et al. 




Similar to endosomes, phagosomes and autophagosomes are both labeled with PI(3)P, 
and acquire PI(3,5)P2 as they mature into phagolysosomes or autolysosomes (Poccia and Larijani 
2009). 
Therefore, phosphoinositides represent a labeling system that serves regulatory functions 
for endocytic trafficking. Vesicles destined to fuse with the plasma membrane (secretary vesicles 
and recycling endosomes) are generally labeled with PI(4)P, while vesicles destined to fuse with 
LELs are generally labeled with PI(3)P. A series of kinases and phosphatases are responsible for 
the conversion between different phosphoinositide species. 
Apart from phosphoinositides, cells have developed a complementary system to 
coordinate the functions of different organelles along the endocytic trafficking pathway. Ras 
small GTPases are a superfamily of proteins serving a variety of cellular functions. Among the 
Ras proteins, several sub-families are known to regulate endocytic trafficking, with the Rab and 
Arf families being the most studied (Mizuno-Yamasaki, Rivera-Molina et al. 2012). Rab proteins 
are mainly involved in coordinating sequential endocytic events, while Arf proteins typically 
regulate vesicle budding. Rab proteins are the largest subfamily of the Ras GTPases, consisting 
of over 60 members in human (Rojas, Fuentes et al. 2012, Pfeffer 2013).  
Small GTPases participate in marking membrane identity and in regulating membrane 
trafficking events through association with specific membranes (Pfeffer 2013). Small GTPases 
like Rabs and Arfs transit between two states: a GTP-bound, active state and a GDP-bound, 
inactive state. Small GTPases acquire the GTP molecule through the action of helper proteins 
called Guanine nucleotide exchange factors (GEF). When associated with GTP, small GTPases 
localize onto specific membranes and regulate the activity and/or localization of downstream 
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effectors (Blumer, Rey et al. 2013). After finishing the job, the GTPase activity of small 
GTPases can be turned on by GTPase-activating proteins (GAP), and GTP is thus converted to 
GDP to terminate the action (Stenmark 2009). 
The timed association of small GTPases onto the vesicular membranes thus determines a 
variety of spatiotemporally regulated membrane trafficking events. For example, two tethering 
factors facilitating vesicular fusion, EEA1 and HOmotypic fusion and Protein Sorting complex 
(HOPS) are recruited by Rab5 to early endosomes and by Rab7 to late endosomes, respectively 
(Yu and Hughson 2010). 
Ca2+ is a versatile regulator for many cellular processes. Ca2+ signaling is known to occur 
on a variety of spatial and temporal manners. The Endoplasmic Reticulum (ER)/Sarcoplasmic 
Reticulum (SR) has been considered as the major intracellular source of Ca2+, and ER/SR Ca2+ 
release has been shown to signal important cellular functions, including muscle contraction and 
activation of signaling cascades downstream of G proteins. In recent years, however, the 
lysosome began to be appreciated as an additional Ca2+ store of the cell (Morgan, Platt et al. 
2011). After endocytosis, early endosomes gradually lose their luminal Ca2+ as they undergo 
acidification, but then regain high luminal Ca2+ as they mature into lysosomes, likely through 
lysosome-ER contacts (Kilpatrick, Eden et al. 2013, Lopez-Sanjurjo, Tovey et al. 2013). 
The importance of lysosomal Ca2+ in regulating lysosomal membrane trafficking, 
especially membrane fusion events, has been suggested in multiple studies (Samie, Wang et al. 
2013, Cheng, Zhang et al. 2014, Dayam, Saric et al. 2015). It is generally agreed that Ca2+ plays 
a role in lysosomal membrane fusion events, including lysosome exocytosis, in a manner similar 
to its role in regulating synaptic vesicle release (Fig. 1.2) (Andrews and Chakrabarti 2005, 
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Cheng, Zhang et al. 2015). In neurons, synaptic vesicles are docked to the plasma membrane at 
the synapse. Action potential opens voltage gated Ca2+ channels at the synapse, leading to a rapid 
increase (within 1 ms) in the local Ca2+.  Synaptotagmin, a class of Ca2+-binding membrane 
proteins, sense the increased [Ca2+] and trigger the fusion between synaptic vesicle and the 
plasma membrane through interaction with the Soluble N-ethylmaleimide-sensitive fusion 
Attachment protein Receptor (SNARE) complex. It has been shown by multiple groups that 
Synaptotagmin VII, a member of the Synaptotagmin family, is involved in the regulation of 
lysosome exocytosis (Czibener, Sherer et al. 2006, Idone, Tam et al. 2008, Samie, Wang et al. 
2013). 
Apart from Synaptotagmin VII, multiple Ca2+ sensors have been suggested to regulate 
endolysosomal signaling events, including calmodulin (Peters and Mayer 1998), calcineurin 
(Medina, Di Paola et al. 2015), and ALG-2 (Vergarajauregui, Martina et al. 2009). However, 
most evidences remained inconclusive, leaving the role of Ca2+ in regulating endolysosomal 
membrane trafficking unconsolidated. 
 
1.1.3 The importance of endocytic trafficking to the cell 
The endocytic system, as described above, is a complicated network that requires the 
coordination of many factors and events. Thanks to Darwin, we now know that organisms tend 
to find the best way over the long years of evolution. Therefore, if the functions of the endocytic 
trafficking system do not require such a complicated pathway, it would already have been 
replaced by a much simpler pathway. Throughout the evolution, the components of the endocytic 
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system remained highly conserved, between organisms as far apart as human and yeasts, 
suggesting that all these components are required for proper cell functions. 
So, why do we need such a complicated system for our cells? Let’s take a more detailed 
look at what the endocytic membrane trafficking system does for the cell. 
One of the best defined roles for the endocytic trafficking system is to degrade unwanted 
materials and recycle them. Lysosomes contain hydrolytic enzymes that are able to hydrolyze 
molecules delivered to them, including polypeptides, polysaccharides and esterified lipids. The 
products of the hydrolysis are monomer building blocks (e.g. amino acids) of biomolecules that 
can be re-utilized by the cell. These small molecules are then released into the cytosol through 
specific transporters. In this way, the cell recycles much of its waste in a highly efficient manner. 
Additionally, extracellular macromolecules, or sometimes even larger substances like bacteria or 
cell debris (in the case of phagocytosis), can also be degraded into building blocks through the 
endocytic pathway. Therefore, endocytic trafficking not only represents a recycling system at 
cellular level, but also at the organism level. 
In addition to cargo degradation, studies in recent years have shown a central role of 
lysosomes in nutrient sensing and cellular growth control. The mechanistic Target of Rapamycin 
(mTOR) is a serine/threonine kinase that serves as the master regulator of cell growth from yeast 
to humans. mTOR exist in two different complexes, mTORC1 and mTORC2. mTORC1 is the 
complex responsible for sensing the nutrient availability and extracellular growth signals to 
control the cellular growth in response to environmental cues.  
It has been shown that the activation of mTORC1 requires activation from a small 
GTPase called Rheb that resides on lysosomal membranes (Buerger, DeVries et al. 2006, Menon, 
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Dibble et al. 2014). Therefore, mTORC1 needs to translocate to the lysosome for its proper 
activation. The translocation of mTORC1 onto the lysosome has been shown to require a protein 
complex named Ragulator (Sancak, Bar-Peled et al. 2010). Rheb is only active when stimuli 
from growth factors are present (Menon, Dibble et al. 2014), while Ragulator only recruits 
mTORC1 to lysosome membranes when abundant amino acids are present (Sancak, Bar-Peled et 
al. 2010). Therefore, the cooperation between Rheb and Ragulator ensures that mTORC1 only 
activates cellular growth when there is enough material (amino acids) and when it is instructed to 
do so (growth factors). Interestingly, several studies have shown that the recruitment of 
mTORC1 onto the lysosome requires amino acids originating from the lysosome lumen, but not 
from cytosol. When lysosomes have low amino acid contents, mTORC1 does not get activated 
regardless of cytosolic amino acids (Zoncu, Bar-Peled et al. 2011). Thus, lysosomes not only 
provide a platform, but also actively participate in regulating cellular growth. 
Apart from the roles on cellular recycling and nutrient sensing, endocytic trafficking also 
plays important roles in other aspects. For example, the activity of multiple plasma membrane 
receptors and channels/transporters is regulated through endocytosis and exocytosis, through 
which the amount of protein on the cell surface can be quickly adjusted according to cellular 
needs. Also, multiple substances, including hydrolytic enzymes and ATP, are shown to be 
purposely released into the extracellular environment through lysosome exocytosis (Czibener, 
Sherer et al. 2006, Sivaramakrishnan, Bidula et al. 2012). 
The importance of endocytic trafficking, especially the function of lysosomes, has been 
proved by various lysosome storage diseases (LSDs). Lysosome storage diseases are caused by 
mutations in endocytic proteins, including lysosomal hydrolytic enzymes, specific transporters, 
key regulators of vesicle transport/fusion/fission, key regulators of cargo recognition/sorting, etc. 
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The dysfunction of these proteins leads to the accumulation of substances within the endocytic 
system, especially in the lysosomes (Pagano, Puri et al. 2000, Yanagawa, Tsukuba et al. 2007, 
Samie and Xu 2014). More often than not, the accumulation of a substance (e.g. a particular lipid) 
affects the endocytic pathway, leading to the secondary dysfunction of multiple proteins, and 
secondary accumulation of other substances. Because of this, most LSDs would end up with 
accumulation of a similar spectrum of substances (Pagano, Puri et al. 2000, Yanagawa, Tsukuba 
et al. 2007, Samie and Xu 2014).  
A common symptom shared by LSDs is early onset of severe neurodegeneration. The 
existence of long neurites means that neurons have very high requirement for endocytic transport 
through long distances. Also, neurons are terminally differentiated, non-dividable cells, therefore 
rely heavily on cellular clearance systems to maintain their health. Many LSD patients are also 
accompanied with motor/vision defects. Due to their severe phenotypes, most LSD patients 
unfortunately face early deaths. 
Except for LSDs, which are caused by primary dysfunction of certain genes regulating 
the endocytic pathway, much more common chronical diseases, including Alzheimer’s Disease 
and Parkinson’s Disease, are shown to be related with hypofunction of the lysosomal degradative 
pathway (Lee, Yu et al. 2010, Follett, Norwood et al. 2014, Erie, Sacino et al. 2015). Normally, 
intracellular and extracellular toxic materials are degraded through autophagy and phagocytosis, 
respectively. Under diseases conditions, abnormal amounts of toxic materials accumulate in the 
body, exceeding the ability of self-clearance. Thus, up-regulation of the endocytic pathway may 




1.2 Lysosomal membrane trafficking: purposes, events, and regulators 
1.2.1 Lysosome plays a central role in the endocytic membrane trafficking 
Among the many different types of endocytic vesicles, lysosomes play a central role in 
the coordination of the endocytic membrane trafficking. As described above, the endocytic 
system contains multiple routes, with vesicles emerging from endocytosis, phagocytosis, or 
autophagy. Except for recycling endosomes, which contain membrane proteins to be delivered 
back to the plasma membrane, all endocytic vesicles are eventually delivered to lysosomes. 
These fusion vesicles are often times named after their origin, such as endolysosomes, 
phagolysosomes, and autolysosomes. 
Lysosomes determine the fate of substances delivered to them. Polypeptides, for example, 
are broken down to amino acids by cathepsins, and then transported across lysosome membrane 
into the cytosol through amino acid transporters (Sagne, Agulhon et al. 2001, Boll, Foltz et al. 
2002). Digestible polysaccharides are also broken down to monosaccharides, as well as 
RNA/DNA to single nucleotides. Each of these molecules are thought to be transported out of 
lysosomes through specific transporters. Lipids, on the other hand, are unesterified by esterases, 
delivered onto the lysosomal membrane, and then transported out of lysosomes (mainly to the 
Golgi apparatus) on transport vesicles (Pagano, Martin et al. 1991), or through direct membrane 
contact with other organelles (Chu, Liao et al. 2015).  
Except for releasing hydrolysis products, lysosomes can also deliver substances to the 
extracellular space through exocytosis. This function has been shown to play roles in cell 
migration (Colvin, Means et al. 2010) and transmitter release (notably ATP) (Shin, Lee et al. 
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2012). Thus, through accepting materials and redistributing them, lysosomes serve as the 
recycling and soring center for the cell. 
 
1.2.2 Trafficking events on the lysosome – motility, fusion, and fission 
The roles of lysosomes determine that they undergo heavy trafficking in cells. Like other 
membrane-bound organelles, researches on lysosomal trafficking have been focused on three 
aspects: the directional movement of lysosomes, and the fusion and fission of lysosome 
membranes (Fig. 1.3). 
In order to meet with cargo vesicles, or to fulfill particular purposes such as exocytosis, 
lysosomes have to travel inside the cells in a directed manner. Such movements are mostly 
carried out through microtubule-based motor proteins (Rosa-Ferreira and Munro 2011, Tan, 
Scherer et al. 2011), although actin-based short range movements also contribute to movements 
close to the plasma membrane (Hissa, Pontes et al. 2013) (Fig. 1.3, brown arrows).  
Most microtubules inside the cells exhibit a radial pattern, with their minus-ends 
clustering at the microtubule organizing center (MTOC), which is usually located very close to 
the cell nucleus, and their plus-ends stretching out to the cell periphery (Brinkley 1985). 
Therefore, the directional movement of lysosomes along microtubules determines their location 
inside the cells. The localization of lysosomes is often described as “perinuclear” or “juxta-
nuclear” when they are close to the nucleus or “peripheral” when they are away from the nucleus. 
There is a good reason for such classifications, as researchers have found an interesting 
relationship between the “perinuclearity” (i.e the degree of proximity to the nucleus) of 
lysosomes and cellular behaviors. It has been shown that lysosomes undergo somewhat 
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synchronized perinuclear movement when the cell undergoes acute starvation, i.e. depletion of 
extracellular nutrient/growth factors (Yu, McPhee et al. 2010, Korolchuk, Saiki et al. 2011). This 
is hypothesized to promote the fusion between lysosomes and autophagosomes, the generation of 
the latter triggered by acute starvation (Yu, McPhee et al. 2010, Korolchuk, Saiki et al. 2011). 
This hypothesis is supported by the finding that the microtubule minus-end directed motor the 
dynein complex is required for the sufficient delivery of autophagic contents to the lysosomes 
(Kimura, Noda et al. 2008, Xu, Li et al. 2013). Additionally, it is often noticed that within the 
same cell, perinuclear lysosomes are generally enlarged compared to peripheral lysosomes, 
indicating that these lysosomes have merged with other vesicles (Yu, McPhee et al. 2010, 
Korolchuk, Saiki et al. 2011). 
Once reaching the destination, lysosomes will carry out their function, usually through 
membrane fusion with other vesicles (Fig. 1.3, green arrows), or with the plasma membrane 
(Fig. 1.3, blue arrow). As mentioned above (1.1.2), Ca2+-regulated, SNARE-mediated 
membrane fusion machinery has been proposed to be responsible for lysosomal fusion events. To 
prepare for the fusion event, the lysosome would first get into contact with the target membrane 
through tethering factors. Tethering factors determine the specificity of membranes in contact, 
and thus determine the specificity of the membrane fusion.  
The lysosomal tethering complex, HOPS (Solinger and Spang 2013), was first 
characterized in yeast, and best studied for its role in promoting the fusion between yeast 
vacuoles, the counterpart of lysosomes in yeasts. Loss of HOPS complex components leads to 
fragmented vacuoles in yeast, suggesting their important roles in vacuole fusion (Wickner 2010). 
HOPS complex is able to associate with Ypt7 (or in mammals Rab7), as well as members of the 
SNARE complex (Solinger and Spang 2013). It has been shown that HOPS interacts with 
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specific trans-SNARE complex to facilitate the vesicle fusion, and inhibits fusion with incorrect 
SNARE combinations (Collins and Wickner 2007, Starai, Hickey et al. 2008). Therefore, HOPS 
interacts with the Rab protein to ensure its localization onto the correct membrane, tether the 
membranes and promote fusion with correct vesicles through specific recognition of the correct 
SNARE.  
The fusion of the membranes is proposed to be carried out in a similar fashion as the 
synaptic vesicle release. The importance of the SNARE complex and the Ca2+ sensor 
synaptotagmin VII for lysosomal membrane fusion has been shown in studies using knockdown 
assays as well as dominant negative forms of these proteins (Czibener, Sherer et al. 2006, Idone, 
Tam et al. 2008, Samie, Wang et al. 2013). The best characterized membrane fusion event 
involving lysosomes is lysosomal exocytosis. This is mainly due to technical limitations. Where 
lysosomal exocytosis can be easily monitored through assaying luminal enzyme release, increase 
of plasma membrane capacitance, or surface labeling of lysosomal membrane proteins on the 
plasma membrane due to exocytosis, the membrane fusion between lysosomes and other 
organelles is not directly accessible to extracellular measurements, with the additional 
complication of the similarities between late endosomes, primary lysosomes (lysosomes not 
fused with cargo vesicles yet), secondary lysosomes (lysosomes already accepted cargo), etc.  
In lysosomal exocytosis, it is now clear that local Ca2+ plays an important role, i.e. the 
Ca2+ required for the exocytosis comes directly from the lysosomes per se, but not from other 
sources (Czibener, Sherer et al. 2006, Idone, Tam et al. 2008, Samie, Wang et al. 2013). Multiple 
reports suggest that the Ca2+ is released through a lysosomal ion channel called TRPML1 
(Transient Receptor Potential MucoLipin 1) (Samie, Wang et al. 2013, Cheng, Zhang et al. 2014). 
In proposed models, lysosomes are tethered and docked to the target membrane prior to fusion. 
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When the final signal arrives (e.g. for macrophages, when phagocytosis is initiated), TRPML1 
releases Ca2+ from lysosome lumen, which is immediately picked up by synaptotagmin VII. 
Synaptotagmin VII then binds to the SNARE complex and triggers fusion between the lysosome 
and the plasma membrane (Fig. 1.2). The fusion between lysosomes, or between lysosomes and 
other vesicles, likely occurs in a similar fashion. 
After fusion with other vesicles, the total surface area as well as the volume of lysosomes 
will increase, resulting in enlarged lysosomes. This is most observable during autophagy or 
phagocytosis. In healthy and fed cells, normal lysosome sizes range from 100 nm to up to 0.5-1 
μm as determined by confocal and super-resolution microscopies (Fig. 1.4). During active 
autophagy (e.g. starvation) or phagocytosis, the fusion of lysosomes with much larger cargo 
vesicles (usually 0.5-3 μm for autophagosomes, and up to 5-10 μm for phagosomes depending 
on the particle size) results in large secondary lysosomes usually found at the perinuclear region 
of the cells (Yu, McPhee et al. 2010, Samie, Wang et al. 2013). Recent studies on lysosome 
reformation regarded these lysosomes as consumed lysosomes, since they are occupied by the 
large quantities of cargo and are not available for providing more digestive forces (Yu, McPhee 
et al. 2010, Rong, Liu et al. 2012). As autophagy and phagocytosis require large quantities of 
lysosomes for digestion, the cell will run short of primary lysosomes very quickly in these 
circumstances, and accumulate enlarged secondary lysosomes. To ensure the proper homeostasis 
of lysosome number and size, membrane fission takes place on these lysosomes (Yu, McPhee et 
al. 2010, Rong, Liu et al. 2012, Chen and Yu 2013). 
Not much is known about lysosome membrane fission for many years. Works from the 
last five years or so demonstrated that lysosome membrane fission resembles that of the budding 
off of recycling endosomes from sorting tubules on early endosomes (1.1.1). Specifically, 
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lysosomes will generate tubular structures that protrude from the vesicular part, which will be 
referred to as lysosome tubulation hereafter (Chen and Yu 2013). Membrane fission will take 
place on these tubules through clathrin-mediated membrane budding, the mechanism used for 
endocytosis (Rong, Liu et al. 2012). The vesicle that buds off is proposed to serve the purpose of 
recycling lysosomal membrane lipids and proteins for the generation of new primary lysosomes 
(Fig. 1.3, purple arrow). 
Lysosome tubulation and fission (also named lysosome reformation) may happen at a low 
rate under basal conditions, but is most prominent under conditions of heavy lysosome 
consumption (Chen and Yu 2013). Interestingly, the phenomenon of lysosome tubulation in 
macrophages actively undergoing phagocytosis was reported a long time ago (Swanson, 
Bushnell et al. 1987), but was not linked to lysosome reformation until similar tubulation events 
were characterized during prolonged starvation conditions. Judged by the similarity between 
them, lysosome reformation under phagocytosis and prolonged starvation may share the same 
mechanism. However, as described below, our understandings on both phenomena are 
insufficient to draw conclusion on this point yet. 
Since first characterized in 2010, several aspects of lysosome reformation have been 
characterized, but more remained unclear. It seems that the reformation process, especially the 
generation of the tubular structure, is a quite delicate process. Hyper- or hypo-function of many 
proteins, or even lipids, can lead to the disruption of the reformation process. Conversely, many 
LSD cells show enlarged lysosomes, an indication of defective lysosome membrane fission. 
 
1.2.3 The key regulators coordinating lysosome membrane trafficking 
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The coordination of lysosomal trafficking events would require precise regulation. 
Transport of lysosomes to the right place is a prerequisite for the membrane contact with cargo 
vesicles, and membrane fission should not take place until after the fusion with the cargo vesicle. 
The timing of these events, as mentioned above (1.1.2), can be coordinated through 
phosphoinositides, small GTPases, and Ca2+.  There are also other important regulators required 
for different aspects of lysosome trafficking. Below let’s take a look at some of the key 
regulators of lysosomal trafficking events. 
Motor proteins 
Motor proteins are a class of ATPases that convert energy from ATP hydrolysis to kinetic 
energy represented as directional movement (Reilein, Rogers et al. 2001). Motor proteins are 
commonly sorted into three families: dyneins, kinesins and myosins. Among the three families, 
dyneins and kinesins are microtubule-based, while myosins move along actin filaments. Since 
most of the directional movements of lysosomes are carried along microtubules, dyneins and 
kinesins are the main players in lysosome trafficking. 
Dyneins are huge protein complexes able of driving cargo movements towards the minus-
ends of microtubules, which are usually present at the MTOC close to the cell nucleus. Based on 
their locations, dyneins are separated into two groups, cytoplasmic dyneins and axonemal 
dyneins, the latter usually found in neurites, cilia and flagella (King 2000). Two types of 
cytoplasmic dynein exist, with cytoplasmic dynein 1 responsible for the retrograde transport of 
most intracellular vesicles, including lysosomes (Schiavo, Greensmith et al. 2013). Cytoplasmic 
dynein 1 is a protein complex of about 1.5 MDa consisting of a homodimer of two dynein heavy 
chains (DHC), each of an enormous ~530 kDa size in mammals, a pair of intermediate chains 
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(DIC), a pair of light-intermediate chains (DLIC), and a total of six light chains (DLC) (Kardon 
and Vale 2009, Schiavo, Greensmith et al. 2013). Heavy chains are responsible for the 
association with microtubules, power generation through ATP hydrolysis, and scaffolding 
intermediate chains and light chains. Intermediate chains are the main site for cargo adaptation, 
although some cargo adaptors also bind to heavy chains or light chains (Kardon and Vale 2009, 
Schiavo, Greensmith et al. 2013).  
Lysosomes do not recruit the dynein complex directly, but rather through another huge, 
1.2 MDa adaptor complex called dynactin (Schroer 2004). Dynactin is a multi-subunit complex, 
its most obvious structures under electron microscope (EM) feature a ~40 nm long rod-like 
structure consisting of polymerized actin-related protein Arp1, and a projection arm composed of 
a dimer of the p150glued protein (Schroer 2004). The Arp1 rod resembles actin filament and is 
responsible for the interaction with β-spectrin on cargo vesicles, while the p150glued arm 
associates with the intermediate chain of the dynein complex. Additional proteins, such as 
dynamitin (p50) and p62, are also present for scaffolding, structure stability, and cargo 
recognition (Schroer 2004).  
Dynactin has been shown to bridge lysosomes and dynein through the recruitment by the 
Rab7 effector, Rab7-Interacting Lysosomal Protein (RILP) (Jordens, Fernandez-Borja et al. 
2001), and the lysosomal cholesterol sensor Oxysterol-binding protein Related Protein 1L 
(ORP1L) (Johansson, Rocha et al. 2007). RILP interacts with the C-terminal of p150glued, while 
ORP1L is responsible for the association of dynactin to lysosomal spectrin to activate retrograde 
transport (Johansson, Rocha et al. 2007). Therefore, lysosomes achieve retrograde transport 
towards the MTOC through the recruitment of dynactin (by lysosomal adaptors), which in turn 
recruits the dynein complex. 
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Contrary to dyneins, which exist in huge complexes, the plus-end directed motor proteins, 
kinesins, are much smaller in size. Kinesins are a large protein family with diverse protein 
structures, but all containing a kinesin motor domain, and most of them contain coiled-coil 
domains for dimerization (Verhey and Hammond 2009). 14 kinesin subfamilies have been 
characterized so far, with most kinesins move the cargo towards the plus-end of microtubules, 
except for the kinesin-14 subfamily (and a kinesin-5 member Cin8) (Verhey and Hammond 2009, 
Roostalu, Hentrich et al. 2011). 
Kif5B, a member of the kinesin-1 subfamily, is ubiquitously expressed in all tissues and 
is generally considered as the main kinesin motor responsible for the plus-end motility of 
endocytic vesicles, including lysosomes (Rosa-Ferreira and Munro 2011). Kif5B is a ~110 kDa 
protein consisting of an N-terminal motor domain, a long coiled-coil stem and a C-terminal 
globular domain (Navone, Niclas et al. 1992, Jeppesen and Hoerber 2012). Kif5B associates with 
the kinesin light chain (KLC) at the C-terminal regions. The globular domain and the KLC 
cooperate in cargo recognition (Jeppesen and Hoerber 2012). Without cargo binding, Kif5B is 
autoinhibited through the binding of its C-terminal tail with the motor domain, which arrests the 
motor domain in an ADP-bound state (Carter and Cross 2006, Verhey and Hammond 2009). 
Upon cargo recognition, the association with the cargo releases the tail from the motor domain, 
allowing Kif5B to walk along the microtubule. 
Kif5B has been shown to be recruited to the lysosomes through SKIP (SifA and Kinesin 
Interacting Protein), which is in turn brought to lysosomal surface by a small GTPase Arl8 
(ADP-Ribosylation factor Like protein 8) (Rosa-Ferreira and Munro 2011). Therefore, the 
motility of lysosomes towards different directions inside the cell is mediated through the 




mTORC1 is a master regulator of cell growth in response to nutrient status and 
extracellular growth cues. As described above, the activation of mTORC1 is regulated by the 
lysosomal small GTPase Rheb, and amino acids released from the lysosome lumen. On the other 
hand, the trafficking of lysosomes is reciprocally regulated by mTORC1. 
Inhibition of mTORC1 will activate autophagy, with active generation of 
autophagosomes (Kim, Kundu et al. 2011). The digestion of autophagosomes requires fusion 
with lysosomes at the perinuclear region, resulting in enlarged perinuclear autolysosomes. 
Therefore, inhibition of mTORC1 could result in the retrograde migration of lysosomes towards 
the nucleus. 
Except for an effect on lysosome distribution, mTORC1 is also known to be required for 
lysosome reformation to take place. During prolonged starvation, in spite of the low level of 
extracellular nutrient, mTORC1 gets re-activated due to the digestion of autophagic cargo in the 
lysosome (Yu, McPhee et al. 2010), and the subsequent release of nutrients back to the cytosol. 
Lysosome reformation is activated at this stage, but inhibition of mTOR would abolish the 
reformation, and lead to persistence of enlarged vacuoles (Yu, McPhee et al. 2010). 
Clathrin 
Clathrin is an interesting protein that in cells can coat membranes to form soccer-like 
structure. Clathrin forms triskelion, in which three clathrin heavy chains form the three legs of 
the triskelion, and three light chains bound to the inner portion of the heavy chain legs (Pearse 
1976, Ford, Pearse et al. 2001, Higgins and McMahon 2002). The heavy chains from different 
triskelia can assemble together on the membrane in either pentagon or hexagon shapes, 
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inevitably inducing membrane curvature (Higgins and McMahon 2002). The result of the 
assembly is part of the membrane curving into the cytosol and, with the help of membrane 
scission proteins like dynamin, bud off from the original membrane in a soccer ball shaped 
vesicle (Henley, Cao et al. 1999, Higgins and McMahon 2002, Roux, Uyhazi et al. 2006).  
Due to the ability of forming membrane curvature protruding into the cytosol in a regular 
and well-defined manner, clathrin plays crucial role in membrane fission, and is especially well 
known for the clathrin-mediated endocytosis (Pearse 1976). Recent evidences have also pointed 
out that the same clathrin-mediated membrane fission pathway is used for lysosome membrane 
fission (Rong, Liu et al. 2012), i.e. reformation. Depletion of clathrin or PI(4,5)P2, the 
phosphoinositide required for the membrane recruitment of clathrin, suppressed the reformation 
of lysosomes (Rong, Liu et al. 2012). 
Cytosolic pH 
pH inside the cells is usually tightly regulated, as most proteins require optimized pH for 
their proper functions. Therefore, on a long term basis, the intracellular and extracellular pH in 
our body is maintained at a stable level, which is ~7.4 for extracellular environment, and ~7.2 for 
the cytosol (Deutsch, Taylor et al. 1982). 
During acute starvation, the pH of the cytosol is temporarily increased, in some studies as 
much as from 7.2 to 7.7 (which equals to ~3 times difference in [H+]) (Korolchuk, Saiki et al. 
2011). Interestingly, a gross acidification of lysosomes under acute starvation is also reported, 
proposed to be caused by active v-ATPase pumping protons into the lysosome lumen in 
compensation to the suddenly increased luminal volume through fusion with autophagosomes 
(Wong, Li et al. 2012, Mauvezin and Neufeld 2015). The two events are probably correlated, as 
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rapid acidification of lysosome lumen would lead to a loss of cytosolic protons and thus 
increased cytosolic pH, but this has not been established yet. 
It has been known for many years that cytosolic pH impacts on the positioning of 
lysosomes inside the cells (Heuser 1989). More acidic cytosolic pH results in a more peripheral 
distribution of lysosomes, while alkalization of the cytosol results in the accumulation of 
lysosomes at the perinuclear region (Heuser 1989). This is in accordance with the cytosolic pH 
observed during starvation, in which lysosomes become more perinuclear with a concurrent 
alkalization of the cytosol. 
TRPML1 
TRPML1 is a lysosomal Ca2+ permeable cation channel, the malfunction of which causes 
a severe neurodegeneration disease called mucolipidosis type IV (MLIV) (Bargal, Avidan et al. 
2000, Bassi, Manzoni et al. 2000). As the main topic of this thesis, more details about the 
channel are discussed in the separate section below. 
 
1.3 The lysosomal Ca2+-permeable channel TRPML1 
1.3.1 Biophysical properties of the TRPML1 channel 
TRPML1 was first mapped in patients with MLIV, and identified as a channel that 
belongs to the transient receptor potential channel superfamily (Bargal, Avidan et al. 2000, Bassi, 
Manzoni et al. 2000). Two other channels of the same subfamily, TRPML2 and TRPML3, were 
later identified from a genomic mapping of the mutations in the Varitint-Waddler mice (Di 
Palma, Belyantseva et al. 2002). While TRPML1 is ubiquitously expressed in all tissues, 
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TRPML2 and TRPML3 exhibit more restricted expression patterns (Kim, Li et al. 2007, 
Cuajungco, Silva et al. 2015). 
TRPML1 is a 580 a.a. protein of ~65 kDa size (Bargal, Avidan et al. 2000, Bassi, 
Manzoni et al. 2000). Like other channels in the TRP family, TRPML1 consists of six 
transmembrane domains (S1 to S6, supported by experimental and computational evidences, but 
not structurally confirmed), with the N-terminal and the C-terminal both facing the cytosol. It 
contains a large luminal loop between S1 and S2, and a pore region spanning between S5 and S6 
(Sun, Goldin et al. 2000). 
TRPML1 is known to be well co-localized with LEL markers such as Lamp1 when 
overexpressed (Dong, Cheng et al. 2008). Due to restrictions in specific antibodies, the 
localization of endogenous TRPML1 on the LEL is not sufficiently visualized, but rather 
confirmed through electrophysiology recordings (Dong, Cheng et al. 2008, Dong, Shen et al. 
2010). Under lysosomal patchclamp, endogenous TRPML1 usually exhibits little or no current at 
basal conditions, but shows an inwardly-rectifying (ions entering the cytosol from the lysosome 
lumen) current that is largely non-selective for cations (Dong, Cheng et al. 2008, Dong, Shen et 
al. 2010).  
Two di-leucine motifs facilitate TRPML1’s lysosomal localization (Pryor, Reimann et al. 
2006). The two motifs are 10 a.a. away from the N-terminal and 2 a.a. away from the C-terminal, 
respectively. Replacement of the leucines in both motifs to alanines will significantly increase 
the plasma membrane localization of overexpressed channels, but will not fully exclude 
lysosomal localization (Pryor, Reimann et al. 2006). TRPML1 can localize to lysosomes either 
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through direct transport from the Golgi upon protein maturation, or through endocytosis after 
being delivered to the plasma membrane by secretory vesicles or by lysosome exocytosis.  
TRPML1 is shown to be permeable to multiple cations, including Ca2+, Fe2+, Zn2+, Na+, 
and K+, but not H+ (Dong, Cheng et al. 2008). Among all the ions permeable, TRPML1 is most 
well studies for its role as a Ca2+ permeable channel, mainly because of versatile roles Ca2+ plays 
in the cell. To date, Ca2+ release from TRPML1 has been shown to be important for several 
aspects of membrane trafficking around the lysosomes. As a process that requires precise timing, 
membrane trafficking would require acute mechanisms as triggers. Therefore, the Ca2+ release 
from TRPML1 would require upstream signal cues that allow it to be rapidly turned on or off. 
 
1.3.2 The regulation of TRPML1 through endogenous and artificial molecules 
As a lysosomal ion channel, the search for endogenous agonists/antagonists of TRPML1 
is much harder compared to plasma membrane channels. It is not until lysosomal patchclamp 
technique was developed that researchers started to gain knowledge on how the channel activity 
is modulated. 
It was shown from early studies that TRPML1 activity is potentiated by acidic luminal 
pH (Dong, Cheng et al. 2008), which makes perfect sense since this is a lysosomal ion channel 
that functions on vesicles with very acidic luminal pH. An endogenous agonist of the channel, 
though, was not discovered until 2010. Not surprisingly, the late endosome and lysosome 
localized phosphoinositide, PI(3,5)P2, became the first identified endogenous molecule that 
could activate the channel with high potency (EC50 around 50 nM) (Dong, Shen et al. 2010). 
PI(3,5)P2 binds to TRPML1 through a stretch of positively charged residues on the cytosolic N-
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terminal, as mutations of these residues to Glu (named TRPML1-7Q) could abolish the 
activation from PI(3,5)P2 (Dong, Shen et al. 2010). A follow-up study showed that two of the 
residues, R61K62, are crucial residues conferring PI(3,5)P2 specificity for activation (Zhang, Li et 
al. 2012).  
Apart from PI(3,5)P2, a recent report showed that mTORC1 phosphorylates TRPML1 
under nutrient conditions to inhibit the channel, and that removal of phosphorylation can thus 
potentiate TRPML1 current (Onyenwoke, Sexton et al. 2015). However, such mechanism likely 
plays a permissive role, allowing the channel to be activated under de-phosphorylated state, 
rather than directly activating the channel. Therefore, PI(3,5)P2 remains the only established 
endogenous molecule that can directly activate the channel. 
PI(4,5)P2 is a isomer of PI(3,5)P2, differing only with the position of the phosphate on the 
inositol ring. PI(4,5)P2 is abundant on the plasma membrane, while PI(3,5)P2 is enriched on 
lysosomal membranes (Balla and Varnai 2002, Li, Wang et al. 2013). Interestingly, PI(4,5)P2 
does not activate TRPML1, but instead inhibits the channel with a sub-micromolar IC50 (~0.2 
μM) (Zhang, Li et al. 2012). Since opening of the channel on the plasma membrane will cause 
excessive Ca2+ influx into the cell, as well as unwanted changes in the membrane potential, this 
inhibitory mechanism likely plays a role to prevent channel activation at the wrong place. The 
residues crucial for the interaction between TRPML1 and PI(4,5)P2 has been mapped to the 
positively-charged residues R42R43R44 through mutagenesis analysis (Zhang, Li et al. 2012). 
TRPML1 activity can also be inhibited by a type of luminal lipids, sphingomyelins (Shen, 
Wang et al. 2012). Sphingomyelins are a class of membrane lipids consisting of a 
phosphocholine or a phosphoethanolamine head group, and a ceramide tail (consisting of a 
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sphinosine and a fatty acid). Sphingomyelins are enriched on plasma membrane on the outer 
layer facing the extracellular space, and can be carried into lysosomes through endocytosis. 
Sphingomyelins are broken down to ceramide in lysosomes and recycled to the Golgi through 
lysosome-to-Golgi retrograde transport (Jenkins, Canals et al. 2009, Schuchman 2010). Under 
normal conditions, sphingomyelins may serve in addition to PI(4,5)P2 to prevent TRPML1 from 
plasma membrane activation. In disease conditions (e.g. in Niemann-Pick Diseases), however, 
loss of sphinomyelinase activity, or secondary mechanisms can result in the accumulation of 
sphingomyelins (Schuchman 2010). The subsequent inhibition of TRPML1 to various degrees 
(depending on the amount of accumulation) is thought to contribute to the development of 
disease syndromes (Shen, Wang et al. 2012). 
Artificial agonists and antagonists of TRPML1 have been identified through screens of 
small synthetic molecules. One such screen identified a small molecule SF-51 that is capable of 
activating TRPML1 in higher-micromolar range (Grimm, Jors et al. 2010). SF-51 was later 
modified to ML-SA1 (MucoLipin Synthetic Agonist 1, see Fig. 1.5), which differs by a single 
C=C double bound (Shen, Wang et al. 2012). ML-SA1 activated TRPML1 with higher potency 
than SF-51, and was shown to be able to activate endogenous TRPML1 in cell biology assays 
(Shen, Wang et al. 2012, Samie, Wang et al. 2013). Newer agonists, named after the ML-SA 
series, ML-SA3 and ML-SA5, have been identified since, with different structures than ML-SA1 
and even higher potency (Wang, Gao et al. 2015). 
Artificial antagonists of TRPML1, ML-SI1 and ML-SI3 (Fig. 1.5), were identified 
through similar screens with similar potency to the ML-SA agonists, but instead inhibited the 
channel (Samie, Wang et al. 2013, Cheng, Zhang et al. 2014). The regions of the channel 




1.3.3 TRPML1 has important functions in lysosome membrane trafficking 
Indications of TRPML1 in lysosome membrane trafficking came along with the 
characterization of the symptoms of MLIV, the genetic disease caused by the loss of TRPML1 
activity (Nilius, Owsianik et al. 2007, Wakabayashi, Gustafson et al. 2011). MLIV patients 
exhibit early onset of neurodegeneration and psychomotor defects, which are canonical 
symptoms for lysosome storage diseases (Wakabayashi, Gustafson et al. 2011). At cellular level, 
MLIV patient fibroblasts or TRPML1 knockout (ML1KO hereafter) mouse fibroblasts exhibit 
enlarged LELs, accumulation of autophagosomes, and accumulation of lipids such as cholesterol 
and lactosylceramide in the lysosomes (Pagano, Puri et al. 2000, Cheng, Shen et al. 2010). These 
phenotypes are all in line with dysfunctionality in the lysosomal trafficking pathway. 
Numerous studies have been done on TRPML1 to figure out the role it plays in regulating 
lysosomes. Early qualitative analyses have shown phenotypes suggesting delayed lysosome-to-
Golgi transport (Pryor, Reimann et al. 2006), delayed autophagosome delivery to the lysosome 
(Curcio-Morelli, Charles et al. 2010), hyperacidified lysosome lumen (Soyombo, Tjon-Kon-Sang 
et al. 2006) and accumulation of some ions like Fe2+ and Zn2+ in the lysosomes (Dong, Cheng et 
al. 2008, Eichelsdoerfer, Evans et al. 2010). These studies, however, did not provide detailed 
mechanisms as to how TRPML1 functions to regulate these aspects. For example, delayed 
lysosome-to-Golgi transport indicates defects in lysosome membrane fission (the generation of 
retrograde transport vesicles); delayed autophagosome delivery to the lysosome indicates defects 
in lysosome and autophagosome fusion. But how could TRPML1 regulate the fusion and fission 
of lysosomes together? And which are the upstream and downstream molecules regarding 
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TRPML1 in both processes? Questions like these were not answered in early studies, mostly due 
to the lack of proper tools (such as agonists and antagonists) and insufficient knowledge about 
the protein per se. 
More recent studies, especially after the characterization of the artificial agonists and 
antagonists, were more effective and definitive in dissecting TRPML1’s roles. Two notable 
studies carried out in the Xu lab have identified TRPML1’s roles in Ca2+ mediated lysosome 
exocytosis with great detail and also identified some of the downstream targets. 
The first paper, published by Samie et al. in 2013 on Developmental Cell (Samie, Wang 
et al. 2013), reported that TRPML1 regulates lysosome exocytosis during phagocytosis of large 
particles. The concept is that during phagocytosis, a large part of the plasma membrane is 
engulfed as phagosome and lost from the plasma membrane. In order to maintain plasma 
membrane amount, endocytic vesicles would fuse with plasma membrane upon activation of the 
phagocytosis pathway, right before the actual phagocytosis takes place. It was shown earlier that 
while endosomes participate in small particle phagocytosis, lysosomes participate in the 
phagocytosis of large particles (>3 μm). 
Samie et al. showed that TRPML1 is required for the phagocytosis to proceed through 
promotion of Ca2+ regulated lysosome exocytosis. It is shown that upon particle recognition, 
lysosomes are trafficked to the particle contact site and PI(3,5)P2 levels increase, allowing 
TRPML1 to be activated. Ca2+ release from TRPML1 then activated the lysosomal Ca2+ sensor 
synaptotagmin VII (Syt VII) to trigger lysosome exocytosis (Fig. 1.6). 
This study represents the first report regarding TRPML1’s mechanism of action in 
lysosome membrane trafficking steps. A year later, Cheng et al. published a report on Nature 
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Medicine (Cheng, Zhang et al. 2014) describing a similar Ca2+- and TRPML1-dependent 
regulation of lysosome exocytosis that is required in sarcolemma membrane damage repair. The 
report showed that the muscular dystrophy phenotype observed in ML1KO mice is muscle-
primary and is due to the impaired membrane repair upon membrane damage (which happens 
very often in skeletal muscles). It is shown that TRPML1 is required for this process, promoting 
lysosome exocytosis after membrane damage to repair the damage site. Boosting up TRPML1 
activity through viral infection is also shown to exhibit rescue effects on muscular dystrophy in 
mdx mice, the mouse model of muscular dystrophy (Cooper 1989). 
In 2015, Dayam et al. reported an additional role of TRPML1 in membrane fusion 
(Dayam, Saric et al. 2015), being required for the phagosome and lysosome fusion after 
phagocytosis (Fig. 1.6). It is shown that in TRPML1 knockdown RAW macrophages, or in these 
cells treated with the PI(3,5)P2 synthesis inhibitor, Apilimod, as well as the membrane permeable, 
fast Ca2+ chelator, BAPTA-AM, the fusion between phagosomes and lysosomes is significantly 
delayed. However, no detailed mechanism is tested or speculated. 
 
1.4 The goal of the study 
Previous studies, especially the several recent reports described above, have clearly 
shown that TRPML1 regulates lysosome membrane trafficking, notably the fusion between 
lysosomal membrane and other intracellular membranes. Some insights about the mechanisms of 
the TRPML1-Ca2+ regulatory pathway of lysosomal membrane fusion have also been provided. 
These findings, however, cannot fully account for all the phenotypes seen with ML1KO and 
MLIV patient cells. Especially, the observed phenotype of enlarged late endocytic vesicles seen 
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in ML1KO and MLIV cells cannot be explained by any of the above findings. The perinuclear 
localization of the LEL vesicles seen in ML1KO cells, as well as in cells overexpressing 
TRPML1, is also puzzling at this point. 
Seeing these apparent blanks in our understandings towards TRPML1’s functions, I aim 
to investigate TRPML1’s functions apart from Ca2+-regulated membrane fusion (Fig. 1.6). The 
first goal was to identify TRPML1’s role in regulating the motility of lysosomes (Chapter II), 
and its downstream target(s) along the pathway (Chapter III). The second goal was to examine 
TRPML1’s role in lysosome membrane fission, using the model of lysosome reformation under 
prolonged starvation or active phagocytosis (Chapter IV). In addition to these main questions, I 
also developed a genetically encoded PI(3,5)P2 biosensor, which was published and has already 




Fig. 1.1 The endocytic trafficking network. 
A schematic view of the endocytic trafficking network in animal cells. Luminal pH and 
dominant phosphoinositides of each compartments are labeled with different colors. During 
endocytosis, a piece of the plasma membrane is excised and enters the cytosol in the form of a 
nascent endosome (NE; a). Nascent endosomes fuse with each other (b) and recruit early 
endosomal proteins to become early endosomes (EE; b). Membrane receptors are sorted and 
recycled back to the plasma membrane through recycling endosomes (RE; c). Material destined 
for degradation is passed on to the late endosomes (LE; d), which are also referred to as multi-
vesicular bodies (MVB) due to the intraluminal vesicles (ILVs) that contain membrane proteins 
sorted for degradation. Hydrolytic enzymes are transported to late endosomes through transport 
vesicles (TV) from Golgi (e). Membrane receptors carrying the enzymes are shuttled back to 
Golgi through retrograde transport. Late endosomes mature into lysosomes (LY) either through 
further acidification, or through fusion with existing lysosomes (f). During starvation or when 
organelles are damaged, lysosomes also accept cargo from autophagosomes (AP) carrying 
damaged organelles or cytosolic material for degradation (g). The resulting autophagic 
lysosomes (AL) are usually larger than endocytic lysosomes. Lysosomes can undergo Ca2+-
dependent exocytosis (h). Lysosomal membrane proteins are recycled from autophagic 
lysosomes by fission processes that happen on tubular structures (i). The mechanism of recycling 






Fig. 1.2 A proposed model of Ca2+-release-regulated lysosomal membrane fusion. 
The initiation of vesicle fusion is coordinated by Rab protein and tethering complexes that 
mediate the assembly of SNAREs (left). After SNARE assembly, lysosome is in a ready-to-fuse 
state. Upon signaling, PI(3,5)P2 is produced on the lysosomal membrane, leading to Ca2+ release 






Fig. 1.3 Three major aspects about lysosome membrane trafficking. 
In cells, lysosomes undergo microtubule-based directional transport (brown arrows) to their 
destination, where they can fuse with cargo vesicles (green arrows) or undergo lysosomal 
exocytosis (blue arrow). After completion of cargo fusion, secondary lysosomes can undergo 
membrane fission (purple arrow) to recycle membrane components for the generation of new 





Fig. 1.4 Lysosome size revealed by super-resolution microscopy. 
Mouse fibroblast transfected with Lamp1-GFP was subject to live imaging using STED super-
resolution microscopy 2 days post-transfection. Lysosomes appeared to be of variable sizes, but 





Fig. 1.5 The structures of synthetic agonists and antagonists of TRPML1. 
Chemical structures of the ML-SAs and ML-SIs used. Each agonist/antagonist is structurally 





Fig. 1.6 The goal of the study is to identify new roles of TRPML1 in regulating lysosome 
membrane trafficking. 
TRPML1 has been shown to regulate lysosome exocytosis and fusion with phagosomes through 
its Ca2+ release (black arrows). It remains to be tested whether TRPML1 also regulates other 





TRPML1 Mediates Retrograde Transport of Lysosomes Independent 
of the Rab7-RILP-ORP1L Pathway2 
 
2.1 Abstract 
Lysosome motility is crucial to its functions inside the cell. Directional movement of 
lysosomes in animal cells is carried out through microtubule-based motor proteins, with kinesin-
1 responsible for the plus-end directed movements towards cell peripheral, and cytoplasmic 
dynein responsible for the minus-end directed movements towards the microtubule-organizing 
center (MTOC) close to the nucleus. Dynein-mediated minus-end movement of lysosomes has 
been shown to be mediated by Rab7 and its effector RILP, with the lysosomal cholesterol sensor 
ORP1L facilitating this process. Here I report an on-demand pathway that drives minus-end 
directed lysosome movement in response to cellular cues such as acute starvation, mTOR 
inhibition, or elevated cytosolic pH. TRPML1, a lysosomal Ca2+ permeable channel, is shown to 
mediate this novel retrograde transport of lysosomes independent of the previously described 
Rab7-RILP pathway. 
                                                          
2 Originally Submitted in Nature Cell Biology. With authors listed as Xinran Li, Nicholas Rydzewski, 





Lysosomes serve as the degradation and nutrient sensing center of animal cells. 
Lysosomes accept cargo through fusion with various cargo-delivery vesicles including 
endosomes, autophagosomes and phagosomes, and undergo lysosome reformation afterwards. 
The membrane fusion and fission of lysosomes would require the ability to move directionally 
inside the cells. Lysosome motility relies on microtubule-based motor proteins, and the direction 
of the movement is determined by the motor proteins attached to lysosomes (Rosa-Ferreira and 
Munro 2011, Tan, Scherer et al. 2011). 
Previous researches characterized the important functions of Rab7 and its effector protein, 
RILP, in promoting minus-end (i.e. retrograde) transport of lysosomes (Jordens, Fernandez-Borja 
et al. 2001, Johansson, Rocha et al. 2007, Rocha, Kuijl et al. 2009, van der Kant, Fish et al. 
2013). Rab7 and RILP interact with the dynein adaptor complex dynactin to bring the motor 
protein to the lysosome surface (Jordens, Fernandez-Borja et al. 2001). Recent researches also 
showed that this process requires the cooperation from the lysosomal cholesterol sensor ORP1L 
(Johansson, Rocha et al. 2007, Rocha, Kuijl et al. 2009, van der Kant, Fish et al. 2013).  
Consistent with previous findings, the constitutively active Rab7, Rab7-Q67L, which is 
locked in its GTP-bound state, can induce perinuclearly-localized lysosomes (Bucci, Thomsen et 
al. 2000). Similar phenotype is observed for RILP overexpression (Cantalupo, Alifano et al. 
2001). This perinuclear localization of lysosomes is most likely caused by the excessive 
recruitment of dynein that outcompetes kinesin and drags all lysosomes towards the MTOC. On 
the other hand, overexpression of the dominant negative form of Rab7, Rab7-T22N, induces 
dispersal of lysosomes towards the peripheral areas of the cell (Bucci, Thomsen et al. 2000, 
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Cantalupo, Alifano et al. 2001). Therefore, manipulation of the activity of the Rab7-RILP 
pathway can dictate the intracellular distribution of lysosomes. 
An important thing to point out, though, is that all previous researches characterizing 
retrograde transport of lysosomes were carried out with cells under normal, unstressed conditions. 
It is now known that lysosomes can undergo rapid changes in their distribution facing urgent 
conditions, e.g. upon deprivation of serum factors or amino acids (Korolchuk, Saiki et al. 2011). 
Under such conditions, lysosomes very rapidly (within an hour) get recruited to the perinuclear 
region where they fuse with autophagosomes to complete autophagy. Under such acute 
conditions, it is unlikely that lysosome cholesterol levels, therefore ORP1L levels, would 
undergo dramatic changes. Therefore, it remains unclear whether such shifts in lysosome 
distribution are mediated through the same regulatory machinery. 
Prior to this study, there were already indications that TRPML1 might play a role in 
regulating lysosome positions. It was noticed that in both ML1KO cells and TRPML1 
overexpressing cells, lysosomes appeared to be perinuclear (Vergarajauregui, Martina et al. 2009, 
Wakabayashi, Gustafson et al. 2011). However, such contradictory results were hard to analyze 
or come up with a model to explain. Due to the recent characterization of small molecule 
agonists and antagonists of TRPML1, I now possess the tools for us to determine the role of 
TRPML1 in regulating lysosome positioning through acute manipulation of its activity. 
 
2.3 Results 
2.3.1 TRPML1 is necessary for the on-demand retrograde transport of lysosomes towards 
microtubule organizing center 
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To investigate the role of TRPML1 in lysosome positioning, I utilized a wide variety of 
mammalian cells, including Cos1, HeLa, and primary mouse fibroblasts. This is to check if the 
phenomena I observe are due to cell type-specific effects or represent a more general function. 
To monitor the distribution of late endosomes and lysosomes (LEL, hereafter all referred to as 
lysosomes for simplicity), I utilized multiple methods of labeling including lysotracker, 
fluorescently-labeled dextran, and GFP/mCherry fused to the cytosolic C-terminal of Lamp1, a 
canonical lysosome marker (Fig. 2.1a, 2.1b). Lysotracker is a dye that is membrane permeable 
under normal pH, but becomes membrane impermeable when protonated under acidic pH, 
producing concentrated fluorescence in very acidic organelles (see Materials and Methods). 
Fluorescently-labeled dextrans (Oregon-green or tetramethylrhodamine for green and red colors, 
respectively) are non-digestible polysaccharides that enter the lysosomes through endocytosis. 
Since lysotracker fluorescence is dependent on luminal pH, while dextran labeling requires 
active endocytosis and efficient delivery of endocytic vesicles to the lysosomes, both of which 
are not ensured under experimental conditions that I study, I choose to use Lamp1 as the 
lysosome marker in the majority of the experiments. 
Under normal conditions, lysosomes were scattered throughout the cytoplasm, showing a 
dispersed pattern (Fig. 2.1 & 2.2). Upon serum starvation, autophagy is triggered, indicated by 
the generation of autophagosomes that are labeled with LC3 (Fig. 2.3a). LC3 (ATG8 in yeast) is 
a small protein that attaches to the autophagosome membrane during autophagosome elongation 
(Olivier, Proulx et al. 1989). The attachment of LC3 to the autophagosome membrane requires a 
cleavage on its C-terminal by ATG4 to expose its Glycine residue, which is used to conjugate to 
phosphatidylethanolamine on the autophagosome membrane (Ichimura, Kirisako et al. 2000). 
Therefore, mature LC3 (LC3-II) shows a smaller apparent protein mass in western blots than 
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immature LC3 (LC3-I) (usually from ~16 kDa to ~14 kDa). When attached to tandem 
fluorephores of GFP and RFP, LC3 can also serve as an indicator of autophagosomes versus 
autolysosomes (Kimura, Noda et al. 2007), with autophagosomes showing fluorescence in both 
green and red channels, while autolysosomes showing only red fluorescence due to the quench of 
GFP signal by acidic pH. 
The accumulation of autophagosomes is most prominent at the perinuclear regions (Fig. 
2.3a). Consistent with recent reports (Thoreen, Kang et al. 2009, Korolchuk, Saiki et al. 2011), 
upon starvation, a rapid redistribution of lysosomes towards the perinuclear regions was seen 
(Fig. 2.1b, 2.2a-c, 2.2f). More specifically, the lysosomes were recruited close to the MTOC 
(Fig. 2.3b). The redistribution of lysosomes is thought to promote the fusion between lysosomes 
and autophagosomes. This is supported by the fact that the perinuclear Lamp1-positive vesicles 
seen in starved cells were of a larger size compared to fed cells (Fig. 2.2a, 2.2b, insets), 
suggesting that these vesicles were secondary lysosomes, most likely autolysosomes. 
Torin-1 is a potent ATP-competitive mTOR inhibitor that can trigger autophagy through 
inhibition of mTORC1 (Thoreen, Kang et al. 2009). Under Torin-1 treatment, lysosomes also 
underwent a redistribution to the perinuclear region (Fig. 2.2e, 2.2g), consistent with the 
hypothesis that the redistribution is for the fusion between lysosomes and autophagosomes. 
To better understand the kinetics of the redistribution of lysosomes, I proceeded to 
analyze the directional movement of lysosomes using fluorescence recovery after photobleaching 
(FRAP). Under normal conditions, the amount of lysosomes traveling towards the plus-end or 
towards the minus-end of microtubules showed no significant differences, although generally 
slightly more lysosomes were moving towards the minus-end (Fig. 2.4a, 2.4d). Acute starvation 
44 
 
(within 30 minutes) triggered a selective increase of lysosomes trafficking towards the minus-
end (i.e. MTOC), without affecting the amount of lysosomes trafficking to the other direction 
(Fig. 2.4b, 2.4d). This result clearly suggests that starvation promotes perinuclear migration of 
lysosomes through the up-regulation of the minus-end motility, but not the suppression of the 
plus-end motility. 
The motility of lysosomes trafficking towards both directions was greatly reduced under 
BAPTA-AM treatment, a fast, membrane permeable Ca2+ chelator (Data not shown). Thus, Ca2+ 
is important in regulating lysosome motility. TRPML1 is a Ca2+ release channel on the lysosome. 
I therefore tested whether TRPML1 plays specific roles in the regulation of lysosome motility 
utilizing synthetic agonists/antagonists to acutely manipulate TRPML1 activity (Fig. 2.5a). The 
benefit of using synthetic molecules, compared to the traditional ML1KO/shRNA/RNAi 
methods, is to get rid of the interference of secondary effects, such as accumulation of lysosome 
lipids, caused by the chronic inhibition of TRPML1. 
To test whether TRPML1 plays a role in the promotion of perinuclear migration of 
lysosomes under acute starvation, I used two structurally unrelated TRPML1 inhibitors, ML-SI1 
and ML-SI3 (Samie, Wang et al. 2013). Both inhibitors were able to block the perinuclear 
accumulation of lysosomes under starvation (Fig. 2.2a, 2.2b, 2.2d, 2.2f), suggesting that 
TRPML1 activity is required for the process. Likewise, the perinuclear migration of lysosomes 
under Torin-1 treatment was also suppressed through TRPML1 inhibition (Fig. 2.2e, 2.2g). 
Interestingly, inhibition of TRPML1 during short term starvation also led to the accumulation of 
autophagosomes not fused with lysosomes, indicated by GFP-RFP-LC3 (Fig. 2.6). This would 




Consistent with the effects on lysosome distribution, FRAP analysis showed that the 
elevated retrograde transport of lysosomes under starvation was blocked by TRPML1 inhibition 
(Fig. 2.4c, 2.4d). Therefore, TRPML1 activity might be selectively required for the up-regulation 
of the minus-end directed motility of lysosomes. It is worth noting, however, that inhibition of 
TRPML1 under normal conditions had only a subtle effect on lysosome distribution (Fig. 2.2d, 
2.2f). Moreover, FRAP assay showed that inhibition of TRPML1 did not suppress all lysosome 
movements towards the minus-end under starvation, but rather only brought it down to pre-
starvation levels (Fig. 2.4d). This suggests that TRPML1 is only responsible for the on-demand 
up-regulation of the minus-end motility of lysosomes, but plays little role in regulating 
housekeeping retrograde transport of lysosomes. 
Starvation is shown to cause a quick elevation in cytosolic pH, reportedly from 7.1 to 7.7 
within 45 minutes in HeLa cells (Korolchuk, Saiki et al. 2011). Alkalization of the cytosol is 
sufficient to induce perinuclear migration of lysosomes (Heuser 1989). Whole-endolysosomal 
TRPML1 currents were also facilitated by alkaline cytosolic pH and inhibited by acidic cytosolic 
pH (Fig. 2.5b). TRPML1 inhibition also suppressed the migration of lysosomes towards the 
perinuclear region under cytosolic alkalization (Fig. 2.7a-c), driven by the treatment of 
Ammonia Ringer’s solution (see Methods part for the recipe). Despite the apparent starvation 
caused by switching to the Ammonia Ringer’s, mTORC1 activity remained relatively unaffected 
during the treatment period (30 min), suggesting that the process is not mediated through mTOR 
inhibition (Fig. 2.7d). 
Collectively, the above data suggest that TRPML1 activity is required to drive the on-
demand retrograde migration of lysosomes in response to acute conditions such as autophagy 




2.3.2 TRPML1 activation is sufficient to promote Ca2+-dependent retrograde transport of 
lysosomes 
Having confirmed the necessity of TRPML1 in the process, I proceeded to test whether 
artificial activation of TRPML1 is sufficient to up-regulate the retrograde transport of lysosomes. 
When HeLa cells, Cos1 cells, or WT mouse fibroblasts were treated with a synthetic TRPML1 
agonist, ML-SA1, lysosomes were apparently much more perinuclear (Fig. 2.8a-c, 2.8g). Similar 
perinuclear localization was observed in fibroblasts treated with two other structurally-unrelated 
TRPML1 agonists, ML-SA3 and ML-SA5 (Wang, Gao et al. 2015) (Fig. 2.9a), suggesting that 
the effect seen with ML-SA1 was specific to TRPML1 activation. Overexpression of TRPML1, 
but not the other two TRPML family members TRPML2 and TRPML3, also resulted in the 
perinuclear accumulation of lysosomes (Fig. 2.8d, 2.8g, 2.9b-e). Therefore, activation of 
TRPML1 is already sufficient to induce perinuclear localization of lysosomes. The effects of 
TRPML1 overexpression on lysosome re-distribution can be reversed by either the application of 
BAPTA-AM, or by the TRPML1 inhibitors (Fig. 2.8e, 2.8f, 2.8i). 
In FRAP analyses, as well as time-lapse imaging, acute application of ML-SA1 (within 
30 minutes) increased the minus-end directed migration of lysosomes selectively and 
significantly (Fig. 2.10a-c). Conversely, time-lapse imaging showed that ML-SI3 resulted in the 
dispersal of lysosomes in TRPML1 overexpressing fibroblasts, an effect opposite to ML-SA1 
(Fig. 2.10d). To test organelle specificity, the distribution of mitochondria was compare with or 
without ML-SA1 application, which showed no difference (Fig. 2.11). Collectively, these results 
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suggest that TRPML1 activation is sufficient to up-regulate retrograde transport and the 
perinuclear accumulation of lysosomes. 
 
2.3.3 Chronic effects of cholesterol accumulation on lysosome distribution 
It is known that lysosomes are distributed perinuclearly in many LSD cells (Samie and 
Xu 2014, Xu and Ren 2015). ML1KO mouse fibroblasts display similar perinuclear lysosome 
localization (Fig. 2.12). This distribution, however, is opposite to that seen with transient 
inhibition of TRPML1 shown above. To mimic the chronic loss of TRPML1 activity in ML1KO 
cells, we treated WT fibroblasts with increased lengths of TRPML1 inhibitors under complete 
medium. Within 6 hours, inhibition of TRPML1 did not result in significant difference in 
lysosome distribution compared to untreated cells. Longer treatments (from 18 hours up to 48 
hours) resulted in progressively more perinuclear lysosome distribution (Fig. 2.13a-c). Therefore, 
some properties must be different between transient and long-term inhibition of TRPML1 that 
lead to the differences in the lysosome distribution. 
One thing that is different between short term inhibition of TRPML1 and long term loss 
of TRPML1 activity is the secondary accumulation of lysosomal substances due to defective 
trafficking (Pagano, Puri et al. 2000, Samie and Xu 2014). Importantly, a variety of membrane 
lipids including cholesterol are known to accumulate in lysosomes in ML1KO cells. Given the 
established role of lysosomal cholesterol and its sensor ORP1L in promoting minus-end motility 
of lysosomes in cooperation with Rab7 and RILP (Johansson, Rocha et al. 2007, Rocha, Kuijl et 
al. 2009), I designed experiments to test whether cholesterol accumulation could account for the 
abnormal lysosome distribution observed in ML1KO cells and other LSD cells. 
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First of all, using filipin staining, which stains unesterified free cholesterol, I confirmed 
that significant elevation of lysosomal cholesterol was observed in ML1KO fibroblasts, as well 
as in WT fibroblasts that were treated with the TRPML1 inhibitor ML-SI3 for a long period (1 
day), but not in WT fibroblasts treated with a short period (1 hour) of ML-SI3 (Fig. 2.14a, 2.14b, 
2.14d). Hence, the degree of cholesterol accumulation in these cells corresponds well with the 
degree of perinuclear distribution of lysosomes observed. Fibroblasts from NPC1 (Niemann-Pick 
type C1 protein) knockout mouse, the mouse model for the human cholesterol storage disease 
Niemann-Pick type C (Reid, Sugii et al. 2003, Kwiatkowska, Marszalek-Sadowska et al. 2014), 
were used as a positive control for cholesterol accumulation (Fig. 2.14c, 2.14d). It is noticeable 
that the accumulated cholesterol, which co-localize well with Lamp1 (Fig. 2.14f), showed 
primarily perinuclear distribution in these conditions (Fig. 2.14). 
Intracellular accumulation of cholesterol can be reduced using the statin class drugs to 
inhibit cholesterol synthesis, while depleting extracellular cholesterol. I utilized one of such 
drugs, simvastatin (Rocha, Kuijl et al. 2009), in combination with serum depletion (because Fetal 
Bovine Serum used in cell culture contains liposomes positive for cholesterol) to remove 
lysosomal cholesterol. Filipin staining in cells treated with simvastatin clearly showed a 
significant decrease in cholesterol levels in ML1KO, NPCKO, but not in WT fibroblasts (Fig. 
2.14a-c, 2.14e). The reduction of cholesterol resulted in more peripherally-localized lysosomes 
in ML1KO fibroblasts and NPCKO fibroblasts (Fig. 2.12a-d). In NPCKO fibroblasts, co-
application of ML-SI3 resulted in a further shift of lysosomes to the peripheral, due to the 
activation of TRPML1 under serum starvation conditions I used for cholesterol depletion (Fig. 
2.12c, 2.12d). In contrast, cholesterol depletion in WT fibroblasts did not result in significant 
changes in the lysosome distribution under starvation (Fig. 2.12e, 2.12f). These results suggest 
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that the perinuclear lysosome distribution in ML1KO, NPCKO, and probably in other LSD cells 
is caused by the excessive accumulation of cholesterol independent of TRPML1. The data also 
suggest that the lysosome distribution under starvation, on the other hand, is mainly dependent 
on TRPML1 activation, but not cholesterol. 
 
2.3.4 TRPML1 promotes retrograde trafficking of lysosomes independent of the Rab7-RILP 
pathway 
Cholesterol is known to promote retrograde transport of lysosomes through ORP1L’s 
cooperation with Rab7 and RILP (Johansson, Rocha et al. 2007, Rocha, Kuijl et al. 2009). To 
further test the relationship between TRPML1’s role in lysosome motility and the Rab7-RILP 
pathway, I manipulated the activity of the two pathways to observe their influence on each other. 
In WT fibroblasts, overexpression of the constitutively active form of Rab7, Rab7-Q67L 
(Spinosa, Progida et al. 2008), as well as overexpression of the Rab7 effector RILP (Cantalupo, 
Alifano et al. 2001), resulted in perinuclear accumulation of lysosomes (Fig. 2.15a-d). This 
lysosome distribution was unaffected with the inhibition of TRPML1 through ML-SI3 (Fig. 
2.15a-d), suggesting that TRPML1 is not downstream of either Rab7 or RILP.  
The dominant negative form of Rab7, Rab7-T22N, is known to cause dispersal of 
lysosomes to the peripheral of cells by inhibition of the Rab7-RILP pathway (Bucci, Thomsen et 
al. 2000, Cantalupo, Alifano et al. 2001). Overexpression of the Rab7-T22N construct in 
ML1KO fibroblasts (Fig. 2.16c, 2.16d), or in WT fibroblasts treated with ML-SI3 for 18 hours 
(Fig. 2.13d) redistributed the lysosomes to the peripheral, confirming that the perinuclear 
distribution of the lysosomes in these cells is caused by the Rab7 pathway. Overexpression of 
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Rab7-T22N, however, did not suppress the retrograde migration of lysosomes under acute 
starvation, or short-term application of ML-SA1 (Fig. 2.16a, 2.16b). These data suggest that the 
Rab7-RILP pathway is also not downstream of TRPML1. Therefore, TRPML1 regulates 
lysosome motility independent of the Rab7-RILP pathway. 
 
2.4 Discussion 
Lysosome motility is important for the functions of lysosomes in cargo degradation, 
lysosome exocytosis, and nutrient sensing. The canonical Rab7-RILP pathway demonstrates how 
lysosomes are transported along the microtubule towards the minus-end, i.e. retrograde transport, 
under normal conditions. It remained to test whether lysosomes adopt the same mechanism for 
their retrograde movement under acute situations like starvation. 
In the first part of my study, I showed that the lysosomal Ca2+ release channel, TRPML1, 
participates in the up-regulation of retrograde motility of lysosomes under acute starvation, 
mTOR inhibition and cytosolic alkalization.  To be specific, TRPML1 activity is required for the 
additional retrograde transport of lysosomes under the described conditions, and artificial 
activation of TRPML1 itself is sufficient to accumulate lysosomes at the perinuclear region. I 
have also showed that TRPML1 regulates this process through its role as a Ca2+ release channel. 
The conclusion that TRPML1 up-regulates retrograde transport of lysosomes to promote 
perinuclear accumulation of lysosomes is mainly based on the FRAP assay. Although the data 
are clear and strong, similar to most assays, this assay is not 100% conclusive. One thing to note 
is that although microtubules often have their minus ends close to the MTOC, and their plus ends 
reaching out to the peripheral, they sometimes do wind and/or turn backwards. This means that 
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occasionally a lysosome may travel towards the plus end, but retrogradely towards the nucleus, 
or vice versa. Co-expression of fluorescently-tagged tubulins may solve this uncertainty. 
However, this complexity does not impact on the conclusion that TRPML1 promotes retrograde 
transport of lysosomes, since retrograde transport is defined as the transport towards the 
perinuclear region irrelevant to the polarity of the microtubules.  
One thing that I noticed during the FRAP assay, is that under all experimental conditions 
tested, the majority of the lysosomes remained immotile, moving very little distances towards 
any direction. Therefore, it is worthy to test whether the activation of TRPML1 turns immotile 
lysosomes into motile lysosomes, or switches the direction of movement of those already motile 
lysosomes, or both? The data of the FRAP assay show an increase of the net number of moving 
lysosomes under TRPML1 activation or under starvation (Fig. 2.4 & 2.10), apparently 
suggesting that TRPML1 activation is able to turn immotile lysosomes into motile, retrogradely 
moving lysosomes, but is not sufficient to tell whether TRPML1 activation can switch the 
direction of the already moving lysosomes. One follow-up experiment available to test this is to 
use photo-convertible fluorescent protein tagged markers to label lysosomes. This would allow 
tracking of single lysosomes’ trafficking status, thus enable us to monitor if there’s direction 
switch of lysosomes under TRPML1 activation. 
It remains an interesting question whether starvation, mTOR inhibition and cytosolic 
alkalization converge and share the same mechanism to activate the TRPML1 pathway. It is 
known that cytosolic pH is elevated under acute starvation, likely caused by the acidification of 
autolysosomes which requires a lot of protons (Korolchuk, Saiki et al. 2011, Mauvezin and 
Neufeld 2015). If this is true, mTOR inhibition should have a similar effect to starvation in 
causing elevation of cytosolic pH. Therefore, starvation and mTOR inhibition may affect 
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lysosome motility through cytosolic alkalization. However, one drawback of this hypothesis is 
that luminal acidification of autolysosomes does not occur until the fusion between lysosomes 
and autophagosomes happen, which in the current understanding is the purpose of retrograde 
transport of lysosomes per se. It is also possible that starvation or mTOR inhibition use other 
mechanisms to initiate the retrograde transport of lysosomes, and the cytosolic alkalization 
generated after the formation of autolysosomes serves as a positive feedback. 
Perinuclear lysosome distribution, as mentioned above, is observed in many LSD cells, 
including ML1KO (Samie and Xu 2014, Xu and Ren 2015). I have shown here that this 
phenotype is likely caused by cholesterol accumulation in the LSD cells, and that this perinuclear 
distribution of lysosomes is caused by the activation of the Rab7-RILP pathway, independent of 
TRPML1. 
On top of the above finding, I characterized the relationship between TRPML1 and the 
Rab7-RILP pathway. Through experiments with constitutively active and dominant negative 
constructs, I found that the TRPML1 pathway and the Rab7-RILP pathway are independent of 
each other, and my data suggest a model where they form complementary pathways. Under 
normal conditions, TRPML1 remains mainly inactive. Endocytic vesicles acquire cholesterol 
from the plasma membrane or endocytosed liposomes that aid the Rab7-RILP pathway to 
transport the lysosomes towards MTOC in a constitutive manner. Under urgent needs, cells use 
the other pathway, through TRPML1 activation, to cause rapid retrograde transport of lysosomes. 
 




GFP-TRPML1, Lamp1-GFP and Lamp1-mCherry constructs were generated as described 
previously (Li, Wang et al. 2013). RILP-GFP was provided by Dr. Roberto Botelho (Ryerson 
University, Toronto). Rab7-T22N-GFP and Rab7-Q67L-GFP mutants were generated with a 
site-directed mutagenesis kit. All constructs were verified with sequencing. 
Mouse lines 
Characterizations of TRPML1 and NPC1 KO mice were described previously 
(Venugopal, Browning et al. 2007, Shen, Wang et al. 2012). Animals were used under approved 
animal protocols and the Institutional Animal Care Guidelines of the University of Michigan. 
Mammalian cell culture and transfection 
Mammalian cells were cultured in a 37 °C, 5% CO2 incubator. Mouse fibroblasts were 
isolated and cultured as previously described (Li, Wang et al. 2013). Immortalized cell lines 
(Cos1 and HeLa) were originated from ATCC and cultured following standard tissue culture 
protocols. Unless indicated, all cells were cultured in Dulbecco’s Modified Eagle Medium 
(DMEM, Invitrogen) supplemented with 10% FBS (Gemini and Sigma). For fibroblasts, 
transfection was performed using the Neon electroporation kit (Invitrogen). All other cells were 
transfected with Lipofectamine 2000 (Invitrogen). Culture media were refreshed 18-24 hours 
after transfection, and cells were imaged around 48 hours post transfection to allow sufficient 
recovery from transfection stress (lysosomes in transfected cells generally exhibited perinuclear 
localization pattern within 1 day post transfection likely due to cell stress). 
Ammonia Ringer’s solution  
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The formula of Ammonia Ringer’s was adapted from that of Acidic Ringer’s solution 
(Durchfort, Verhoef et al. 2012, Li, Wang et al. 2013). Specifically, acetic acid was replaced by 
ammonia chloride to alkalize the cytosol.  The solution contained (in mM) 130 HCl, 20 NH4Cl, 5 
KCl, 2 CaCl2, 1 MgCl2, 2 NaH2PO4, 10 HEPES, and 10 glucose; after mixing the solution was 
adjusted to a pH of 7.9 with NaOH.  To prevent precipitation, NaH2PO4 was made separately as 
a 100× stock solution and added fresh right before use. 
Starvation 
For starvation, complete medium was replaced with DMEM without supplements 
through four careful, extensive washes. For drug treatments under starvation conditions, drugs 
were mixed into the starvation medium directly. 
Immunolabeling 
Lamp1-GFP transfected cells were rinsed with phosphate-buffered saline (PBS) and fixed 
in 4% paraformaldehyde for 20 min at room temperature (RT).  Fixed cells were washed and 
blocked with 2% bovine serum albumin in PBS for 2 hous, and then incubated overnight with 
primary antibodies in the blocking solution.  Cells were then washed and incubated with 
secondary antibodies for 1 hour before being subjected to fluorescent imaging. 
Filiin staining and quantification 
Filipin staining was performed as described previously. Briefly, filipin was dissolved in 
DMSO at 25 mg/mL as a stock solution.  The working solution (0.05 mg/mL) was prepared fresh 
in PBS with 10% FBS.  To stain intracellular cholesterol, cultured cells were rinsed with PBS, 
and then fixed with 3% paraformaldehyde in PBS at RT for 1 h.  Fixed cells were washed with 
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PBS and then incubated with 1.5 mg/mL glycine in PBS at RT for 10 min to quench the 
paraformaldehyde.  Finally, the cells were incubated with filipin working solution at RT for 2 h, 
and washed with PBS four times before imaging.  All manipulations involving Filipin were kept 
strictly in dark until imaging 
ImageJ was used to analyze the staining results. For each individual cell, the fluorescence 
intensities of three randomly selected areas close to the cell border were averaged, subtracted 
with the image background noise (intensity of void areas), then multiplied by the cell area, and 
considered intracellular background intensity.  Lysosomal intensity, representing the net intensity 
of the brighter puncta filipin signal inside the cells, was taken as the total fluorescence intensity 
of the cell minus intracellular background intensity.  Note that because lysosomes are the 
primary storage sites of unesterified cholesterol under cholesterol storage conditions (see Fig. 
2.14f), the puncta filipin signal was presumed to be originated from lysosomal cholesterol. 
Lysosomal cholesterol was then normalized as 100 x lysosomal intensity/intracellular 
background intensity. 
Cholesterol depletion 
Depletion of cholesterol was performed as described previously (Rocha, Kuijl et al. 2009). 
Briefly, 50 μM of activated simvastatin was applied to DMEM without FBS, and then 
supplemented with 230 μM mevalonate (to supply essential nonsterol isopreniods) in the absence 
of cholesterol. Cells were washed extensively and incubated in the cholesterol-depleting medium 
for 3 hours before imaging. 
Fluorescence imaging and image analysis 
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Live imaging was performed with an Olympus Spindisk Confocal microscope equipped 
with a heated chamber to maintain the specimen temperature at ~37 °C.  Except for FRAP 
experiments, which were carried out using a 3x1 μm z-stack setting for fast speed, all live 
imaging were taken using a 0.3 μm step size z-stack setting from top to the bottom of the cells.  
GFP-tagged proteins were visualized with a 488/515 (excitation/emission in nm) filter set; 
mCherry-tagged proteins were visualized with a 561/607 filter set.  Quantification was 
performed in ImageJ. 
Photobleaching and quantification of lysosome movements. 
Photobleaching experiments were performed with the FRAP function of Metamorph 
software in an Olympus spindisk confocal system.  Briefly, after cells were incubated at ~37 °C 
for 10 min, a region (10 μm × 25-30 μm, corresponding to 42 pixels × 106–127 pixels at 60× 
magnification) was selected in which anterograde and retrograde movement could be 
distinguished easily and unambiguously.  Each selected area had at least 100 lysosomes 
immediately adjacent to each side.  The selected area was photobleached with an 800 ms/pulse 
protocol (561 nm excitation) and then live-imaged for 5 min (1 frame/s) with a z-stack of three 
1-μm steps using a 561/607 filter set.  The frames were converted to a movie in Metamorph.  The 
midline of each bleached area was drawn, and the number of lysosomes crossing the midline in 
each direction during the 5-min imaging time was counted.  If the same lysosome re-crossed the 
midline in the opposite direction without first exiting the bleached area it was not multi-counted. 
Quantification of lysosome distribution 
For an illustration of the quantification please see Fig. 2.17. Specifically, lysosome 
distribution was analyzed in fibroblasts with cell areas in the range of 2,500-7,500 μm2, and in 
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HeLa cells ranging 800-2,500 μm2.  The nuclear area was excluded during quantification.  
Average Lamp1 intensities were measured for the whole cell (Itotal), the area within 10 μm of the 
nucleus (Iperinuclear), and the area >15 μm from the nucleus (Iperipheral). For HeLa cells, the latter 
two areas were within 5-10 μm of the nucleus, respectively.  The perinuclear and peripheral 
normalized intensities were first calculated and normalized as I<10 = Iperinuclear/Itotal – 100 and 
I>15 = Iperipheral/Itotal – 100, respectively (I<5 and I>10 for HeLa cells).  The perinuclear index 
was defined as I<10 – I>15 (I<5 – I>10 for HeLa cells).  Quantifications were done by 
researchers blind to the experimental groups presented. 
Endolysosomal electrophysiology 
Endolysosomal electrophysiology was performed in isolated enlarged endolysosomes 
with a modified patch-clamp method as described previously (Dong, Shen et al. 2010, Wang, 
Zhang et al. 2012, Zhang, Li et al. 2012). Briefly, cells were treated with 1 μM vacuolin-1 for 1–
12 hours.  Enlarged vacuoles (up to 5 μm) were isolated manually with a patch pipette, and then 
whole-endolysosome voltage clamp recordings were performed.  The vacuolar membrane was 
ruptured with a series of voltage steps. Whole-endolysosome configuration was verified by the 
re-appearance of capacitance transients after break-in.  Whole-endolysosomal currents were 
elicited by repeated voltage ramps from -120 to 120 mV (400 ms) with an inter-ramp interval of 
2 s.  The pipette (luminal) solution was modified Tyrode’s, including (in mM) 145 NaCl, 5 KCl, 
2 CaCl2, 1 MgCl2, 10 HEPES, 10 MES, 10 glucose (pH adjusted with NaOH to pH 4.6).  The 
bath (internal/cytoplasmic) solution contained (in mM) 140 K-gluconate, 4 NaCl, 1 EGTA, 2 
MgCl2, 0.39 CaCl2 , 20 HEPES (pH adjusted with KOH to 7.2; free [Ca2+]i  ~ 100 nM estimated 
using MaxChelator software).  Bath solutions were applied via a perfusion system that allowed a 
complete solution exchange within a few seconds.  Data were collected using an Axopatch 2A 
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patch clamp amplifier, Digidata 1440, and pClamp 10.2 software (Axon Instruments).  Whole-
endolysosome currents were digitized at 10 kHz and filtered at 2 kHz.  All experiments were 
conducted at RT (21–23 ºC), and all recordings were analyzed with pClamp 10.2, and Origin 8.0 
(OriginLab, Northampton, MA) 
Chemicals and reagents 
The following chemicals were obtained from vendors indicated in parentheses after each 
name: ML-SA1 (Princeton BioMolecular Research), ML-SI1, Filipin, Simvastatin (Sigma), 
PI(3,5)P2 (Echelon), ML-SI3 (AKOS), BAPTA-AM, tetramethylrhodamine-dextran, and 
Mitotracker (Invitrogen). γ-tubulin antibody was purchased from Sigma (T5326). 
Statistical analysis 
Statistical data are presented as means ± standard error of the mean (SEM).  Comparisons 
between the experimental groups were made using analyses of variance (ANOVAs).  All data are 





Fig. 2.1 Distribution of lysosomes under normal or starved conditions with different 
labeling methods. 
WT fibroblasts were transfected with Lamp1-GFP and co-labeled with either lysotracker (a), or 








Fig. 2.2 TRPML1 activity is required for the starvation- and Torin-1-driven perinuclear 
accumulation of lysosomes. 
 (a, b) Representative HeLa cells (a) and Cos1 cells (b) transfected with the late-endosome and 
lysosome marker Lamp1-mCherry under 2 hours serum starvation with (right) or without 
(middle) the TRPML1 inhibitor ML-SI3 (25 μM).  Insets illustrate the size of lysosomes with 
and without starvation (same magnification, blue arrows indicate enlarged lysosomes).  (c) 
Representative WT mouse fibroblasts transfected with Lamp1-mCherry in 2 hours starvation 
condition (right).  (d) Lysosome (labelled with Lamp1) distribution in WT fibroblasts in the 
presence of the TRPML1 inhibitor ML-SI1 (25 μM) with (right) or without (left) starvation.  (e) 
Lysosome distribution in WT fibroblasts treated with mTOR inhibitor Torin 1 (1 μM) or together 
with ML-SI3 (25 μM) for 2 h.  (f) Quantitative analyses of lysosome distribution in the 
experiments shown in (c) and (d).  The intracellular distribution of Lamp1-positive vesicles was 
quantified as described in Materials & Methods.  Fibroblasts were chosen for most quantification 
analyses for their large cell area, regular shape, and ML1 KO availability.  (g) Quantification of 
groups shown in (e).  Red lines in images outline cell boundaries and the red “N” marks the 
nucleus.  Graphed data are presented as means ± SEM, number of cells used for quantification 






Fig. 2.3 Concurrent accumulation of autophagosomes and lysosomes towards the 
perinuclear region under acute starvation. 
(a) HeLa cells stably expressing GFP-RFP-LC3 were subjected to starvation for 2 hours (lower 
panel).  The GFP channel shows puncta that label autophagosomes specifically, but not 
autolysosomes.  (b) WT fibroblasts were transfected with Lamp1-GFP and left untreated (top), 
or starved for 2 hours (bottom), then fixed and immunolabelled for γ-tubulin to visualize 






Fig. 2.4 FRAP analysis reveals that TRPML1 is responsible for the increased retrograde 
transport of lysosomes under starvation. 
(a-c) FRAP analysis of lysosome movement in WT fibroblasts without any treatment (a), with 
15–30 min starvation (b), or with starvation in the presence of 25 μM ML-SI3 (c).  Snap images 
immediately after (top panels) or 5 min (bottom panels) after photobleaching are shown.  
Lysosomes that traveled across the midline of the photobleached region (yellow line) towards the 
nucleus (retrograde) are labeled green; those moving away from the nucleus (anterograde) are 
63 
 
labeled red.  (d) Quantification of lysosomes in (a-c) undergoing retrograde or anterograde 
transport. Graphed data are presented as means ± SEM, number of cells used for quantification 






Fig. 2.5 Effect of synthetic agonists/antagonists and cytosolic pH on TRPML1 activity. 
(a) ML-SA1 (10 μM)-activated whole-lysosome TRPML1 currents were inhibited potently by 
the TRPML1 inhibitor ML-SI3 (2.5 μM). (b) PI(3,5)P2-activated whole-endolysosome TRPML1 






Fig. 2.6 Inhibition of TRPML1 suppresses autolysosome formation 
(a-c) HeLa cells stably expressing GFP-RFP-LC3 were left untreated (a), starved for 2 hours (b), 
or starved for 2 hours in the presence of 25 μM ML-SI3 (c).  (d) Quantification of the number of 
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puncta that were GFP- and RFP-positive (autophagosomes, AP) over the number of puncta that 
were only RFP-positive (autolysosomes, AL) for groups shown in (a-c).  Graphed data are 
presented as means ± SEM, number of cells used for quantification are shown in the brackets. *p 






Fig. 2.7 TRPML1 activity is required for alkalization-induced lysosome retrograde 
migration 
(a, b) Lamp1-mCherry-transfected WT fibroblasts were treated with 30 min ammonia Ringer’s 
solution in the presence (b) or absence (a) of 25 μM ML-SI3.  (c) Quantification of groups 
shown in (a) and (b).  (d) Western blot showing the phosphorylated form of S6K (pS6K) in 
HeLa cells starved for 2 hours, treated with 1 μM Torin-1 for 2 hours, or treated with ammonia 
Ringer’s for 30 min.    Red lines outline cell boundaries and nuclei are marked with a red “N”.  
Graphed data are presented as means ± SEM, number of cells used for quantification are shown 






Fig. 2.8 Activation of TRPML1 is sufficient to promote Ca2+-dependent retrograde 
migration of lysosomes. 
HeLa cells (a) Cos1 cells (b) and WT fibroblasts (c) with (bottom) and without (top) 25 μM ML-
SA1 for 2 hours.  (d-f) Lysosome distribution in TRPML1-overexpessing WT fibroblasts (d) 
treated with 10 μM BAPTA-AM for 1 hour (e) or 25 μM ML-SI1 for 2 hours (f).  (g) 
Quantification of lysosome distribution in the experiments shown in (c) and (d).  (h) 
Quantification of experimental group shown in (e).  (i) Quantification of experimental group 





Fig. 2.9 Retrograde migration of lysosomes is specifically promoted by TRPML1 
hyperactivity. 
 (a) WT fibroblasts treated with ML-SA3 (25 μM) or ML-SA5 (1 μM), two structurally-
independent TRPML1 agonists, for 1 hour.  (b) In TRPML1-overexpressing cells, the majority 
of lysosomes were localized in the perinuclear region in the presence or absence of 25 μM ML-
SA1.  (c) Quantifications of groups shown in (b).  (d) Representative images showing WT 
fibroblasts overexpressing TRPML2 or TRPML3.  (e) Quantification of groups shown in (d).  
Red lines outline cell boundaries and nuclei are marked with a red “N”.  Graphed data are 
presented as means ± SEM, number of cells used for quantification are shown in the brackets. *p 





Fig. 2.10 Activation of TRPML1 promotes retrograde transport of lysosomes shown by 
FRAP and time-lapse imaging. 
(a) FRAP analysis of lysosome retrograde transport upon 25 μM ML-SA1 application. (b, c) The 
same WT fibroblast expressing Lamp1-mCherry, and right before (b) or after 30 minutes (c) of 
25 μM ML-SA1 treatment. (d) Quantification of lysosomes shown in (j) undergoing retrograde 
and anterograde transport after photobleaching. Graphed data are presented as means ± SEM, 
number of cells used for quantification are shown in the brackets. *p < .05, **p < .01 in ANOVA.  






Fig. 2.11 TRPML1 activation increases the retrograde transport of lysosomes selectively, 
but not mitochondria. 
(a) Representative images of Lamp1-GFP-transfected fibroblasts stained with MitoTracker (100 
nM) for 1 hour.  (b) MitoTracker in the presence of 25 μM ML-SA1.  (c) Quantification of 
groups shown in (a) and (b).  Upon ML-SA1 treatment, lysosomes became more perinuclear, 





Fig. 2.12 Cholesterol mediates the perinuclear lysosome pattern in LSD cells. 
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(a) Representative images showing Lamp1-mCherry-transfected ML1 KO fibroblasts in starved 
cells that were treated with simvastatin and mevalonolactone to deplete cholesterol.  (b) 
Quantification of groups shown in (a).  (c) Representative images showing Lamp1-mCherry 
transfected NPC1 KO fibroblasts (upper left), starved for 3 hours (upper right), starved with 
cholesterol depletion (bottom left), or starved with cholesterol depletion in the presence of 25 
μM ML-SI1 (bottom right).  (d) Quantification of groups shown in (c).  (e) Effect of cholesterol 
depletion on starvation-induced lysosome redistribution in WT fibroblasts.  (f) Quantification of 
observations shown in (e).  Red lines outline cell boundaries and nuclei are marked with a red 
“N”.  Graphed data are presented as means ± SEM, number of cells used for quantification are 








Fig. 2.13 Effect of prolonged, pharmacological inhibition of TRPML1 on lysosome 
distribution. 
(a) Lysosome distribution in WT fibroblasts treated with vehicle (0.1% DMSO) (upper right), 
ML-SI1 25 μM for 18 hour (bottom left), or ML-SI3 25 μM for 18 hour (bottom right) in 
complete medium.  (b) Quantification of the groups shown in (a).  (c) Time-dependence of 
TRPML1 inhibition of lysosome distribution in WT fibroblasts in complete medium.  (d) 
Representative images showing lysosome distribution in Rab7-T22N-expressing cells in the 
presence of ML-SI3 (25 μM) for 18 hours.  Red lines outline cell boundaries and nuclei are 
marked with a red “N”.  Graphed data are presented as means ± SEM, number of cells used for 




Fig. 2.14 Characterization of the cholesterol accumulation under prolonged TRPML1 
inhibition or in LSD model cells. 
(a) Filipin staining of WT fibroblasts (upper left) and WT fibroblasts depleted of cholesterol with 
simvastatin (upper right), WT fibroblasts treated with 25 μM ML-SI3 for 1 hour (bottom left) or 
24 hours (bottom right). (b) ML1 KO fibroblasts with (right) or without (left) cholesterol 
depletion.  (c) NPC1 KO fibroblasts with (right) or without (left) cholesterol depletion.  (d) 
Quantitative comparison of filipin staining in WT fibroblasts treated with different durations of 
ML-SI3 versus ML1 KO and NPC1 KO fibroblasts.  (e) Quantification of filipin stating in WT, 
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ML1 KO, NPC1 KO fibroblasts with or without cholesterol depletion.  (f) Representative images 
showing ML1 KO fibroblasts transfected with Lamp1-mCherry, and stained with filipin.  
Intracellular puncta filipin staining co-localized well with Lamp1.  Graphed data are presented as 
means ± SEM, number of cells used for quantification are shown in the brackets. *p < .05, **p 






Fig. 2.15 TRPML1 is not downstream of Rab7 and RILP in promoting retrograde 
migration of lysosomes. 
(a, b) Representative images showing WT fibroblasts overexpressing Lamp1-mCherry and 
RILP-GFP (a) or Rab7-Q67L-GFP (b) in the presence or absence of 25 μM ML-SI3 for 2 hours.  
(c) Quantification of groups shown in (a).  (d) Quantification of groups shown in (b).  Red lines 
outline cell boundaries.  Graphed data are presented as means ± SEM, number of cells used for 





Fig. 2.16 The Rab7-RILP pathway does not work downstream of TRPML1. 
(e) Representative images showing WT fibroblasts transfected with Lamp1-mCherry and Rab7-
T22N-GFP, then left untreated (upper panels), serum starved for 2 hours (middle panels), or 
incubated with 25 μM ML-SA1 for 2 hours (bottom panels).  (f) Representative images showing 
ML1 KO fibroblasts overexpressing Lamp1-mCherry and Rab7-T22N-GFP.  (g) Quantification 
of groups shown in (e).  (h) Quantification of the group shown in (f).  Graphed data are presented 
as means ± SEM, number of cells used for quantification are shown in the brackets. *p < .05, **p 






Fig. 2.17 Quantification of the perinuclear index. 
To quantify the distribution of lysosomes, cells were divided into four regions: the nucleus 
(region 1); the perinuclear region (region 2, within 10 μm to the nucleus in fibroblasts or within 5 
μm to the nucleus in HeLa cells); the intermediate region (region 3, between 10-15 μm to the 
nucleus in fibroblasts or 5-10 μm to the nucleus in HeLa cells); the peripheral region (region 4, 
further than 15 μm to the nucleus in fibroblasts or 10 μm to the nucleus in HeLa cells), as 
illustrated by the top-left image. The fluorescence intensity of the perinuclear region and the 
peripheral region were calculated using equations at bottom-left. The resulting normalized 
fluorescence intensity shown in the top-right graph was further combined together as described 




Identification of the Upstream and Downstream Players in the 
TRPML1-Mediated Lysosome Retrograde Trafficking Pathway3 
 
3.1 Abstract 
Experiments described in Chapter II identified TRPML1 as a novel regulator of the 
retrograde transport of lysosomes in an on-demand manner, independent of the previously 
established Rab7-RILP pathway. The next step is to identify the upstream and downstream 
molecules of the TRPML1 pathway, so that the mechanism of action can be deduced. Here I 
show that PI(3,5)P2 is required for TRPML1 activation in the retrograde transport, while a 
TRPML1-interacting calcium sensor, ALG-2, serves as the downstream target of TRPML1. 
ALG-2 bridges Ca2+ signaling from TRPML1 and the dynein adaptor complex dynactin, while 
the motor protein dynein serves as the final effector of the pathway.  
 
3.2 Introduction 
                                                          
3 Originally Submitted in Nature Cell Biology. With authors listed as Xinran Li, Nicholas Rydzewski, 




Ca2+ is a versatile regulator of cellular processes. One reason for its versatility is due to 
the many kinds of Ca2+ sensor proteins sensing Ca2+ signals in different pathways. 
Data in Chapter II suggest that TRPML1 regulates retrograde transport of lysosomes 
through its Ca2+ release. Therefore, a Ca2+ sensor must be downstream of TRPML1 to pass on 
the signal. Multiple Ca2+ sensor proteins are known to interact with TRPML1, or play a role 
downstream of TRPML1. Among these proteins, synaptotagmin VII (Syt VII) is shown to be 
involved in regulating lysosome exocytosis in macrophages downstream of TRPML1 (Samie, 
Wang et al. 2013). This protein contains two C2 domains that are responsible for the binding to 
Ca2+ and the interaction with membrane lipids, especially PI(4,5)P2 (Bai and Chapman 2004). It 
is hypothesized that Syt VII regulates lysosome exocytosis similar to Syt I in regulating synaptic 
vesicle release, where the Ca2+-binding induces a conformational change of Syt I, leading to the 
structural change of the SNARE complex that allows membrane mixture of the vesicle and the 
plasma membrane.  
Calcineurin is another Ca2+ sensor that was recently reported (Medina, Di Paola et al. 
2015) to be downstream of TRPML1 in the signaling of the master regulator of lysosome 
biogenesis, Transcription Factor E-Box (TFEB). TFEB has been shown to be phosphorylated by 
mTOR under normal conditions, retaining it in the cytosol through the recognition by 14-3-3 
(Pena-Llopis, Vega-Rubin-de-Celis et al. 2011). Under starvation or stressed conditions, 
TRPML1 activates the Ca2+-regulated phosphatase calcineurin, which de-phosphorylates TFEB, 
allowing it to dissociate from 14-3-3 and enter the nucleus, promoting transcription of a variety 
of lysosomal genes (Medina, Di Paola et al. 2015). 
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Another Ca2+ sensor shown to interact with TRPML1 is the penta-EF hand protein 
Apoptosis-Linked Gene-2 (ALG-2). ALG-2 is a small, 190 a.a. protein that mainly consists of 
five EF hands for Ca2+ binding, although two of the EF hands (EF1 and EF3) were shown to be 
more critical for its Ca2+ sensor role (Vergarajauregui, Martina et al. 2009). ALG-2 has been 
shown to be able to physically interact with TRPML1 in a Ca2+-dependent manner, i.e. Ca2+ 
binding of ALG-2 is required for its interaction with TRPML1 (Vergarajauregui, Martina et al. 
2009). ALG-2 has been shown to be involved in multiple membrane trafficking steps, being able 
to interact with Sec31A (Shibata, Suzuki et al. 2007, Helm, Bentley et al. 2014) and ALIX 
(Inuzuka, Suzuki et al. 2010, Okumura, Katsuyama et al. 2013), two proteins involved in ER-to-
Golgi vesicle transport and ESCRT-mediated late endosomal membrane abscission, respectively 
(Shibata, Suzuki et al. 2007, Helm, Bentley et al. 2014, Scheffer, Sreetama et al. 2014). The role 
for its interaction with TRPML1, however, remained unidentified.  
In this chapter, I show experimental results that suggest ALG-2 as the downstream Ca2+ 
sensor of the TRPML1 pathway. I also show that the upstream activator of TRPML1, PI(3,5)P2, 
is required for the process, and that ALG-2 serves as the bridge linking TRPML1’s Ca2+ release 
to the dynein adaptor complex dynactin. 
 
3.3 Results 
3.3.1 The role of PI(3,5)P2 in retrograde trafficking of lysosomes 
PI(3,5)P2 is a lysosome-localized phosphoinositide (Li, Wang et al. 2013) that regulates 
autophagy during nutrient deprivation (Vicinanza, Korolchuk et al. 2015) and is the only known 
endogenous agonist of TRPML1. PI(3,5)P2 binds directly to a stretch of positively-charged 
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residues on the N-terminal of TRPML1 (Dong, Shen et al. 2010). Mutation of these residues to 
glutamine (TRPML1-7Q) completely abolishes the sensitivity to PI(3,5)P2, while retaining its 
sensitivity to synthetic agonists like ML-SA1 (Dong, Shen et al. 2010). Therefore, as the only 
known candidate for upstream signaling to TRPML1, I investigated the role of PI(3,5)P2 in 
regulating retrograde trafficking of lysosomes. 
Prolonged depletion of PI(3,5)P2 leads to severely enlarged lysosomes that can occupy 
the majority of the cellular space. Therefore, only short-term depletion of PI(3,5)P2 was applied. 
Under 1 hour treatment with 1 μM YM 201636 or Apilimod, two well-established synthetic 
inhibitors of the PI(3,5)P2 and PI(5)P synthesizing enzyme PIKfyve (Jefferies, Cooke et al. 2008, 
Cai, Xu et al. 2013, Martin, Harper et al. 2013, Ho, Choy et al. 2015), lysosome distributions 
were slightly, but significantly more peripheral (Fig. 3.1a, 3.1b). The depletion of PI(3,5)P2 also 
effectively suppressed the retrograde migration of lysosomes under acute starvation or mTOR 
inhibition by Torin-1 (Fig. 3.1c-f). These results suggest that PI(3,5)P2 or PI(5)P plays a critical 
role in the regulation of retrograde motility of lysosomes.  
PI(5)P/PI(3,5)P2 depletion was unable to affect the perinuclear accumulation of 
lysosomes under ML-SA1 treatment, suggesting that TRPML1 might be the downstream target 
of the phosphoinositides (Fig. 3.1a, 3.1b). Consistently, overexpression of the PI(3,5)P2 
insensitive mutant TRPML1-7Q did not result in significant change of lysosome distribution as 
overexpression of the WT channel (Fig. 3.1g, 3.1h). ML-SA1 treatment increased the 
perinuclear localization of lysosomes reliably in TRPML1-7Q-overexpressing cells (Fig. 3.1g, 
3.1h). Taken together, these results suggest that PI(3,5)P2 is essential for the TRPML1-regulated 
lysosome transport under physiological conditions, and that synthetic agonists can be used to 




3.3.2 TRPML1-dependent retrograde migration of lysosomes is through cytoplasmic dynein 
In animal cells, microtubules-based motor proteins are responsible for the long-range 
transport of vesicles (Schroer 2004, Verhey and Hammond 2009, Akhmanova and Hammer 
2010). Kif5B and cytoplasmic dynein I are shown to be responsible for the transport of 
lysosomes in mammalian cells (Tanaka, Kanai et al. 1998, Jordens, Fernandez-Borja et al. 2001, 
Johansson, Rocha et al. 2007, Rosa-Ferreira and Munro 2011). Overexpression of dominant-
negative Kif5B (Kif5B-DN) (Silver and Harrison 2011) in mouse fibroblasts produced a very 
strong clustering of lysosomes at the perinuclear region, whereas overexpression of the dominant 
negative dynein intermediate chain 2 (DynCI2-DN) (King, Brown et al. 2003) resulted in a 
predominantly peripheral localization of lysosomes (Fig. 3.2a, 3.2b, 3.2e). As expected, 
starvation or ML-SA1 did not result in any significant changes in the peripheral localization 
pattern of lysosomes with DynIC2-DN overexpression (Fig. 3.2b-d, 3.2f). The overexpression of 
DynIC2-DN also shifted filipin-positive puncta structure in ML1KO fibroblasts to the cell 
periphery, without correcting the cholesterol accumulation phenotype (Fig. 3.2g). Treatment of 
the dynein inhibitor Ciliobrevin D (Sainath and Gallo 2015) for 2 hours also reversed the 
perinuclear distribution of lysosomes caused by ML-SA1 or TRPML1 overexpression in WT 
fibroblasts (Fig. 3.2 h-k). Collectively, these results suggest that cytoplasmic dynein is 
responsible for the TRPML1-dependent retrograde transport of lysosomes. 
 
3.3.3 ALG-2 acts as the downstream effector of TRPML1 to promote minus-end motility of 
lysosomes through interaction with the dynactin complex 
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As a Ca2+ dependent TRPML1 interacting protein, I tested whether ALG-2 can serve as 
the downstream effector of TRPML1 in regulating lysosome motility. Indeed, ALG-2 
overexpression in fibroblasts resulted in the perinuclear accumulation of lysosomes similar to 
TRPML1 hyperactivation (Fig. 3.3a, 3.3e, 3.4a). In contrast, overexpression of another 
lysosomal Ca2+ sensor, Syt VII, did not affect lysosome distribution (Fig. 3.5). In accordance 
with the Ca2+-dependence of the interaction between TRPML1 and ALG-2, overexpression of a 
Ca2+-binding defective EF-hand mutant of ALG-2 (ALG-2 E47A/E114A, or ALG-2-EEAA) 
(Vergarajauregui, Martina et al. 2009) had no effect on lysosome distribution (Fig. 3.3c, 3.3e). 
TRPML1 inhibition also abolished the effect of ALG-2 overexpression (Fig. 3.3b, 3.3e). On the 
other hand, activation of TRPML1 with ML-SA1 increased the co-localization of GFP-ALG-2 
with Lamp1-mCherry (Fig. 3.4), consistent with the previous reports. Therefore, ALG-2 may 
serve as a Ca2+ effector of TRPML1 to promote retrograde migration of lysosomes. 
TRPML1 interacts with ALG-2 through a stretch of three amino acids (R44, L45 and K46) 
on the N-terminal of TRPML1 (Vergarajauregui, Martina et al. 2009). Mutations of these 
residues (e.g. TRPML1-R44/A or TRPML1-R44LK/AAA) greatly decreases or abolishes the 
interaction between ALG-2 and TRPML1 (Vergarajauregui, Martina et al. 2009). TRPML1-
R44LK/AAA showed much smaller currents in electrophysiology recordings compared with WT 
channel, while TRPML1-R44/A showed similar activation properties as the WT channel (Fig. 
3.6a-c). Therefore, I used TRPML1-R44/A as a control for the study. As mentioned in Chapter II, 
lysosomes in ML1KO fibroblasts displayed a perinuclear pattern likely caused by excessive 
accumulation of cholesterol that activates the Rab7-RILP pathway (Fig. 2.12). Overexpression of 
either WT TRPML1 or the ALG-2 binding deficient mutant TRPML1-R44/A in ML1KO 
fibroblasts rescued the cholesterol accumulation (Fig. 3.6f, 3.6g). Overexpression of the WT 
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channel did not suppress the perinuclear distribution of lysosomes but rather resulted in a 
lysosome distribution similar to that produced by overexpression of the channel in WT cells due 
to the constitutive activity of TRPML1 under overexpression (Fig. 3.6d, 3.6e). In contrast, 
overexpression of TRPML1-R44/A reversed the perinuclear distribution of lysosomes in ML1KO 
fibroblasts (Fig. 3.3d, 3.3f). Hence, physical interaction between TRPML1 and ALG-2 is 
required for the retrograde transport of lysosomes under physiological conditions.  
It is known that cytoplasmic dynein does not interact with lysosomes directly, but 
through the dynactin complex, which in turn interacts with lysosomal proteins for its recruitment. 
In co-immunoprecipitation experiments (Co-IP), ALG-2-mCherry was able to pull down 
dynamitin, a member of the dynactin complex (Schroer 2004), with specificity (Fig. 3.7). 
Overexpression of dynamitin causes the dynactin complex to disassemble. However, ALG-2-
mCherry pulled down both overexpressed dynamitin and endogenous dynamitin (Fig. 3.7a, 3.7b). 
This suggests that dynamitin, but not other members of the dynactin complex, might be the 
protein responsible for the interaction with ALG-2. Interestingly, ALG-2 pulled down dynamitin 
in a Ca2+-independent manner (Fig. 3.7a), suggesting a model where ALG-2 is constitutively 
associated with the dynactin complex, and recruits the complex to lysosome surface upon Ca2+ 
release from TRPML1. 
To further investigate the role of ALG-2 in retrograde transport of lysosomes, I generated 
and characterized ALG-2 KO HeLa cells using the CRISPR-Cas9 system (Cong and Zhang 2015) 
(Fig. 3.8a, 3.8b). At resting conditions, ALG-2 KO cells displayed a dispersed lysosome pattern 
that is not significantly different from the WT (although slightly more peripheral) (Fig. 3.8c, 
3.8h). Under acute starvation or ML-SA1 application, however, these cells showed a sharp 
contrast to WT cells by not responding to these treatments in regard to lysosome positions (Fig. 
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3.8d, 3.8e, 3.8h). These data strongly suggest that ALG-2 is required for the retrograde migration 
of lysosomes under TRPML1 activation or acute starvation. Consistent with results described in 
Chapter II, perinuclear accumulation of lysosomes caused by RILP overexpression was not 
blocked by ALG-2 KO (Fig. 3.8f, 3.8g), suggesting that ALG-2 is responsible specifically for 
the TRPML1 pathway, but not for the Rab7-RILP pathway. Additionally, in ALG-2 KO HeLa 
cells, basal LC3-II levels were dramatically elevated compared to WT cells, and starvation did 
not induce further increase in LC3-II/LC3-I ratio (Fig. 3.8i, 3.8j). Collectively, these results 




In this Chapter I showed data that support a model on how TRPML1 regulates retrograde 
transport of lysosomes. In this model, PI(3,5)P2 is required to activate TRPML1 under acute 
trafficking cues. When TRPML1 is activated, ALG-2 senses the Ca2+ elevation, and brings the 
dynactin complex to the lysosome through interacting with TRPML1. Dynactin complex recruits 
cytoplasmic dynein to allow the final transport of lysosomes in the minus-end direction. 
As the only known endogenous agonist of TRPML1 (Dong, Shen et al. 2010), it is not 
surprising to find that PI(3,5)P2 is required for TRPML1’s function in retrograde transport of 
lysosomes. However, upon starvation, bulk cellular PI(3,5)P2 levels reportedly drop to about 40% 
of the pre-starvation levels (Zolov, Bridges et al. 2012, Li, Wang et al. 2013). Therefore, 
activation of TRPML1 under starvation is unlikely caused through a direct increase in the 
PI(3,5)P2 levels, and PI(3,5)P2 may only play a permissive role in this process, allowing the 
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channel to open in its presence, simply serving as the location identifier to ensure the activation 
of TRPML1 is at the correct place. 
Starvation is shown to cause mTOR inhibition and cytosolic alkalization, the latter shown 
in Chapter II to directly trigger retrograde migration of lysosomes. However, TRPML1 channel 
activity is only slightly increased upon cytosolic alkalization. mTOR was reported recently to 
suppress TRPML1 function through phosphorylation (Onyenwoke, Sexton et al. 2015), and may 
also regulate the subcellular localization of endogenous TRPML1, as suggested by studies on 
Drosophila TRPML (Wong, Li et al. 2012). Additionally, unidentified endogenous TRPML1 
agonists may be produced during acute starvation and autophagy induction. It is likely multiple 
mechanisms mentioned above may locally activate TRPML1 in lysosomes during acute 
conditions. 
The finding that the ALG-2 non-binding TRPML1-R44/A can rescue the lysosome 
distribution phenotype as well as the cholesterol accumulation in ML1KO fibroblasts is very 
interesting. This would suggest that firstly, TRPML1 plays a role in clearing cholesterol out of 
lysosomes, which has been implied through previous studies  (Pagano, Puri et al. 2000, Samie 
and Xu 2014, Wang, Gao et al. 2015). Secondly, the clearance of cholesterol from lysosomes is 
independent of TRPML1’s interaction with ALG-2 and the downstream pathway. Therefore, 
other downstream effectors of TRPML1 have to be responsible for the clearance of cholesterol 
from the lysosomes. This would be an interesting topic for future studies. 
ALG-2 has been shown to be involved in several vesicular trafficking steps, including 
ER-to-Golgi transport (Shibata, Suzuki et al. 2007, Helm, Bentley et al. 2014). It is known that 
Golgi is the organelle that normally resides closest to the MTOC, and may even play a role itself 
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in organizing microtubules (Rios 2014). Therefore, any transport towards the Golgi likely 
requires retrograde motility. Since ALG-2 associates with the dynactin complex, can it also 
regulate ER-to-Golgi transport through recruiting the dynactin complex to those transport 
vesicles? This would be a very interesting question to test. 
Previous studies showed that TRPML1 has multiple downstream Ca2+ effectors, such as 
Synaptotagmin VII for lysosome exocytosis (Samie, Wang et al. 2013), and calcineurin for 
TFEB activation (Medina, Di Paola et al. 2015). How could TRPML1 regulate diverse 
downstream Ca2+ signaling pathways without messing them up? There are multiple possible 
mechanisms to ensure the specificity of the Ca2+ signaling. First, subcellular localization of the 
lysosome may have a direct impact on the availability of the downstream pathways. For example, 
it would not be possible to have lysosome exocytosis if the lysosome is away from the plasma 
membrane. Second, the downstream signaling pathway may require the presence of additional 
cofactors/substrates, or the absence of blockers. For example, activation of TRPML1 under fed 
conditions is unlikely going to cause TFEB translocation, due to the active mTORC1 complex 
present to re-phosphorylate TFEB. Therefore, TFEB translocation only happens when TRPML1 
is active, and mTORC1 is inactive. 
 
3.5 Materials and Methods 
DNA subcloning 
Dominant-negative Kif5B (human Kif5B a.a. residues 592-963) was subcloned to 
pmCherry-C1 (Clontech) using Kif5B cDNA as the template with the following pair of primers: 
forward, CCG GAA TTC ACT CTA CAT TAG CAA AAT G; and reverse, GTC GGA TCC 
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TTA CAC TTG TTT GCC TC.  Dominant-negative dynein intermediate chain 2 (GFP-DYNIC2-
DN) and GFP-dynamitin (both gifts from Dr. Kristen Verhey at the University of Michigan) 
have been characterized previously. mCherry-ALG-2 and GFP-TRPML1-R44LK/AAA were 
provided by Dr. Rosa Puertollano (NHLBI, NIH). mCherry-ALG2-E47E114/AA, GFP-TRPML1-
R44/A mutants were generated with a site-directed mutagenesis kit. Other constructs are 
described in Chapter II. All constructs were verified with sequencing and confirmed with 
western blotting 
Mouse lines; mammalian cell culture and transfection; starvation; fluorescence imaging 
and image analysis; quantification of lysosome distribution; endolysosomal 
electrophysiology, and statistical analysis 
Same materials and protocols as described in Chapter II were applied. 
Generation of ALG-2 KO HeLa cells using CRISPR/Cas9 
A SpCas9 plasmid was obtained from Addgene (#48139).  Primers for guide RNA 
generation are as following:  
#1 forward: CACCGAGGGCCGGGGCGGTAAGAGT;  
#1reverse: AAACACTCTTACCGCCCCGGCCCTC;  
#2 forward: CACCGCTCTTACCGCCCCGGCCCTG;  
#2 reverse: AAACCAGGGCCGGGGCGGTAAGAGC.   
ALG-2 KO HeLa cells were generated using protocols established previously (Cong and 
Zhang 2015).  Briefly, primers were annealed and incorporated onto the plasmid using the BpiI 
site.  WT HeLa cells were transfected with the plasmid and followed by a 2-day puromycin 
selection after transfection for 24h.  The cells were then plated on 96-well plates with an average 
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density of 0.5 cell per well.  Single colonies were selected and sequenced.  Identified mutant 
lines were confirmed by western blotting using anti-ALG-2. 
Co-immunoprecipitation 
Transfected cells (Cos1 cells for double-overexpression and HEK 293 cells for Co-IP 
with endogenous protein) from 10 cm dishes were incubated with 1 mL of lysis buffer (1% NP-
40, 0.25% Na-deoxycholate, 1 mM Na3VO4, 1 mM NaF, 150 mM NaCl, 0.5 mM CaCl2 in 50 
mM Tris-HCl, adjusted to pH 7.4) for 30 min at 4 °C with occasional vortex. Lysates were 
centrifuged at 16,000 ×g for 10 min, and supernatants were incubated with 3 μg of primary 
antibodies at 4 °C for 1 hour. After addition of 30 μl of protein A/G plus-agarose, lysates were 
incubated at 4 °C overnight with gentle shaking.  Agarose beads were then collected through 
centrifuge at 500 ×g for 5 min. Beads were washed four times in lysis buffer, then heated to 
60 °C for 10 min in NuPAGE loading buffer. Proteins were blotted with anti-GFP/mCherry 
(1:5000), or anti-Dynamitin (1:1000). 
Chemicals and reagents 
Chemicals additional to those described in Chapter II are as follows: YM 201636 
(Symansis), Ciliobrevin D (EMD Millipore), Apilimod (Axon Medchem BV). Dynamitin 
antibody was purchased from BD Biosciences (611002), and ALG-2 antibody was purchased 







Fig. 3.1 PI(3,5)P2 is required as an agonist of TRPML1 to promote perinuclear migration 
of lysosomes. 
(a) Lysosome distribution in WT fibroblasts treated with 1 μM apilimod for 1 hour (left), 1 μM  
YM 201636 for 1 hour (middle), or 1 μM YM 201636 plus 25 μM ML-SA1 (right).  (b) 
Quantification of groups shown in (a).  (c) Lysosome distribution in WT fibroblasts starved for 1 
hour (left), or starved for 1 hour in the presence of 1 μM apilimod (middle) or YM 201636 
(right).  (d) Quantification of groups shown in (c).  (e) Lysosome distribution in WT fibroblasts 
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treated with 1 μM Torin-1 for 1 hour in the presence of 1 μM apilimod (middle) or YM 201636 
(right).  (f) Quantification of groups shown in (e).  (g) Lysosome distribution in TRPML1-7Q-
transfected cells in the presence (right) or absence (middle) of 25 μM ML-SA1 for 1 hour.  (h) 
Quantification of groups shown in (g), compared to cells expressing Lamp1 alone.  Red lines 
outline cell boundaries and nuclei are marked with a red “N”.  Graphed data are presented as 
means ± SEM, number of cells used for quantification are shown in the brackets. *p < .05, **p 





Fig. 3.2 TRPML1 promotes retrograde migration of lysosomes through cytoplasmic dynein. 
(a) Lysosome (labeled with Lamp1-EGFP) distribution in WT fibroblasts transfected with 
mCherry-tagged dominant-negative Kif5B (Kif5B-DN).  (b-d) Lysosome (labeled with Lamp1-
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mCherry) distribution in WT fibroblasts transfected with GFP-tagged dominant-negative 
cytoplasmic dynein intermediate chain 2 (DynIC2-DN), then left untreated (b), starved for 2 
hours (c), or treated with 25 μM ML-SA1 for 2 hours (d).  (e) Quantification of lysosome 
distribution in groups shown in (a) and (b).  (f) Quantification of lysosome distribution in groups 
shown in (b-d).  (g) Representative images showing ML1KO fibroblasts transfected with 
DynIC2-DN-GFP, and stained with filipin.  White arrows indicate lysosomal cholesterol in 
DynIC2-DN overexpression cells, while yellow arrows indicate lysosomal cholesterol in non-
transfected cells.  (h) Effect of dynein inhibitor ciliobrevin D (20 μM, 2 hours) on lysosome 
distribution in TRPML1-expressing fibroblasts.  (i) Quantification of lysosome distribution in 
cells shown in (h).  (j) WT fibroblasts treated with ML-SA1 (25 μM) or together with ciliobrevin 
D (20 μM) for 2 hours.  (k) Quantification of lysosome distribution in cells shown in (j)  Red 
lines outline cell boundaries; “N” marks nuclei. Graphed data are presented as means ± SEM, 
number of cells used for quantification are shown in the brackets. *p < .05, **p < .01 in 






Fig. 3.3 ALG-2 mediates TRPML1-dependent minus-end directed transport of lysosomes. 
(a) Lysosome distribution in WT fibroblasts co-transfected with Lamp1-GFP and mCherry-
ALG-2.  (b) Lysosome distribution in mCherry-ALG-2-transfected cells treated with ML-SI3 (25 
μM) for 1 hour.  (c) Lysosome distribution in WT fibroblasts co-transfected with Lamp1-GFP 
and mCherry-ALG-2-EEAA (E47A/E114A).  (d) Lysosome distribution in ML1 KO fibroblasts 
transfected with Lamp1-mCherry alone (top), Lamp1-mCherry + GFP-TRPML1 (middle), or 
Lamp1-mCherry + GFP-TRPML1-R44/A (bottom).  (e) Quantification of lysosome distribution 
in experiments shown in (a-c).  (f) Quantification of groups shown in (d).   Red lines in images 
outline cell boundary and the red “N” marks the nucleus.  Graphed data are presented as means ± 
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SEM, number of cells used for quantification are shown in the brackets.  *p < .05, **p < .01 in 





Fig. 3.4 Co-localization of overexpressed ALG-2-GFP and Lamp1-mCherry. 
(a-c) WT fibroblasts co-transfected with ALG-2-GFP and Lamp1-mCherry, then left without 
treatment (a), treated with 25 μM ML-SI3 for 2 hours (b), or treated with 25 μM ML-SA1 for 2 
hours (c).  Some perinuclear bright dots of ALG-2 not co-localized with Lamp1 were seen in all 
treatment conditions.  Treatment of ML-SI3 and ML-SA1 resulted in less (ML-SI3) or more 
(ML-SA1) co-localization with Lamp1 compared to non-treated control cells, respectively.  





Fig. 3.5 Overexpression of lysosomal Ca2+ sensor Synaptotagmin VII does not affect 
lysosome distribution. 
(a, b) WT fibroblasts overexpressing Lamp1-mCherry with (a) or without (b) Syt VII co-
expression.  (c) Quantification of groups shown in (a, b). Red lines outline cell boundaries and 
nuclei are marked with red “N”.  Graphed data are presented as means ± SEM, number of cells 






Fig. 3.6 Different rescue effects of TRPML1 and TRPML1-R44/A overexpression in 
ML1KO fibroblasts. 
(a-c) Representative whole-lysosome currents in cells overexpressing WT TRPML1 (a), 
TRPML1-R44/A (b), or TRPML1-R44LK/AAA (c). Whole-lysosome currents were elicited by 
the endogenous agonist PI(3,5)P2 or the synthetic agonist ML-SA1.  (d) Overexpression of 
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TRPML1 in ML1 KO fibroblasts causes perinuclear accumulation of lysosomes, but contrary to 
ML1 KO fibroblasts without TRPML1 expression, was reversible through application of 25 μM 
ML-SI3 for 2 hours.  (e) Quantification of groups shown in (d).  (f, g) Filipin staining of ML1 
KO fibroblasts overexpressing TRPML1 (f) or TRPML1-R44/A (g).  Purple arrows indicate cells 
with overexpression.  Red lines outline cell boundaries and nuclei are marked with a red “N”.  
Graphed data are presented as means ± SEM, number of cells used for quantification are shown 





Fig. 3.7 Direct interaction between ALG-2 and dynamitin. 
(a) Co-immunoprecipitation of ALG-2 and dynamitin in Cos-1 cells doubly transfected with 
mCherry-ALG-2 and GFP-Dynamitin, in the absence or presence of 0.5 mM Ca2+ in the lysis 
buffer.  Cell lysates were directly loaded (input), or immunoprecipitated with either anti-GFP or 
anti-mCherry antibody, and then blotted against GFP.  (b) Cells expressing mCherry or 
mCherry-ALG-2 were subject to Co-IP with either anti-mCherry or anti-Dynamitin, then blotted 
against mCherry (top) or Dynamitin (bottom).  Asterisk indicates a non-specific band seen with 
HEK293 lysates.  (c) Cos1 cells expressing either mCherry or mCherry-ALG-2 were subject to 
Co-IP with either anti-mCherry or anti-GFP antibodies, then blotted against mCherry.  (d) Cos1 
cells co-expressing GFP-dynamitin and mCherry-ALG-2 were subject to Co-IP with either anti-







Fi.g 3.8 ALG-2 is required for the TRPML1-promoted acute retrograde migration of 
lysosomes. 
(a) DNA sequencing results of the two ALG-2 CRISPR KO HeLa cell lines, the red “ATG” 
indicates start codon.  Mutant #1 had a 2bp deletion on all chromosomes, while mutant #2 had 
various lengths of out-of-frame deletions.  (b) Western blot confirmation of the ALG-2 KO.  (c) 
Representative images showing Lamp1-mCherry distribution of WT (left) and the two mutant 
lines in complete medium without any treatment.  (d, e) WT (d) and ALG-2 KO (e) cells under 2 
hours of 25 μM ML-SA1 treatment (left), or under 2 hours of serum starvation (right).  Mutant 
#2 was chosen for further studies based on their more extended morphology.  (f, g) WT (f) and 
ALG-2 KO (g) cells overexpressing Lamp-mCherry and RILP-GFP in the presence of 25 μM 
ML-SI3 for 2hours.  Red asterisks in RILP panels indicate cells not expressing RILP-GFP.  (h) 
Quantification of the groups shown in (c-e).  (i, j) Western blot analysis of endogenous LC3 in 
WT or ALG-2 KO HeLa cells upon 2 hours starvation.  LC3-II over LC3-I ratio normalized to 
WT control cells from 5 independent experiments were quantified in (j).  Red lines in images 
outline cell boundary and the red “N” marks the nucleus.  Graphed data are presented as means ± 
SEM, number of cells used for quantification are shown in the brackets.  *p < .05, **p < .01 in 







TRPML1 Regulates Lysosome Tubulation through Tuning of the 
Minus-end Pulling Force4 
 
4.1 Abstract 
Lysosome tubulation is a process in which tubular structure protrude from the vesicular 
part of lysosomes. Lysosome tubulation serves as a platform for lysosome reformation, and is 
most prominent during heavy lysosome consumptions, e.g. under prolonged starvation or during 
active phagocytosis. Current knowledge on the mechanisms of lysosome tubulation is quite 
limited, although the functions of various proteins have been found to be required for proper 
lysosome tubulation to take place. I show here that TRPML1 activity is required for lysosome 
tubulation in a bell-shaped manner, where too high or too low activity would both lead to the 
abolishment of lysosome tubulation. I have thus proposed a model in which TRPML1 regulates 




                                                          
4 Originally Submitted in Nature Cell Biology. With authors listed as Xinran Li, Nicholas Rydzewski, 




Lysosome tubulation is a process long observed (Swanson, Bushnell et al. 1987), but only 
recently characterized (Yu, McPhee et al. 2010). It has been proposed that lysosome tubulation 
serves as a platform for lysosome reformation, in which “protolysosomes” bud off from the 
tubular structures to recycle lysosomal membrane and proteins for the generation of new 
functional lysosomes (Yu, McPhee et al. 2010, Chen and Yu 2013). This is thought to replenish 
the pool of lysosomes during heavy consumption periods like prolonged starvation and active 
phagocytosis.  
Lysosome tubulation seems to be a quite delicate process, because the disruption of the 
function of many lysosomal proteins or nutrient-sensing proteins can lead to abnormal lysosome 
tubulation, in most cases the loss of tubulation (Rong, McPhee et al. 2011, Mrakovic, Kay et al. 
2012, Rong, Liu et al. 2012, Sridhar, Patel et al. 2013). mTORC1 is the first regulator identified 
for lysosome tubulation during prolonged starvation (Yu, McPhee et al. 2010). It was shown that 
while inactivated during acute starvation, mTORC1 gets reactivated under prolonged starvation 
because of the release of amino acids from lysosomes through digestion of autophagic materials. 
This reactivation of mTORC1 is somehow required for the reformation of lysosomes under 
prolonged starvation (Yu, McPhee et al. 2010). 
Apart from mTOR, the clathrin-mediated membrane fission pathway is also identified to 
be important for lysosome tubulation and reformation (Rong, Liu et al. 2012). It was shown that 
PI(4,5)P2, which is responsible for the membrane recruitment of clathrin, is required to be 
present on lysosomes during lysosome reformation. Clathrin and clathrin adaptor complex AP2, 
obviously, were also shown to be necessary for the process (Rong, Liu et al. 2012). PI4KIII and 
PI4P5K1A/1B, which are phosphoinositol-kinases responsible for the generation of PI(4)P and 
107 
 
PI(4,5)P2, respectively, were also shown to be involved in the regulation of lysosome tubulation 
and reformation in quite complicated manners (Rong, Liu et al. 2012, Sridhar, Patel et al. 2013). 
Motor proteins kinesin and dynein were suggested to be necessary for lysosome 
tubulation using macrophage phagocytosis as the model (Mrakovic, Kay et al. 2012). This is not 
surprising because the generation of tubular structures on lysosomes inevitably requires the 
pulling force from two opposite directions, and microtubule-based motor proteins are well fit for 
this purpose. The same study also identified Rab7-RILP and Arl8-SKIP as compulsory 
regulators of the tubulation process, being responsible for the recruitment of dynein and kinesin, 
respectively (Mrakovic, Kay et al. 2012). 
Although many proteins are identified to regulate the lysosome tubulation process, more 
questions remain to be answered. It remains a question as to the mechanism of the generation of 
lysosomal tubules, as well as tubule extension. The mechanism through which the loss of activity 
of some of the regulators e.g. mTORC1 (Yu, McPhee et al. 2010) and the lysosomal transporter 
spinster (Rong, McPhee et al. 2011) can lead to the failure of lysosome tubulation is also 
unknown. In summary, systematic explanations to the regulation of lysosome tubulation, and to 
the question of how lysosome tubulation is affected in such a variety of different conditions, are 
still lacking. Therefore, I proceeded to test the functions of TRPML1 in lysosome tubulation and 
sought a more general model underlying the failure of lysosome tubulation. 
 
4.3 Results 
4.3.1 TRPML1 and lysosomal Ca2+ are required for lysosome tubulation 
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My results shown in Chapters II and III showed that TRPML1 regulates the minus-end 
motility of lysosomes through ALG-2’s recruitment of dynein complex. Provided the previous 
report that motor proteins are required for the tubulation (Mrakovic, Kay et al. 2012), I examined 
whether TRPML1 is required for lysosome tubulation. 
First of all, I confirmed the necessity of motor proteins in regulating lysosome tubulation 
through the overexpression of dominant negative motor protein constructs. I found that the loss 
of activity of either Kif5B or dynein abolished lysosome tubulation during autophagic lysosome 
reformation (Fig. 4.1a). As the previous report was done in macrophages using phagocytosis as 
the model, this result would suggest that motor proteins are likely required for lysosome 
tubulation regardless the circumstances under which lysosome tubulation happen. 
I then investigated the role of TRPML1 in lysosome tubulation under various conditions 
in different cell types, including tubulation in prolonged starvation in fibroblasts (Fig. 4.2a, 4.2b) 
and NRK cells (Fig. 4.1b, 4.1c), tubulation after LPS activation of phagocytosis in macrophages 
(Fig. 4.2c, 4.2d), and the previously unreported constitutive tubulation in CV1 cells (Fig. 4.2e, 
4.2f). In all conditions, ML1KO or acute inhibition of TRPML1 abolished lysosome tubulation 
(Fig. 4.1 and 4.2). The Ca2+ chelator BAPTA-AM inhibited tubulation potently in CV1 cells 
(Fig. 4.2e, 4.2f), and a strong temperature dependence of tubulation was observed (Fig. 4.3). It is 
worth noting that tubulation in macrophages also required mTOR activity (Fig. 4.4). 
 
4.3.2 PI(3,5)P2 is required for TRPML1-dependent lysosome tubulation 
PI(3,5)P2 was shown to be required for TRPML1-mediated retrograde transport of 
lysosomes (Chapter III). Inhibition of the PI(3,5)P2 and PI(5)P synthesis enzyme PIKfyve 
through YM 201636 inhibited lysosome tubulation in prolonged starvation (Fig. 4.5a, 4.5c). The 
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requirement for PI(3,5)P2 is further confirmed through genetic approaches using Vac14KO 
fibroblasts. Knocking-out of Vac14, a scaffold protein required for PIKfyve activity, results in 
~50% reduction in cellular PI(3,5)P2 levels (Jin, Chow et al. 2008). During prolonged starvation, 
Vac14KO fibroblasts showed moderately reduced lysosome tubulation, but can be rescued with 
acute application of ML-SA1 (Fig. 4.5a, 4.5c). Furthermore, although overexpression of 
TRPML1-7Q, which is insensitive to PI(3,5)P2, failed to rescue the lysosome tubulation 
phenotype in ML1KO fibroblasts, delivery of a low dose of ML-SA1 in TRPML1-7Q transfected 
ML1KO cells restored lysosome tubulation to near normal levels (Fig. 4.5b, 4.5d). 
 
4.3.3 TRPML1 regulates lysosome tubulation by tuning the balance between minus-end and 
plus-end motility of lysosomes 
Normally, if the activation of a protein is required for a certain process, then more 
activity of the protein would boost up the process it regulates. Interestingly, while loss of 
TRPML1 activity abolished lysosome tubulation, hyper-activation of TRPML1 through 
TRPML1 overexpression or through ML-SA1 application also abolished lysosome tubulation 
(Fig. 4.6a-c, 4.6f). This observation led to a hypothesis where a balance between the plus- and 
the minus-end motility of the lysosome may be important for the generation of tubular structures 
on lysosomes (Fig. 4.6g). In this case, hyper or hypo activation of TRPML1 would disrupt the 
balance, resulting in an inverted U-shape relationship between TRPML1 activity and lysosome 
tubulation. 
Consistent with the hypothesis, I found that in TRPML1 overexpressing fibroblasts, low 
concentration of TRPML1 inhibitors restored lysosome tubulation (Fig. 4.6d, 4.6f), while high 
concentrations of the inhibitor blocked lysosome tubulation (Fig. 4.6e, 4.6f). Likewise, in ALG-2 
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overexpressing fibroblasts, a slightly elevated degree of tubulation was observed under complete 
medium, but tubulation was inhibited during prolonged starvation (Fig. 4.1d). 
 
4.4 Discussion 
Lysosome motility is required for many lysosome functions including lysosome 
tubulation (Mrakovic, Kay et al. 2012). Under heavy consumption of lysosomes, lysosome 
tubulation is triggered to allow the recycling of lysosomal proteins and lipids to replenish the 
pool of functional lysosomes. Dysfunction of many lysosome-related proteins can lead to the loss 
of lysosome tubulation, but underlying mechanisms for most of their effects have not been 
characterized.  
My results shown in this chapter demonstrate a possible common mechanism leading to 
the loss of lysosome tubulation in many dysfunctional conditions. A shared characteristic of most 
LSDs or other lysosome-related dysfunctions is the storage of various substances in the 
lysosomes, including cholesterol (Pagano, Puri et al. 2000, Yanagawa, Tsukuba et al. 2007, 
Samie and Xu 2014). My data suggest that the balance between the plus-end motility and the 
minus-end motility of lysosomes is important for the elongation and/or maintenance of the 
tubular structures. Therefore, disruption of this balance will likely disrupt lysosome tubulation 
regardless of the circumstance under which tubulation is triggered. Since cholesterol 
accumulation, as shown in Chapter II, can lead to elevated minus-end transport of lysosomes, it 
is likely that cholesterol storage will disrupt the balance between opposite directions’ pulling 
forces. This would in turn lead to the destabilization of the tubular structure, or failure for the 
generation of tubular structures. Accordingly, in many disease models, the restoration of 
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lysosome tubulation may be accomplished simply by tuning the balance between plus-end and 
minus-end motilities. 
 
4.5 Materials and Methods 
DNA subcloning; Mammalian cell culture and transfection; Starvation; Fluorescence 
imaging and image analysis; Statistical analysis 
Same materials and protocols described in Chapter II and Chapter III were applied. 
Mouse lines 
Characterizations of TRPML1 and Vac14 KO mice were performed as described 
previously (Venugopal, Browning et al. 2007, Zhang, Zolov et al. 2007, Jin, Chow et al. 2008). 
Animals were used under approved animal protocols and the Institutional Animal Care 
Guidelines of the University of Michigan. 
Quantification of lysosome tubulation 
Cells were chosen randomly with the criterion that their fluorescence was strong enough 
to visualize tubular structures. Only tubules longer than 2 μm were included in the analysis to 
reduce false-positive hits (see Fig. 4.7).  Quantifications were done by researchers blind to the 
experimental groups presented. 
Chemicals and reagents 
Chemicals additional to those described in Chapters II and III are as follows: LPS 




Fig. 4.1 Regulation of lysosome tubulation by TRPML1 and ALG-2. 
(a) Quantification of lysosome tubulation in CV-1 cells. Dominant-negative constructs of Kif5B 
and DynIC2 eliminated spontaneous tubulation in Lamp1-GFP-expressing CV1 cells almost 
completely.  (b) Representative images of Lamp1-mCherry-transfected NRK cells starved for 16 
hours (left), or starved for 16 hours with the last 2 hours in the presence of 25 μM ML-SI3 
(middle) or ML-SI1 (right).  (c) Quantification of groups shown in (b).  (d) Quantification of 
lysosome tubulation in WT fibroblasts transfected with Lamp1-GFP, or Lamp1-GFP plus ALG-
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2-mCherry, with or without starvation for 24 hours. ALG-2 expression inhibited lysosome 
tubulation strongly in starved cells. Graphed data are presented as means ± SEM, number of cells 





Fig. 4.2 TRPML1 and Ca2+-dependent lysosome tubulation in various cell types and 
conditions. 
(a) Lamp1-mCherry-transfected fibroblasts were starved for 24 hours.  A high level of lysosome 
tubulation was seen in WT fibroblasts, but not in ML1 KO fibroblasts or in WT fibroblasts 
treated with ML-SI1 (25 μM) during the last hour of starvation.  (b) Quantification of lysosome 
tubules in the groups shown in (a).  (c) Lysosome tubulation in macrophages loaded with 
tetramethylrhodamine-dextran (1 hour loading, 2 hours chase) and activated with 
lysopolysaccharides (LPS) for 3 hours.  Lysosome tubulation was prominent in WT 
macrophages (left), but not in ML1 KO macrophages (middle) or WT macrophages treated with 
ML-SI1 (25 μM, 30 min; right).  (d) Quantification of the groups shown in (c).  (e) Effects of 
ML-SI1 (25 μM, 1 hour) or BAPTA-AM (10 μM, 1 hour) on spontaneous lysosome tubulation in 
Lamp1-GFP-expressing CV1 cells.  (f) Quantification of groups shown in (e).  Graphed data are 
presented as means ± SEM, number of cells used for quantification are shown in the brackets. *p 





Fig. 4.3 Lysosome tubulation exhibits a strong temperature dependence. 
(a) Time-lapse images showing a CV1 cell overexpressing Lamp1-EGFP, and treated with a 
temperature protocol shown in (b).  (b) Quantifications of lysosome tubulation in CV1 cells 






Fig. 4.4 Lysosome tubulation in macrophages requires mTOR activity. 
Quantification of the average tubulation per cell in WT macrophages loaded with 
tetramethylrhodamine-dextran (1 hour loading, 2 hours chase) and activated with 
lysopolysaccharides (LPS) for 3 hours (Ctrl), or co-applied with 400 nM Torin-1 together with 
LPS. Graphed data are presented as means ± SEM, number of cells used for quantification are 





Fig. 4.5 PI(3,5)P2 is required for lysosome tubulation through activation of TRPML1. 
(a) Representative WT fibroblasts starved for 24 hours and treated with 1 μM YM 201636 for 30 
min (left), Vac14 KO fibroblasts starved for 24 hours (middle), and starved Vac14 KO 
fibroblasts treated with 10 μM ML-SA1 for 30 min (right).  (b) Lysosome tubulation after 24 
hours starvation of ML1 KO fibroblasts transfected with Lamp1-mCherry alone (left), Lamp1-
mCherry together with GFP-TRPML1-7Q with (right) or without (middle) a low dose (1 μM) of 
ML-SA1 for 1 hour.  (c) Quantification of the groups shown in (a).  (d) Quantification of the 
groups shown in (b).  Graphed data are presented as means ± SEM, number of cells used for 








(a, b) Effect of ML-SA1 (20 μM, 1 hour) on lysosome tubulation in mouse fibroblasts.  (c-e) 
Effects of 1 μM (d) or 25 μM (e) ML-SI1 on lysosome tubulation in TRPML1-overexpressing 
WT fibroblasts.  ML-SIs were applied during the last 2 hours of starvation.  (f) Quantifications of 
the groups shown in (c–e).  (g) Model illustrating the proposed role of TRPML1 in the regulation 
of lysosome motibility and tubulation.  Under normal growth conditions (I), lysosomes are 
mostly peripherally distributed.  During acute starvation (II), the TRPML1-ALG-2 pathway is 
activated to increase minus-end-directed motility of lysosomes, resulting in rapid redistribution 
of lysosomes to the juxtanuclear region, thereby facilitating autophagosome-lysosome fusion.  
After prolonged starvation (III), reactivation of mTOR turns on the machinery for lysosome 
tubulation and reformation.  While the TRPML1-ALG-2 pathway remains active, the plus-end 
motility of lysosomes is increased.  Subsequently, the “balanced” driving forces on both 
directions result in the generation of tubular lysosomes.  Graphed data are presented as means ± 
SEM, number of cells used for quantification are shown in the brackets. *p < .05, **p < .01 in 






Fig. 4.7 Lysosome tubulation revealed by super-resolution microscopic imaging. 
Same region of a Lamp1-GFP-transfected fibroblast starved for 24 hours under conventional (left) 
or STED super-resolution (right) confocal imaging.  The super-resolution image was taken 6 s 
after the conventional confocal image.  Yellow arrows point to several small lysosomes that are 
lined-up to have a tubular appearance under the conventional confocal images; red arrows point 





A Genetically Encoded Fluorescent Probe to Visualize Intracellular 
PI(3,5)P2 Localization and Dynamics5 
 
5.1 Abstract 
Phosphatidylinositol 3,5-bisphosphate [PI(3,5)P2] is a low-abundance phosphoinositide 
presumed to be localized to endosomes and lysosomes, where it recruits  cytoplasmic peripheral 
proteins and regulates endolysosome-localized membrane channel activity. Cells lacking 
PI(3,5)P2 exhibit lysosomal trafficking defects, and human mutations in the PI(3,5)P2-
metabolizing enzymes cause lysosome-related diseases. The spatial and temporal dynamics of 
PI(3,5)P2, however, remain unclear due to the lack of a reliable detection method. Of the seven 
known phosphoinositides, only PI(3,5)P2 binds, in the low nanomolar range, to a cytoplasmic 
phosphoinositide-interacting domain (ML1N) to activate LEL-localized TRPML1 channels. 
Here I show the generation and characterization of a PI(3,5)P2-specific probe, generated by the 
fusion of fluorescence tags to the tandem repeats of ML1N. The probe was mainly localized to 
the membranes of Lamp1-positive compartments, and the localization pattern was dynamically 
altered by either mutations in the probe, or by genetically or pharmacologically manipulating the 
                                                          
5 Originally published in Proc Natl Acad Sci USA (PNAS). 2013 Dec 24;110(52):21165-70. With authors 
listed as Xinran Li, Xiang Wang, Xiaoli Zhang, Mingkun Zhao, Wai Lok Tsang, Yangling Zhang, 
Richard Gar Wai Yau, Lois S. Weisman, and Haoxing Xu. 
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cellular levels of PI(3,5)P2. Through the use of time-lapse live cell imaging, I found that the 
localization of the PI(3,5)P2 probe was regulated by serum withdrawal/addition, undergoing 
rapid changes immediately prior to membrane fusion of two LELs. The development of a 
PI(3,5)P2-specific probe may facilitate studies of both intracellular signal transduction and 
membrane trafficking in the endosomes and lysosomes. 
 
5.2 Introduction 
Phosphorylated phosphoinositide lipids are produced on the cytosolic side of cellular 
lipid bilayer membranes, and they mark the identity of intracellular membranes, as well as 
regulate organelle-specific membrane signaling pathways and trafficking events (Di Paolo and 
De Camilli 2006, Lemmon 2008). The subcellular localization of the phosphoinositides is, 
therefore, important information towards understanding the functions of these lipids.  
The recent development of specific fluorescent probes has greatly enhanced the 
understanding of phosphoinositide signaling (Balla 2007, Lemmon 2008). Specific probes were 
developed against PI(3)P, PI(4)P, PI(4,5)P2, PI(3,4)P2, and PI(3,4,5)P3, through fusion of 
fluorescent tags with the phosphoinositide binding domains of their effector proteins. For 
example, GFP or mCherry are fused with the FAPP1-PH domain for PI(4)P, the PLC∆-PH 
domain for PI(4,5)P2, the Akt-PH domain for both PI(3,4)P2 and PI(3,4,5)P3, and the Hrs-FYVE 
and EEA1-FYVE domains for PI(3)P (Halet 2005, Balla 2007). An effective probe for PI(3,5)P2, 
however, remained lacking.  
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Due to the lack of specific probes, the subcellular localization and the functions of 
PI(3,5)P2 are poorly understood. PI(3,5)P2 is proposed to be mainly localized to late endosomes 
and lysosomes (Dove, Dong et al. 2009), and also to early endosomes (Zhang, McCartney et al. 
2012). This is based on the location of its synthesizing enzyme, PIKfyve. Consistent with the 
LEL localization of PI(3,5)P2, it was recently shown to be an endogenous agonist for TRPML1 
and two pore channel 2 (TPC2), which are LEL-localized ion channels (Dong, Shen et al. 2010, 
Wang, Zhang et al. 2012). Despite these evidences, the localization and dynamics of PI(3,5)P2 
remained to be established.  
The lack of a probe for PI(3,5)P2 was mainly due to two reasons. First, PI(3,5)P2 is a 
poorly characterized phosphoinositide, and it has only a few known effectors, most of which 
exhibit relatively low affinities for PI(3,5)P2 (Tsuruta, Green et al. 2009, Bridges, Ma et al. 2012). 
Second, intracellular PI(3,5)P2 levels are much lower than other phosphoinositide, reportedly 
around 1/10 of PI(3)P and less than 1/100 of PI(4,5)P2 (Zhang, Zolov et al. 2007, Lemmon 2008, 
Zolov, Bridges et al. 2012). Therefore, the lower affinity to a lower abundance phosphoinositide 
makes it difficult to develop an effective probe using peripheral PI(3,5)P2 binding proteins 
exhibiting low affinity. The lysosomal ion channel TRPML1, on the other hand, is activated by 
PI(3,5)P2 in a low nanomolar range (EC50 ~ 50 nM) (Dong, Shen et al. 2010). Moreover, the 
interaction site between TRPML1 and PI(3,5)P2 is known. Therefore, I utilized the N-terminal 






5.3.1 A fluorescent PI(3,5)P2 probe based on the PI(3,5)P2-interacting domain of TRPML1 
exhibits membrane localization that is dependent on the presence of PI(3,5)P2 
PI(3,5)P2 activates TRPML1 with high specificity and affinity, with no other 
phosphoinositides exhibiting any activation effect (Dong, Shen et al. 2010). Binding assays using 
GST fusion protein of the N-terminal segment (residues 1-68, ML1N) showed direct interaction 
between ML1N and PI(3,5)P2 (Dong, Shen et al. 2010). Therefore, fluorescently tagged ML1N 
might serve as a high affinity PI(3,5)P2 probe. To increase the affinity and specificity, a tandem 
repeat of ML1N, namely ML1N*2, was fused with GFP or mCherry on its N-terminal (Fig. 
5.1a).  
Fusion protein of GST-GFP-ML1N*2 showed higher specificity towards PI(3,5)P2 in 
vitro in protein-lipid binding assays than GST-ML1N. in liposome binding assay, which mimics 
the vesicular membrane in living cells, the GST-GFP-ML1N*2 specifically recognized PI(3,5)P2 
with a Kd of ~ 5 μM (Fig. 5.1b), but not other phosphoinositide tested except for weak binding to 
PI(5)P (Fig. 5.2a). In PIP strip and PIP-beads binding assays, the tandem fusion protein also 
bound predominantly with PI(3,5)P2, with weak bindings towards PI(4,5)P2, PI(3,4,5)P3 and 
PI(3)P (Fig. 5.1c, 5.1d). Collectively, these results indicated that the tandem probe manifests a 
high in vitro specificity for PI(3,5)P2 over other phosphoinositides. 
To determine the intracellular localization of the probe, Cos1 cells were transfected with 
either GFP- or mCherry-tagged ML1N or ML1N*2. ML1N probe was mainly localized to the 
cytosol, with limited localization on Lamp1-positive vesicles (Fig. 5.1e). In contrast, GFP-




Previous development of other phosphoinositide probes showed that mutations of key 
residues for phosphoinositide binding could block the localization of the probe to specific 
membranes (Halet 2005, Balla 2007). Therefore, I generated ML1N-7Q*2 or ML1N-2A*2, 
corresponding to the mutation of all phosphoinositide-interacting residues to Glu (7Q), or only 
the two key Arg to Ala (2A), both characterized previously using electrophysiology (Zhang, Li et 
al. 2012). ML1N-7Q*2 showed a diffused cytosolic pattern in cells, while ML1N-2A*2 showed 
similar cytosolic localization with very weak co-localization with Lamp1-positive vesicles (Fig. 
5.2d, 5.2e), possibly due to the incomplete loss of PI(3,5)P2 affinity (Fig. 5.2c). Quantification 
of the co-localization between the probe and Lamp1 (see Methods) showed that ML1N-7Q*2 
was completely absent from Lamp1-positive vesicles (3.4 ± 0.5 %, Fig. 5.2e), while Ml1N-2A*2 
showed very low levels of co-localization (11.8 ± 1.2 %, Fig. 5.2e), compared to the high co-
localization for the WT ML1N*2 probe (52.3 ± 1.4 %, Fig. 5.2e). These results suggest that the 
localization of ML1N*2 onto Lamp1-positive vesicles correlates with the PI(3,5)P2 binding 
affinity of the probe. 
To further define the location of the probe, cells were transfected or stained with various 
organellar markers of the endocytic pathway (Fig. 5.2f-k). In Cos1 cells, about half of the 
Lamp1 signal co-localized with ML1N*2 (Fig. 5.2b, 5.2e). A high degree of co-localization 
between ML1N*2 and Lamp1 was also observed in mouse fibroblasts, Chinese Hamster Ovary 
cells (CHO), and Human Embryonic Kidney 293T (HEK293T) cells (Fig. 5.3). In addition, the 
probe also co-localized well with lysotracker (Fig. 5.2g). No consistent plasma membrane (PM) 
localization was seen, although patchy regions of PM localization of the probe could be seen in 
some cells (Fig. 5.4). The early endosomal marker EEA1 showed significant co-localization with 
the probe (31.5 ± 2.4%, Fig. 5.2h, 5.2k), consistent with ~40% co-localization of Vac14 and 
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EEA1 observed previously (Zhang, McCartney et al. 2012). A commonly used PI(3)P probe 
GFP-FYVE*2 (Gillooly, Morrow et al. 2000) showed a high degree of co-localization with the 
mCherry-ML1N*2 probe (65.7% ± 3.4%, Fig. 5.2i, 5.2k), reflecting the fact that PI(3)P is the 
precursor and the primary metabolite of PI(3,5)P2. A high degree of co-localization between the 
PI(3,5)P2 synthesizing enzyme PIKfyve and the probe is also observed (52.1% ± 4.2%, Fig. 5.2j, 
5.2k). 
The results presented above suggest that the probe localize to endolysosomal 
compartments likely due to its binding to PI(3,5)P2. PI(3,5)P2 levels inside the cells were 
manipulated to examine this. 
YM 201636 inhibits PI(3,5)P2 synthesis through inhibition of PIKfyve, resulting in 
enlarged vacuoles over longer treatment times (> 1 hour). In Cos1 cells (Fig. 5.5a, 5.5c) or NIH 
3T3 cells (Fig. 5.4), YM 201636 dramatically reduced the co-localization of the probe with 
Lamp1. The effect of YM 201636 was entirely reversible (Fig. 5.5c). The effect of YM 201636 
was specific as vesicular localization of PI(3)P probe GFP-FYVE*2 was not affected (Fig. 5.6). 
Under YM 201636 treatment, a small number of vacuoles retained localization of the ML1N*2 
probe, raising the possibility that in the absence of PI(3,5)P2, the ML1N*2 probe recognizes 
another epitope, e.g. a protein or lipid. It is also possible that the incomplete inhibition of 
PIKfyve through YM 201636 (PI(3,5)P2 levels reportedly reduced to 20% of pre-inhibition 
levels) resulted in re-distribution of the remnant PI(3,5)P2 pool inside the cells, resulting in 
concentrated PI(3,5)P2 in critical regions. Interestingly, when purified GST-GFP-ML1N*2 
proteins were exogenously applied to the fixed cells, GFP fluorescence exhibited a vesicular 
localization pattern co-localized with Lamp1, which was abolished by YM 201636 treatment for 
30 min (Fig. 5.7).  
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The kinase activity of PIKfyve can also be inhibited by overexpression of dominant 
negative PIKfyve (Ikonomov, Sbrissa et al. 2009). In Cos1 cells co-transfected with YFP-
PIKfyve-DN, mCherry-ML1N*2, and Lamp1-GFP, enlarged vacuoles were seen with profound 
decrease in the co-localization between Lamp1 and the probe (23.6 ± 2.4 %, Fig. 5.5b, 5.5c). 
PIKfyve KO mice are embryonic lethal (Ikonomov, Sbrissa et al. 2011), but Vac14 and 
Fig4 KO, two proteins required for PIKfyve activation, allow the mice to survive postnatally 
with ~50% reduction of intracellular PI(3,5)P2 levels (Chow, Zhang et al. 2007, Zhang, Zolov et 
al. 2007). The co-localization between ML1N*2 and Lamp1 was significantly reduced in both 
Vac14KO (18.8 ± 1.3%) and Fig4KO (17.7% ± 2.2%) fibroblasts compared to WT fibroblasts 
(34.3 ± 1.3%) (Fig. 5.5d-g). Taken together, the above results suggest that the endolysosomal 
localization of the probe was dependent on the activity of PIKfyve, and was capable of detecting 
changes in the intracellular PI(3,5)P2 levels. 
 
5.3.2 Endolysosmal PI(3,5)P2 levels are regulated by serum-derived factors 
With the establishment of the probe as a sensor to PI(3,5)P2, I used the probe to track the 
dynamic and regulatory changes of PI(3,5)P2 in living cells. In 3T3L1 adipocytes, insulin has 
been shown to induce a modest increase in PI(3,5)P2 levels in serum-starved cells (Ikonomov, 
Sbrissa et al. 2009, Bridges, Ma et al. 2012). Likewise, serum-derived factors such as hormones 
and growth factors can regulate the levels of PI(3,5)P2 and other phosphoinositides in other cell 
types (Zolov, Bridges et al. 2012). Consistent with these findings, serum starvation elicited a 
striking change in the pattern of the probe localization in Cos1 cells. Under normal conditions, 
the probe showed co-localization with Lamp1-positive vesicles as intensely bright circles or dots, 
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depending on the vacuole size (Fig. 5.2b). In Cos1 cells serum-starved for 6 hours (Fig. 5.8a, 
upper panel) or overnight for 18 hours (Fig. 5.8a, middle panel), the percentage of co-
localization between Lamp1 and the ML1N*2 probe was significantly decreased (34.9 ± 3.0% 
for 6 hours, 22.9 ± 2.5% for 18 hours, Fig. 5.8b). It is also noticeable that the relative intensity of 
the probe on vesicles was reduced compared to serum-replete or normal conditions. When cells 
were replenished with serum for 2 hours, the co-localization of the probe and Lamp1, as well as 
the signal intensity returned to normal levels (Fig. 5.8a, bottom panel, 5.8b). Thus, intracellular 
PI(3,5)P2 levels are regulated by serum factors. At this point, it is unclear what are the hormones 
or growth factors regulating PI(3,5)P2 levels in Cos1 cells, but the identification of such factors 
can be facilitated by the ML1N*2 probe. 
 
5.3.3 PI(3,5)P2 dynamics in relation to endolysosomal membrane fusion in mammalian cells 
PI(3,5)P2 is a key regulator of membrane trafficking in the late endocytic pathway, 
evidenced by the enlarged vacuoles seen in PI(3,5)P2 deficient cells either through YM 201636 
treatment or through Vac14/Fig4 KO. Because PI(3,5)P2 directly activates TRPML1, it was 
hypothesized that PI(3,5)P2 elevation may induce lysosomal Ca2+ release to trigger 
endolysosomal membrane fusion/fission. In Chapters II, III, and IV I discussed my findings that 
PI(3,5)P2 is required for TRPML1’s function in lysosome retrograde motility, which in turn is 
required for proper lysosome fission to take place. It remains interesting to test whether PI(3,5)P2 




To visualize PI(3,5)P2 dynamics in relation to membrane fusion or fission, I performed 
time-lapse confocal imaging in Cos1 cells that were dually transfected with GFP-ML1N*2 and 
Lamp1-mCherry, with Lamp1 revealing the trafficking events and the probe tracking PI(3,5)P2 
dynamics. Due to the small size (100 to 500 nm normally, also see Fig. 4.6) of most Lamp1-
positive compartments, fusion events were not easy to catch due to the technical limitations of 
speed vs. resolution/photobleaching. The naturally occurring rate of fusion between larger 
vesicles (> 1 µm) appeared to be very low (experimental estimation of ~1 event per cell per 100 
minutes). Nevertheless, in the few observations made, a rapid and robust increase in the vacuolar 
GFP fluorescence was detected immediately before fusion of the two Lamp1-positive vesicles 
(Fig. 5.9a, 5.9c). The vacuolar intensity of the probe peaked at the time of fusion, and then 
gradually decreased over time (Fig. 5.9b). In contrast, the intensity of mCherry-Lamp1 and 
cytoplasmic probe remained relatively constant, suggesting that the increase in the probe 
intensity was not the consequence of the fusion. These results suggest that PI(3,5)P2 is rapidly 
produced on vacuolar membrane right before fusion events. 
To facilitate the detection of fusion events between large vacuoles, I treated the cells with 
Acetate Ringer’s solution for 20-30 minutes to acidify cytosolic pH, and then washed out the 
solution with normal medium to restore the pH, which facilitates fusion between vacuoles. In 
Cos1 cells dually transfected with GFP-ML1N*2 and Lamp1-mCherry, withdrawal of the 
Acetate Ringer’s solution resulted in an increased rate of fusion between large vacuoles (increasd 
to ~0.17 events per cell per minute). All vacuoles that underwent fusion had much higher probe 
intensity on the vacuolar membrane than the cytosolic background at the time of fusion 
(averaging 164.4 ± 1.5% of cytosolic intensity). Based on the PI(3,5)P2 dynamics, the fusogenic 
vacuoles could be classified into two groups. The first group (~ 45% of all events recorded) had 
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significant increases (>20%) in their membrane probe intensity within 1 min prior to fusion (Fig. 
5.9d, upper panels, 5.9f), while the second group (~55% of all events) exhibited little or no 
increase in their probe intensity (Fig. 5.9e, upper panels, 5.9f). Interestingly, the basal 
fluorescence intensity of the probe in the second group was significantly higher than that of the 
first group (Fig. 5.9e-f). These results suggest that the vacuole fusion upon the removal of 
Acetate Ringer would require high PI(3,5)P2 levels on the vacuolar membranes. 
 
5.4 Discussion 
The importance of PI(3,5)P2 in endolysosomal membrane trafficking is well accepted, but 
the dynamics and localization of PI(3,5)P2 in intact cells remained unclear, largely due to the 
lack of a method to directly visualize intracellular PI(3,5)P2 pools. In the work presented in this 
chapter, I characterized a genetically encoded PI(3,5)P2 fluorescent probe that can be used to 
track PI(3,5)P2 dynamics in living cells. The PI(3,5)P2 probe, consisting of two repeats of the 
cytosolic N-terminal of TRPML1, responded specifically to changes in the intracellular PI(3,5)P2 
levels and localization.  
The predominantly-LEL localization of the probe was somewhat unexpected. Although 
PI(3,5)P2 is the only phosphoinositide that activates TRPML1, it was shown that PI(4,5)P2 and 
PI(3,4,5)P3 were able to inhibit TRPML1 likely using the same stretch of positively charged 
residues as PI(3,5)P2 (Zhang, Li et al. 2012). Indeed, though weakly, in vitro binding assays 
showed some binding between the ML1N*2 probe and PI(4,5)P2/PI(3,4,5)P3. No consistent PM 
localization of the probe, however, was detected in all cell types tested, although patchy PM 
localization was observed in a small number of cells. One possible explanation is that PI(3,5)P2 
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binds to TRPML1 with much higher affinity than other phosphoinositides. Alternatively, the 
overexpression of the probe may have resulted in PI(3,5)P2 enrichment in the endolysosomes by 
protecting them from degradation, similar to what observed for the PI(4,5)P2 probe (Varnai and 
Balla 1998). It is also possible that ML1N*2 contains additional motifs, either PI(3,5)P2 
dependent or PI(3,5)P2 independent, that can strengthen the LEL localization of the probe. 
Similar phenomenon was described for other phosphoinositide probes, such as the PI(4)P probe. 
Although unidentified, additional recruitment mechanisms may play permissive roles to recruit 
the probe to the LEL membranes. Nevertheless, mechanisms discussed above will not prevent 
the use of the probe to detect PI(3,5)P2 dynamics on LEL membranes. 
The weak binding of the probe to PI(5)P might be problematic, as this lipid is also known 
to be present in late endocytic compartments in mammalian cells, and it is also produced and 
turned over by the same enzymes as PI(3,5)P2 (Zolov, Bridges et al. 2012). Because the 
production of these two phosphoinositides and their turn over are linked, it is likely their 
biological roles are not so well separated, similar to PI(3,4)P2 and PI(3,4,5)P3 on the plasma 
membrane. In this case, the probe may detect the changes of both phosphoinositides, similar to 
that of Akt-PH domain in detecting PI(3,4)P2 and PI(3,4,5)P3 (Balla 2007). 
The lack of effective PI(3,5)P2 probes have long restricted the measurement of 
intracellular PI(3,5)P2 levels to methods like radiolabeled HPLC. Such techniques are lengthy, 
costly, and most importantly, won’t provide any information about subcellular localization and 
dynamics of PI(3,5)P2. By using the new probe developed here, I have shown for the first time 
that PI(3,5)P2 elevation on vacuolar membranes occur prior to fusion, and the clear correlation 
between high membrane PI(3,5)P2 and fusion events. With the aid of high-resolution live 
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imaging in combination with genetic and pharmacological approaches, the PI(3,5)P2 probe may 
prove to be a valuable tool for the study of PI(3,5)P2 signaling. 
 
5.5 Materials and Methods 
Molecular biology 
Tandem repeats of the TRPML1 (accession number CCDS22063.1 in NCBI cDNA 
database) N-terminal segment (residues 1–68) were subcloned from mouse cDNA into a 
pEGFPC3 (Clontech) plasmid by using the following two pairs of primers: F1: GAAGATCTCA 
CCATGGCCAC CCCG; R1: CGGAATTCGC AGCATCAGCT TGCAG; F2: CGGAATTCTC 
ACCATGGCCA CCCC; R2 CGGGATCCAG CATCAGCTTG CAG.  For the mCherry-
ML1N*2 construct, mCherry was inserted into the GFP-ML1N*2 construct from the pmCherry-
C1 plasmid (Clontech) to replace GFP by using the following primers: F: CATCAAGTGT 
ATCATATGCC; R: GAAGATCTAG TCCGGACTTG TACAG.  The ML1N-7Q*2 and ML1N-
2A*2 mutants were generated by site-directed mutagenesis with Pfu Turbo polymerase 
(Stratagene).  A GST-fusion construct was made by inserting the GFP-ML1N*2 fragment into 
the pGEX-4T1 vector (GE Healthcare).  The Lamp1-mCherry construct was made by insertion 
of Lamp1 cDNA into pcDNA3.1 (Invitrogen) followed by fusion of mCherry with the C-
terminus of Lamp1.  All constructs were confirmed by sequencing. 
GST-fusion protein purification 
To purify GST-GFP-ML1N*2, E. Coli strain BL-21 supplemented with pRareCDF 
(optimizing for mammalian codon distribution) was transformed with pGEX4T1-GFP-ML1N*2.  
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Bacteria were inoculated at 37°C in Terrific Broth medium containing Spectinomycin and 
Ampicillin.  Once the O.D. of the culture reached ~2, cells were equilibrated to room 
temperature and protein expression was induced with 250 μM IPTG for 2 hour.  Cells were then 
pelleted and resuspended with PBS containing 0.5 mM EDTA, 0.1mg/ml lysozyme, and 1% v/v 
protease inhibitor cocktail (P8849, Sigma).  Cells were then lysed by sonication and centrifuged.  
The GST-fusion proteins in the supernatant were concentrated using glutathione sepharose beads 
(GE Healthcare).  After extensive washes with PBS, purified proteins were eluted with elution 
buffer (20 mM glutathione, 150 mM NaCl in 50 mM Tris, pH 8.0).   
Liposome binding assay 
Phosphoinositide-containing liposomes (PIPosomes) from Echelon Biosciences were 
used for the assay.  20 μL liposomes were diluted in 1 mL binding buffer (150 mM NaCl, 0.05% 
NP-40 in 50mM Tris, pH 7.5) containing 3 μg GST-GFP-ML1N*2.  After 10 min of incubation, 
liposomes were pelleted at 16,000g for 10 min.  Supernatants were carefully removed and 
liposomes were re-suspended with 1 ml binding buffer.  After six washes, the bound fractions 
were analyzed by western blot using anti-GST antibodies. 
To estimate the affinity (Kd) of PI(3,5)P2-probe binding, liposomes containing 30-3,000 
pmol PI(3,5)P2 or 2 nmol control lipids without PI(3,5)P2 were incubated with various 
concentrations of the purified GST-GSP-ML1N*2 proteins in 100 μL of binding buffer.  The 
mixture was incubated for 1 hour with gentle rotation.  After 10 μL of the mixture was separated 
as input, the liposomes were pelleted at 16,000g for 15 min.  The supernatant was then carefully 
separated as the unbound fraction.  Protein concentrations from input and unbound fractions 
were measured by absorbance at 280 nm and western blot analysis. 
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Lipid strip binding assay 
PIP-strip was purchased from Echelon Biosciences (P-6001), containing 15 different lipid 
species, including all 7 phosphoinositides.  The strip was first blocked with PBST (containing 3% 
BSA) for 1hr, incubated with 0.2 μg/ml GST-GFP-ML1N*2 for 1 hour, and then washed for 6 
times with the blocking buffer.  Bound proteins were recognized with anti-GST antibodies 
(Sigma, G1160) and detected with goat-anti-mouse HRP- conjugated secondary antibodies 
(Invitrogen, 62-6520). 
PIP beads binding assay 
50 μL of 50% phosphoinositide -containing beads (Echelon Biosciences) were incubated 
with 1 mL of binding buffer (150 mM NaCl, 0.25% NP-40 in 50mM Tris, pH 7.5) containing 5 
μg GST-GFP-ML1N*2.  After 2 hours of incubation, beads were pelleted at 500 g for 5 min, and 
beads were re-suspended with 1 mL binding buffer.  After 5 washes, the bound fractions were 
analyzed by western blot using anti-GST antibodies. 
PI(3,5)P2 detection using purified GST-GFP-ML1N*2 proteins 
Lamp1-transfected cells were fixed with 4% PFA, blocked with PBST (containing 3% 
BSA) for 2 hours, incubated with 5 μg/mL GST-GFP-ML1N*2 in the blocking buffer for 2 hours, 
and then subjected to fluorescence microscopy. 
Mammalian cell culture 
Mammalian cells were cultured in a 37°C, 5% CO2 incubator.  MEFs were isolated and 
cultured as described previously (Di Paolo and De Camilli 2006, Jin, Chow et al. 2008).  Cells 
were cultured with DMEM (Invitrogen) supplemented with 10% FBS (Gemini). All other 
135 
 
mammalian cell types (CHO, COS1, and HEK293T) were cultured with DMEM F12 (Invitrogen) 
supplemented with 10% FBS.  For the delivery of the plasmids into the cells, MEF cells were 
electroporated by using an Invitrogen Neon electroporation kit; all other mammalian cells were 
transfected by using Lipofectamine 2000 (Invitrogen).  Cells were typically imaged 24 hours 
post-transfection.  Serum starvation was performed with three washes of PBS to completely 
remove serum.  Cells were then incubated with the respective culture medium without serum for 
the indicated periods.  Acetate Ringer’s solution contained (in mM): 80 NaCl, 70 CH3COOH, 5 
KCl, 2 CaCl2, 1 MgCl2, 2 NaH2PO4, 10 HEPES, 10 MES, and 10 glucose (pH adjusted to 6.9 
with NaOH).  Standard Ringer’s solution contained (in mM): 145 NaCl, 5 KCl, 2 CaCl2, 1 
MgCl2, 10 HEPES, 10 MES, and 10 glucose (pH adjusted to 7.4 with NaOH). 
Confocal Microscopy 
For fixed samples, cells were fixed and immunostained following a standard protocol.  
Briefly, cells were fixed with 4% PFA for 30 min, blocked with 1% BSA for 2 hours, incubated 
with primary antibody overnight, and stained with fluorescent secondary antibody for 1 hour.  
Cells were then imaged with a Leica Confocal microscope.  For live samples, cells were washed 
with DMEM F12 medium without phenol-red (Invitrogen) to reduce background fluorescence.  
Live imaging was performed with an Olympus Spindisk Confocal microscope with a heated 
chamber to maintain the temperature at ~37°C during imaging.  Wavelengths used for each 





Images were analyzed with ImageJ software.  For co-localization analysis, images were 
first split into separate color channels.  The red and green channels were then thresholded on a 
regional basis, with the threshold being 50% above the average background intensity in the 
nearby cytosolic regions.  Co-localization was performed with the Co-localization Plug-in of 
ImageJ.  The percentage of co-localization was defined as the [total number of pixels that are 
positive for both channels/total number of pixels that are positive for the channel other than the 
probe (e.g., Lamp1)] × 100%.  For the measurement of the change in the vacuolar fluorescence 
intensity, the vacuolar membrane area was selected by masking from the Lamp1-mCherry 
channel.  The vacuolar probe intensity was defined as the average intensity of both vacuole 
membranes (before fusion) or the average intensity on the membrane of the fused vacuole 
Endolysosomal electrophysiology 
Endolysosomal electrophysiology was performed in isolated enlarged endolysosomes 
with a modified patch-clamp method as described previously (Dong, Shen et al. 2010, Wang, 
Zhang et al. 2012, Zhang, Li et al. 2012). Briefly, cells were treated with 1 μM vacuolin-1 for 1–
12 hours.  Enlarged vacuoles (up to 5 μm) were isolated manually with a patch pipette, and then 
whole-endolysosome voltage clamp recordings were performed.  The vacuolar membrane was 
ruptured with a series of voltage steps. Whole-endolysosome configuration was verified by the 
re-appearance of capacitance transients after break-in.  Whole-endolysosomal currents were 
elicited by repeated voltage ramps from -120 to 120 mV (400 ms) with an inter-ramp interval of 
2 s.  The pipette (luminal) solution was modified Tyrode’s, including (in mM) 145 NaCl, 5 KCl, 
2 CaCl2, 1 MgCl2, 10 HEPES, 10 MES, 10 glucose (pH adjusted with NaOH to pH 4.6).  The 
bath (internal/cytoplasmic) solution contained (in mM) 140 K-gluconate, 4 NaCl, 1 EGTA, 2 
MgCl2, 0.39 CaCl2 , 20 HEPES (pH adjusted with KOH to 7.2; free [Ca2+]i  ~ 100 nM estimated 
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using MaxChelator software).  Bath solutions were applied via a perfusion system that allowed a 
complete solution exchange within a few seconds.  Data were collected using an Axopatch 2A 
patch clamp amplifier, Digidata 1440, and pClamp 10.2 software (Axon Instruments).  Whole-
endolysosome currents were digitized at 10 kHz and filtered at 2 kHz.  All experiments were 
conducted at RT (21–23 ºC), and all recordings were analyzed with pClamp 10.2, and Origin 8.0 
(OriginLab, Northampton, MA) 
Chemicals and reagents 
The PIKfyve inhibitor YM201636 was purchased from Symansis.  Mouse anti-Lamp1 
antibody was purchased from the Developmental Studies Hybridoma Bank (1D4B).  Monoclonal 
anti-GST antibody was purchased from Sigma (G1160). 
Data analysis 
Statistical data are presented as the mean ± standard error of the mean (SEM).  The 
quantifications shown in figures were performed for a total number (n) of individual cells for 
each group from at least three independent experiments.  Statistical comparisons were made with 
a Student’s t-test.  Asterisks in the figures generally represent P values < 1 × 10-5. P value < 0.01 






Fig. 5.1 Generation of the ML1N*1 and ML1N*2 probe 
(a) Two copies of the cytosolic N-terminal segments of TRPML1 (underlined with black color) 
were fused with either GFP or mCherry. Amino acid residues (R42-44, K55, R57, R61, K62, in 
magenta) were mutated in the ML1N-7Q*2 construct; R61 and K62 were mutated in the ML1N-
2A*2 construct (magenta bold). Blue columns denote α-helices predicted by the PSIPRED 
software. (b) Purified GST-GFP-ML1N*2 proteins bound to PI(3,5)P2-containing liposomes (65% 
PC, 30% PE, and 5% PI(3,5)P2) with a Kd of 5.6 μM. No significant binding was observed for 
control liposomes with 70% PC and 30% PE. (c) GST-GFP-ML1N*2 selectively binds to 
PI(3,5)P2 in a lipid strip assay. The lipid strip contained 15 different types of lipids including all 
seven phosphoinositides. The purified GST-GFP-ML1N*2 proteins were used to probe the strip. 
Proteins bound to the strip were detected using anti-GST antibodies. LPA: lysophosphatidic acid; 
LPC: lysophosphocholine; PI: phosphatidylinositol; PE: phosphatidylethanolamine; PC: 
phosphatidylcholine; S1P: sphingosine-1-phosphate; PA: phosphatidic acid; PS: 
phosphatidylserine. (d) Purified GST-GFP-ML1N*2 proteins exhibited strong binding to 
PI(3,5)P2-conjugated agarose beads, but weak or no binding to beads conjugated with PI(3)P, 
PI(5)P, or PI(4,5)P2. Beads were diluted to a final concentration of 500 nM respective 
phosphoinositide, and incubated with purified GST-GFP-ML1N*2 protien for 2 hours. Proteins 
bound to beads were washed thoroughly and visualized by western blot with anti-GST antibodies. 
(e) Cos1 cells were co-transfected with GFP-ML1N*1 and Lamp1-mCherry, and images 24 




Fig. 5.2 Co-localization of the ML1N-based PI(3,5)P2 probe with endolysosomal markers. 
(a) Purified GST-GFP-ML1N*2 proteins bound strongly to PI(3,5)P2-containing liposomes, but 
not to liposomes containing PI(3)P, PI(5)P, or PI(4,5)P2.  Liposomes, diluted to a final 
concentration of 20 μM total lipids with 1 μM tested phosphoinositide, were incubated with 
purified GST-fusion proteins for 20 min, centrifuged, and visualized by western blot with GST 
antibodies.  (b) GFP-ML1N*2 exhibited a vesicular location and significant co-localization with 
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Lamp1-mCherry. Confocal images were taken 24 hours post-transfection in Cos1 cells that were 
co-transfected with Lamp1-mCherry and GFP-ML1N*2. (c) Charge-neutralizing mutations in 
the phosphoinositide-interacting domain (TRPML1-7Q and TRPML1-2A) selectively impaired 
or abolished the activation of TRPML1 by PI(3,5)P2 (1 µM) in the whole-endolysosome 
configuration. In contrast, ML-SA1 readily activated wild-type (WT) TRPML1, TRPML1-7Q, 
and TRPML1-2A in the same endolysosomes. (d) The localization of the ML1N*2 probe to 
vacuolar membranes was dependent on the basic residues in its phosphoinositide-interacting 
domain. Both ML1N-7Q*2 and ML1N-2A*2 displayed a diffuse, cytosolic localization pattern. 
(e) Quantification of the co-localization index between ML1N*2 and Lamp1 (see Methods for 
the algorithm that was used to analyze the co-localization). (f) Co-localization of GFP-ML1N*2 
with LysoTracker (red) in Cos1 cells. (g) Co-localization of GFP-ML1N*2 with endogenous 
Lamp1 (recognized by a Lamp1 antibody) in MEF cells. (h-k) Co-localization analyses between 
ML1N*2 and other fluorescently tagged endolysosomal proteins/markers in Cos1 or MEF cells 
that were transfected with the indicated constructs for 24 hours. (h) Co-localization of mCherry-
ML1N*2 with the early endosomal marker GFP-EEA1. (i) Co-localization of ML1N*2 with the 
PI(3)P probe GFP-Hrs-FYVE*2. (j) Co-localization of ML1N*2 with YFP-PIKfyve.  (k) 
Quantitative analyses revealed that ML1N*2 exhibited various degrees of co-localization with 
YFP-PIKfyve, GFP-FYVE*2, and GFP-EEA1. Error bars represent SEM. The asterisk indicates 





Fig. 5.3 vacuolar localization of the ML1N*2 probe is independent of cell type and 
fluorescent tag. 
(a) Significant co-localizations between GFP-ML1N*2 and Lamp1-mCherry were observed in 
various cell types, including MEF (upper panels), CHO (middle panels), and HEK293T (lower 
panels). (b) Co-localization between mCherry-ML1N*2 and Lamp1-GFP in Cos1 cells. Scale 





Fig. 5.4 Lysosomal localization of the GFP-ML1N*2 probe is sensitive to YM 201636 
treatment in NIH3T3 cells. 
NIH3T3 cells were co-transfected with GFP-ML1N*2 and Lamp1-mCherry plasmids. Cells were 
treated with 1.6 μM YM201636 for the indicated lengths of time or DMSO for 3 hours or 24 
horus. GFP-ML1N*2 dissociated from Lamp1-mCherry positive compartments after YM 201636 
treatment. In a subset of cells, patchy PM localization (arrow heads) and few GFP-positive 




Fig. 5.5 Genetically or pharmacologically induced drops in PI(3,5)P2 levels diminish or 
abolish the vesicular localization of the ML1N*2 probe. 
(a) GFP-ML1N*2- and Lamp1-mCherry-transfected COS1 cells were treated with YM201636 
(800 nM) overnight prior to confocal imaging analysis. Though Lamp1-positive compartments 
were dramatically enlarged, the GFP-ML1N*2 probe was primarily localized to the cytosol, and 
was not found on enlarged vacuolar membranes.  (b) The vesicular localization of the mCherry-
ML1N*2 probe was significantly reduced in cells co-transfected with the Fab1-DN construct. 
Images were taken 24 hours post-transfection. (c) YM201636 treatment resulted in a progressive 
decrease in ML1N*2’s co-localization with Lamp1. Washout of the drug in the culture medium 
led to a complete recovery of the co-localization. (d-f) The ML1N*2 probe exhibited an apparent 
vesicular localization pattern in WT (d), but not in Vac14-/- (e) or Fig4-/- (f) MEF cells. (g) The 
colocalization index between ML1N*2 and Lamp1 was significantly reduced in Vac14-/- and 




Fig. 5.6 Inhibition of PI(3,5)P2 synthesis reduces the co-localization between the PI(3)P and 
PI(3,5)P2 probes. 
(a) Cos1 cells were cotransfected with the PI(3)P probe GFP-Hrs-FYVE*2 and mCherry-
ML1N*2, and were then treated with YM 201636 for 3 hours (upper panel) or overnight (lower 
panel). (b) The colocalization index between GFP-Hrs-FYVE*2 and mCherry-ML1N*2 was 
reduced by YM 201636 treatment for 3 hours (23.7% ± 4.2%) or overnight (8.9% ± 2.2%), when 
compared with non-treated cells (64.6% ± 2.9%). Error bars represent SEM. The asterisk 





Fig. 5.7 Detection of endogenous PI(3,5)P2 in fixed cells using exogenously-applied purified 
GST-GFP-ML1N*2 proteins. 
(a, b) Lamp1-mCherry-transfected Cos1 cells or fibroblasts were treated without (a) or with (b) 
1 μM YM 201636 for 30 min, fixed, blocked, and then incubated with exogenously-applied 
purified GST-GFP-ML1N*2 protein (see Methods).  GFP fluorescence showed clear co-
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localization with Lamp1-mCherry in (a).  Cells treated with YM 201636 exhibited mostly diffuse 





Fig. 5.8 Endolysosomal PI(3,5)P2 levels are regulated by serum-derived factors. 
(a) In Cos1 cells dually transfected with GFP-ML1N*2 and Lamp1-mCherry, serum starvation 
induced a progressive reduction in the co-localization of ML1N*2 and Lamp1. Re-addition of 
complete medium rapidly (< 2 hours) restored the high degree of co-localization. (b) Serum-
dependent co-localization of the ML1N*2 probe and Lamp1. Error bars represent SEM. The 




Fig. 5.9 Elevated PI(3,5)P2 levels in LELs immediately prior to membrane fusion LELs. 
(a-c) Time-lapse live imaging of Cos1 cells that were dually transfected with GFP-ML1N*2 and 
Lamp1-mCherry. (a) Image of a Cos1 cell immediately before membrane fusion between two 
Lamp1-positive vacuoles occurred (highlighted in the white box). (b) Time-dependent changes 
in the fluorescence intensities of GFP and mCherry for the selected region (white box, panel a). 
(c) Series of images of the selected region at corresponding time points as in (b). One fusion 
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event between two vacuoles occurred between 1 min and 1 min 15 sec. (d. e) GFP-ML1N*2 and 
Lamp1-mCherry dually transfected Cos1 cells were treated with Acetate Ringer’s solution for 30 
min and then subjected to live imaging for 5-20 minutes after returning to normal medium. 
Approximately half of the vacuoles (d) exhibited a significant increase in their membrane 
PI(3,5)P2 before fusion, whereas the other half had little or no changes, but had higher membrane 
PI(3,5)P2 to begin with. The fluorescent intensity of GFP-ML1N*2 was normalized to the 
cytosolic intensity at time 0, and two representative traces are shown; the vertical dotted line 
indicates the time when the fusion took place. The cytosolic intensity of the probe remained 
relatively constant over the time period of the live imaging experiment. Scale bars = 10 μm (for a) 





Conclusions and Future Directions 
 
6.1 Conclusions 
The goal of the study was to examine the possible roles of TRPML1 in regulating aspects 
of lysosome membrane trafficking apart from membrane fusion. The main aims focused on two 
aspects: lysosome motility and lysosome membrane fission (i.e. lysosome reformation). 
Results of this study showed clear evidence that TRPML1 regulates the minus-end 
directed motility of lysosomes under conditions with a demand for the perinuclear recruitment of 
lysosomes. Additionally, TRPML1 is also involved in the regulation of lysosome tubulation, a 
process serving as the pre-requisite of lysosome membrane fission (i.e. lysosome reformation). 
The data suggested that the role of TRPML1 in regulating lysosome tubulation is through its 
regulation of lysosome motility. Therefore, my investigation concluded that TRPML1 regulates 
the minus-end directed motility of lysosomes and lysosome tubulation, the latter likely through 
the regulation of motility. 
Results described in Chapters II and III mapped a detailed mechanism of the regulatory 
pathway. First, these results confirmed that the activity of TRPML1 is necessary to drive the 
retrograde migration of lysosomes under acute conditions, and that the effects of TRPML1 
activation were through its Ca2+ release. Second, TRPML1 activation is sufficient to 
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drive the retrograde migration of lysosomes. Third, it was shown that PI(3,5)P2, the 
phosphoinositide serving as an endogenous agonist of TRPML1, is required for the function of 
TRPML1 in retrograde trafficking of lysosomes. Fourth, the calcium-binding and TRPML1-
interacting protein ALG-2 was shown to be the direct downstream target of TRPML1, and that 
its function requires the interaction with TRPML1. Moreover, the function of ALG-2 is to 
interact with dynamitin, a member of the dynactin complex, to recruit dynein to the lysosomes. 
Therefore, PI(3,5)P2, TRPML1, ALG-2, and dynactin serve as a complete pathway for lysosomal 
recruitment of the dynein complex to initiate retrograde transport of lysosomes. 
My data also showed that TRPML1 regulates lysosome motility through a different 
pathway than the previously characterized Rab7-RILP pathway. Why do the cells need two 
different pathways to regulate the minus-end motility of lysosomes? My results agree with the 
hypothesis that the Rab7-RILP pathway is required for the constitutive housekeeping retrograde 
movement of lysosomes for daily functions, while the TRPML1-ALG-2 pathway is required as 
an emergency plan, being activated under abnormal conditions such as cellular starvation or 
cytosolic alkalization. This is in accordance with the nature of the key regulators for the two 
pathways. Two key regulators for the constitutive pathway are Rab7 and cholesterol, one turns 
on RILP while the other recruits ORP1L. Cholesterol is present on plasma membranes and in 
liposomes, both of which get into early endosomes, late endosomes and lysosomes through 
endocytosis. Therefore, the promotion effect of cholesterol on the retrograde transport of 
lysosomes (probably endosomal vesicles of earlier stages as well) is beneficial for the fate-
determination of endocytic vesicles. However, the amount of cholesterol on lysosomal 
membrane is unlikely able to change rapidly, rendering it unfit for regulations towards acute 
conditions. Similar problems exist for Rab7, which is a key regulator of late endosome and 
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lysosome metabolism, and tends to be present on the LEL membrane all the time. Therefore, the 
cell needs a mechanism to be able to activate and inactivate quickly, and be able to respond to 
signaling cues in a timely fashion. TRPML1 is a Ca2+ permeable, lysosomal TRP channel, and a 
key feature for TRP channels is their ability to serve as sensors for various conditions, including 
heat, cold, taste, and so on, all of which are temporally transient signals. Therefore, TRPML1 is 
well suited for the lysosomal sensing of acute signaling cues. 
The FRAP assay suggested that under TRPML1 activation, or starvation, the up-
regulation of the retrograde transport of lysosomes is not as dramatic as some well-known 
channel-regulated processes (e.g. synaptic release), only doubling the amount of the resting state. 
This may serve biological purposes, as it may not be beneficial to have the movement of 
lysosomes too synchronized. One reason is that the many lysosomes inside the cells have 
multiple tasks, and thus would require the position of lysosomes to be more cautiously regulated. 
Another reason is that transport of additional lysosomes exceeding the needs would be energy-
inefficient, as directional transport of vesicles consumes a lot of ATPs. Therefore, it makes sense 
that the up-regulation of lysosome transport towards any direction would not go crazy under any 
conditions.  
But how does the cell achieve this mild up-regulation of vesicle movement? There are 
several possibilities. First, motor proteins have a characteristic called processivity, which means 
a motor protein can only walk along the microtubule for a limited number of strides before it 
falls off the microtubule due to the random event that both of its heads detach from the 
microtubule during a stride. Therefore, processive motor proteins, including cytoplasmic dynein, 
can only walk along a track for a short distance, while non-processive motor proteins such as 
myosin II detaches from the track after each stride. This nature of motor proteins ensures that a 
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vesicle won’t be carried by a single motor protein for more than a couple of seconds, allowing 
for more accurate manipulation of the position of vesicles. Second, lysosomes, unlike the 
extracellular space, have a very limited amount of Ca2+ within its lumen. Assuming a 1 mM free 
Ca2+ concentration (Wang, Zhang et al. 2012) in the lumen of a 1 μm3 lysosome (which is larger 
than normal lysosomes under fed conditions), this would mean about 600,000 free Ca2+ in the 
lumen of the lysosome. Provided that the single channel conductance of TRPML1 was measured 
to be tens of pico-Siemens (pS) (Dong, Cheng et al. 2008), and the driving force for Ca2+ 
assuming 1 mM luminal and 100 nM cytosolic Ca2+ concentration would be at least 100 mV 
across the lysosomal membrane, a single channel theoretically can deplete the luminal free Ca2+ 
in less than 0.1 second. Therefore, each Ca2+ release event through activated TRPML1 won’t last 
for a long time before it depletes the luminal Ca2+. Thus, the Ca2+ release conducted by TRPML1 
on the lysosome membrane is most likely only intermittent, allowing moderate up-regulation of 
the retrograde motility of lysosomes. 
The involvement of TRPML1 in the regulation of lysosome reformation appeared to be 
more complicated, as both inhibition and hyper-activation of TRPML1 lead to the abolishment of 
lysosome tubulation, a prerequisite and platform for lysosome reformation. This result can be 
explained by a model in which TRPML1 mediates the retrograde motility of the lysosome, 
coordinating with the plus-end motility on the other end (i.e. one end on the vesicular part of 
lysosomes, the other on the tip of the tubular structure) to elongate and maintain the tubular 
structure. This model is supported by the fact that motor proteins responsible for the motility in 
both directions, i.e. both dyneins and kinesins, are indispensable for the tubulation process. One 
experiment to further test this hypothesis is to monitor the lysosome tubulation in ALG-2 KO 
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cells. If the model is true, ALG-2 KO cells should show abolished tubulation similar to that 
observed with acute inhibition of TRPML1. 
What is the trigger for tubulation under different conditions? It is possible that tubulation 
has multiple triggers, but a simpler explanation is that the direct trigger can be the same, but 
different conditions arrive at the same signals to trigger the tubulation. Three things are required 
for the tubulation: plus-end motility, minus-end motility, and neck restriction, the latter 
responsible for separating the vesicular domain from the tubular domain. It is possible that 
lysosome tubulation is an autonomous process. When all three criteria are fulfilled, i.e. balanced 
plus-end and minus-end directed motor proteins are present on the same lysosome, and they are 
separated by a neck restriction mechanism. TRPML1 is shown in this study to be responsible for 
the tubulation in all conditions, likely through the up-regulation of the minus-end motility. 
Activation of mTORC1 was shown previously to be responsible for the autophagic tubulation 
(Yu, McPhee et al. 2010). I have also shown that mTOR activity is required for tubulation in 
activated macrophages (Chapter IV). Provided the previous report that mTOR activity is directly 
correlated with kinesin-1 activity (Korolchuk, Saiki et al. 2011), it is possible that mTOR activity 
is required in the tubulation process for proper plus-end directed motility. Sorting nexins are a 
class of BAR-domain containing proteins that can sense/stabilize membrane curvature, and were 
shown to participate in the generation and stabilization of tubular structures on early endosomes 
(Carlton, Bujny et al. 2004, Cullen 2008). Provided the similarities between lysosomal tubulation 
and early endosomal tubulation, sorting nexins may be responsible for the generation and 
stabilization of lysosomal tubules.  
My data suggest that the effects of TRPML1 activation/inhibition on lysosome 
distribution and tubulation are very acute, with the FRAP assay showing the up-regulation of 
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retrograde transport within a couple of minutes, and with treatments of agonists/antagonists all 
showing significant effects within an hour. Moreover, the identification of ALG-2 and its 
interaction with the dynactin complex suggest that TRPML1 is indeed able to act directly on the 
retrograde transport machinery. My data, however, do not eliminate the possibility that apart 
from the acute effects, TRPML1 may also affect lysosome distribution and tubulation through 
secondary effects, such as up-regulation of lysosome activity (Wang, Gao et al. 2015), up-
regulation of lysosomal gene expression (Medina, Di Paola et al. 2015), etc. Potentially, these 
secondary effects may affect lysosome distribution and tubulation in a long-term basis.  
The similar phenotypes of short-term activation of TRPML1 and the long-term 
inhibition/loss of TRPML1 on lysosome pattern is something to pay attention to. This, as shown 
by the results in Chapter II, is most likely caused by the fact that two different pathways promote 
retrograde transport of lysosomes. One is the TRPML1-ALG-2 pathway, which is activated on-
demand. The other is the previously known Rab7-RILP pathway, which is responsible for the 
routine retrograde trafficking of lysosomes. Under long-term loss of TRPML1 activity, 
cholesterol accumulation occurs in lysosomes, which boosts up the routine retrograde transport 
of lysosomes through the Rab7-RILP pathway. It is worth noting that the cholesterol 
accumulation seems to be independent of the positioning of lysosomes, because dynein 
inhibition, which dissipated lysosomes to the peripheral regions of the cell, did not rescue the 
accumulation of cholesterol in ML1KO fibroblasts. Also, overexpression of TRPML1 wild-type 
and TRPML1-R44/A, the ALG-2 non-interacting mutant channel, both rescued the accumulation 
of cholesterol, but showed opposite distribution of lysosomes.  
Due to the similar effects on lysosome distribution and minus-end motility with short-
term TRPML1 activation and long-term inhibition, it is clear that results obtained through 
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chronic inhibition or loss of TRPML1 must be interpreted with care. For example, it must be 
considered and tested whether an effect seen with long-term inhibition of TRPML1 is through 
the loss of TRPML1 activity itself, or through the secondary accumulation of cholesterol, or 
other substances. One easy way to do this is to use the small molecule inhibitors, which allow 
acute manipulation of TRPML1 activity to be possible. 
In Chapter V, I characterized a genetically-encoded fluorescent probe for the detection of 
intracellular PI(3,5)P2. The generation of a PI(3,5)P2 specific probe is an important step towards 
the understanding about this phosphoinositide. Previously, PI(3,5)P2 was proposed to localize to 
late-endosomes and lysosomes based on its synthesizing enzyme’s localization and the 
localization of most of its identified effectors, but was never proven, as previous methods to 
measure intracellular PI(3,5)P2 were based on HPLC, without providing any information about 
the intracellular localization about the lipid. With the development of a fluorescent probe to 
identify intracellular localization and dynamics, I was able to show for the first time that 
PI(3,5)P2 is indeed localized on late-endosomes and lysosomes, and that it is important for 
lysosome fusion. 
Several reports from other groups utilizing this probe were already published (Samie, 
Wang et al. 2013, McCartney, Zolov et al. 2014, Hong, Qi et al. 2015, Vicinanza, Korolchuk et 
al. 2015), within two years of its generation. It is obvious that the probe showed its unique 
advantage against the previously-utilized HPLC method. The probe was able to visualize the 
increased PI(3,5)P2 levels on lysosomes close to phagocytic cup prior to lysosome exocytosis 
(Samie, Wang et al. 2013), the synaptic activity-dependent increase of PI(3,5)P2 levels in the 
dendrites (McCartney, Zolov et al. 2014), and the localization of PI(3,5)P2 on autophagosomes 
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(Vicinanza, Korolchuk et al. 2015), none of which could be determined with conventional 
methods. 
Although powerful, the probe is not yet perfect, mainly due to one existing problem about 
its apparent slow drop-off rate after PI(3,5)P2 depletion, which was also pointed out in a recently 
published Plos One paper (Hammond, Takasuga et al. 2015). The in vitro binding assays and the 
loss of co-localization with the mutant probes all suggested specificity of this probe to PI(3,5)P2. 
However, it is noticeable that the probe drops off LEL membranes slower than HPLC data would 
predict under PI(3,5)P2 depletion conditions such as YM 201636 treatment and serum starvation, 
both conditions showed to rapidly reach maximal PI(3,5)P2 depletion within the first 30 min of 
treatment (Jefferies, Cooke et al. 2008, Zolov, Bridges et al. 2012). One possibility is that the 
probe was able to protect PI(3,5)P2 from hydrolysis through binding to it, making it inaccessible 
to hydrolytic enzymes. Another possibility is that the binding to PI(3,5)P2 results in 
conformational changes in the probe, making it either able to interact with additional binding 
partners, or able to expose hydrophobic domains facilitating its hydrophobic interaction with the 
membrane. 
 
6.2 Future directions 
A crystal structure of TRPML1 is still unavailable. Therefore, it is unknown to this point 
how exactly ML1N binds to PI(3,5)P2. Without such knowledge, it may prove difficult to 
improve the ML1N-based PI(3,5)P2 probe. Further utilization of the probe in researches 
involving PI(3,5)P2, however, can be expected to increase. 
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The finding of the regulation of retrograde motility of lysosomes through TRPML1 is a 
big step towards understanding the functions of TRPML1, as well as understanding the 
metabolism around the lysosomes. 
One immediate follow-up experiment is to find the motif through which ALG-2 interacts 
with dynamitin. This would enable the generation of mutants with decreased or increased 
lysosome retrograde trafficking under autophagy induction, or other acute circumstances. It is 
also worth examining the possible role of ALG-2 in regulating ER-to-Golgi transport, as ALG-2 
also interacts with Sec31A, a protein found on the transport vesicle membranes (Shibata, Suzuki 
et al. 2007, Helm, Bentley et al. 2014). 
The hypothesis that TRPML1’s regulation on lysosome tubulation is simply through its 
manipulation of lysosome motility is not directly evidenced at this point. It is clear that 
manipulation of TRPML1’s activity can mess up the balance between the plus-end and the 
minus-end motility, which apparently is important in the maintenance of the tubular structure, 
the existence of which naturally would require two opposite forces. It is not tested, however, if 
TRPML1 is required for the tubulation in more than just affecting motility. For example, it 
remains to be tested if TRPML1 also participates in the final fission step, as suggested by results 
from a recent study (Miller, Schafer et al. 2015).  
The identification of TRPML1’s function in lysosome motility, as well as the 
identification of the cause of the ML1KO lysosome distribution phenotype, also has important 
implications in the clinics. It is expected, for example, that pharmacological depletion of 
cholesterol can rescue some of cellular phenotypes seen with MLIV patients similar to NPC 
patients. In other circumstances such as aging-related neurodegeneration diseases, temporally-
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controlled boosting of TRPML1 activity may help clearing accumulated toxic substances 
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